<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3331556</id>
	<title>Embryology - User contributions [en-gb]</title>
	<link rel="self" type="application/atom+xml" href="https://embryology.med.unsw.edu.au/embryology/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Z3331556"/>
	<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Special:Contributions/Z3331556"/>
	<updated>2026-08-23T05:21:46Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.39.10</generator>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=79679</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=79679"/>
		<updated>2011-10-27T04:46:07Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 20 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The septum primum is formed from out growth of membranous tissue from the roof of the atrium, it originates from myocardium which differentiates from the splanchnic mesoderm. The strong, muscular septum secundum grows immediately to the right of the septum primum and develops from left-sided mesenchyme. [[Intermediate - Atrial Ventricular Septation]] &lt;br /&gt;
&lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
*Pulmonary stenosis&lt;br /&gt;
*Transposition of the Great Vessels&lt;br /&gt;
*Aortic Stenosis&lt;br /&gt;
*Coarctation of the Aorta&lt;br /&gt;
*Interrupted Aortic Arch&lt;br /&gt;
[[Advanced - Abnormalities]]&lt;br /&gt;
&lt;br /&gt;
==Lab 12==&lt;br /&gt;
&lt;br /&gt;
'''1. Give examples of 3 systems that continue to develop postnatally.'''&lt;br /&gt;
&lt;br /&gt;
Three systems that continue to develop postnatally include:&lt;br /&gt;
*Respiratory system- with the maturation of alveoli  &lt;br /&gt;
*Nervous System- with the continued growth of the brain&lt;br /&gt;
*Urinary system- Maturation stage of nepheron continues postnatally&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the abnormalities detected by the Guthrie Test and link to one abnormality listed in OMIM.''' &lt;br /&gt;
&lt;br /&gt;
The abnormalities detected by this test include:&lt;br /&gt;
*Phenylketonuria(PKU)&lt;br /&gt;
*Hypothyroidism [http://omim.org/entry/275200?search=hypothyroidism&amp;amp;highlight=hypothyroidism| OMIM entry #275200: HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1]&lt;br /&gt;
*Cystic Fibrosis&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78794</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78794"/>
		<updated>2011-10-20T01:19:55Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Attendance */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 20 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The septum primum is formed from out growth of membranous tissue from the roof of the atrium, it originates from myocardium which differentiates from the splanchnic mesoderm. The strong, muscular septum secundum grows immediately to the right of the septum primum and develops from left-sided mesenchyme. [[Intermediate - Atrial Ventricular Septation]] &lt;br /&gt;
&lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
*Pulmonary stenosis&lt;br /&gt;
*Transposition of the Great Vessels&lt;br /&gt;
*Aortic Stenosis&lt;br /&gt;
*Coarctation of the Aorta&lt;br /&gt;
*Interrupted Aortic Arch&lt;br /&gt;
[[Advanced - Abnormalities]]&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78673</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78673"/>
		<updated>2011-10-19T07:42:11Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Lab 11 */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The septum primum is formed from out growth of membranous tissue from the roof of the atrium, it originates from myocardium which differentiates from the splanchnic mesoderm. The strong, muscular septum secundum grows immediately to the right of the septum primum and develops from left-sided mesenchyme. [[Intermediate - Atrial Ventricular Septation]] &lt;br /&gt;
&lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
*Pulmonary stenosis&lt;br /&gt;
*Transposition of the Great Vessels&lt;br /&gt;
*Aortic Stenosis&lt;br /&gt;
*Coarctation of the Aorta&lt;br /&gt;
*Interrupted Aortic Arch&lt;br /&gt;
[[Advanced - Abnormalities]]&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78672</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78672"/>
		<updated>2011-10-19T07:41:28Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Lab 11 */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The septum primum is formed from out growth of membranous tissue from the roof of the atrium, it originates from myocardium which differentiates from the splanchnic mesoderm. The strong, muscular septum secundum grows immediately to the right of the septum primum and develops from left-sided mesenchyme. [[Intermediate - Atrial Ventricular Septation]] &lt;br /&gt;
&lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
*Pulmonary stenosis&lt;br /&gt;
*Transposition of the Great Vessels&lt;br /&gt;
*Aortic Stenosis&lt;br /&gt;
*Coarctation of the Aorta&lt;br /&gt;
*Interrupted Aortic Arch&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78648</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78648"/>
		<updated>2011-10-19T04:18:32Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Lab 11 */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The septum primum is formed from out growth of membranous tissue from the roof of the atrium, it originates from myocardium which differentiates from the splanchnic mesoderm. The strong, muscular septum secundum grows immediately to the right of the septum primum and develops from left-sided mesenchyme. [[Intermediate - Atrial Ventricular Septation]] &lt;br /&gt;
&lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
Pulmonary stenosis&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78645</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=78645"/>
		<updated>2011-10-19T04:08:05Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;br /&gt;
&lt;br /&gt;
==Lab 11==&lt;br /&gt;
&lt;br /&gt;
'''1. Name the components that give rise to the interatrial septum and the passages that connect the right and left atria.'''&lt;br /&gt;
&lt;br /&gt;
The components that give rise to the interatrial septum are &lt;br /&gt;
The passages that connect the right and left atria are: the foramen secundum, which is the opening of the septum primum and the foramen ovale, the opening of the septum secundum. [http://embryology.med.unsw.edu.au/embryology/images/4/45/ANAT2341_2011_Heart_Dunwoodie.pdf]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the cardiac defects that arise through abnormal development of the outflow tract'''&lt;br /&gt;
&lt;br /&gt;
Pulmonary stenosis&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=77860</id>
		<title>User:Z3331556</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=User:Z3331556&amp;diff=77860"/>
		<updated>2011-10-13T02:39:27Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Attendance */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Attendance==&lt;br /&gt;
--Z3331556 12:55, 28 July 2011 (EST)&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:57, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:14, 11 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:30, 25 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:52, 15 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:36, 22 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 11:05, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 6 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:59, 13 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Lab 1==&lt;br /&gt;
'''1. Identify the origin of In Vitro Fertilization and the 2010 nobel prize winner associated with this technique.'''&lt;br /&gt;
&lt;br /&gt;
The first successful IVF occurred in the UK in 1978 and Robert G. Edwards was awarded the Nobel Prize for this technique in 2010.[[Lecture - 2011 Course Introduction]]&lt;br /&gt;
 &lt;br /&gt;
'''2. Identify a recent paper on fertilisation and describe its key findings.'''&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Improved pregnancy rate with administration of hCG after intrauterine insemination: a pilot study&amp;quot; by Ilkka Y Järvelä, Juha S Tapanainen and Hannu Martikainen. Published on 23 February 2010 by Reproductive Biology and Endocrinology journal. &lt;br /&gt;
They found that Intrauterine insemination (IUI), a common fertility treatment, improved pregnancy rate when hCG (human chorionic gonadotrophin)was administered after instead of before IUI. Pregnancy rates were 10.9% when hCG was given before IUI and 19.6% when hCG was given after IUI.[http://www.rbej.com/content/8/1/18]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 2 congenital anomalies.'''&lt;br /&gt;
 &lt;br /&gt;
-Trisomy 21 (Down Syndrome) occurs when an extra copy of chromosome 21 is present&lt;br /&gt;
&lt;br /&gt;
-Myelodysplasia (Spina bifida) is a condition where the fetus' spin fails to close in the first few months of pregnancy&lt;br /&gt;
&lt;br /&gt;
--[[User:S8600021|Mark Hill]] 10:10, 3 August 2011 (EST) These answers are fine.&lt;br /&gt;
&lt;br /&gt;
==Lab 2==&lt;br /&gt;
'''1. Identify the ZP protein that spermatozoa binds and how is this changed (altered) after fertilisation.''' &lt;br /&gt;
&lt;br /&gt;
The ZP protein that spermatozoa binds to is ZP3, when this occurs an Acrosome Reaction results where the head of the spermatozoa releases enzymes from the acrosomal vesicle (via exocytosis) which digests this protective coating of the egg (ZP3)[http://www.ncbi.nlm.nih.gov/books/NBK26843/figure/A3741/] and exposes ZP2 to surface proteins of sperm [[Lecture - Fertilization]] &lt;br /&gt;
&lt;br /&gt;
'''2.Identify a review and a research article related to your group topic.'''&lt;br /&gt;
&lt;br /&gt;
'''PRIMARY ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
==Lab 3==&lt;br /&gt;
&lt;br /&gt;
'''1. What is the maternal dietary requirement for late neural development?'''&lt;br /&gt;
&lt;br /&gt;
Iodine is an important maternal dietary requirement for late neural development as a severe deficiency of this mineral during pregnancy seriously influences fetal brain development and in the worst case leads to cretinism, a decreased thyroid hormone production that has multiple complications. Recent studies have shown that even a mild iodine deficiency during pregnancy and during the first years of life adversely affects brain development. The World Health Organisation (WHO) considers iodine deficiency as the most common preventable cause of early childhood mental deficiency.[http://www.ncbi.nlm.nih.gov/pubmed/20665419] [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002174/]&lt;br /&gt;
&lt;br /&gt;
'''2. Upload a picture relating to you group project. Add to both the Group discussion and your online assessment page. Image must be renamed appropriately, citation on &amp;quot;Summary&amp;quot; window with link to original paper and copyright information. As outlined in the Practical class tutorial.''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Differentially expressed RefSeq genes in human trisomy 21.jpg|thumb|Differentially expressed RefSeq genes in human trisomy 21]]&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Lab 4==&lt;br /&gt;
&lt;br /&gt;
'''1. The allantois, identified in the placental cord, is continuous with what anatomical structure?'''&lt;br /&gt;
&lt;br /&gt;
The allantois of the placental cord is an extra-embryonic membrane, that originates from the endodermal layer of the trilaminar embryo and extends from the early hindgut. [[Placenta Development]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''2. Identify the 3 vascular shunts, and their location, in the embryonic circulation'''&lt;br /&gt;
&lt;br /&gt;
* Ductus venosus - between the umbilical vein and the inferior vena cava&lt;br /&gt;
* Foramen ovale - between the right and left atrium&lt;br /&gt;
* Ductus arteriosus - between the pulmonary artery and descending aorta &lt;br /&gt;
&lt;br /&gt;
These shunts redirect oxygenated blood away from the lungs, liver and kidneys as these major organ's functions are run by the placenta at this point of the fetus' development [[Intermediate - Vascular Overview]]&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
'''3. Identify the Group project sub-section that you will be researching '''&lt;br /&gt;
&lt;br /&gt;
'''Introduction'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''History of the disease'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Etiology&lt;br /&gt;
&lt;br /&gt;
Diagnosis&lt;br /&gt;
&lt;br /&gt;
'''Genetic Factors''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Physical Characteristics&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Associated medical conditions&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Problems&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Epidemiology&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Management/treatment&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Specialized Facilities/ supportive associations&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Case studies'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Interesting facts'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Current research and developments'''&lt;br /&gt;
&lt;br /&gt;
==Lab 5==&lt;br /&gt;
&lt;br /&gt;
'''1. Which side (L/R) is most common for diaphragmatic hernia and why?''' &lt;br /&gt;
&lt;br /&gt;
Approximately 70 to 90% of Diaphragmatic hernias are 'Bochdalek-type,' or posterolateral hernias, most often occurring on the left posterolateral side. This is because the left pleuro-peritoneal canal is larger than the right, and therefore closing of this side occurs slightly later, hence more chance of hernia occurring on this side. [http://omim.org/entry/142340] [http://staff.um.edu.mt/acus1/Respiratory.pdf]&lt;br /&gt;
&lt;br /&gt;
==Lab 6==&lt;br /&gt;
&lt;br /&gt;
'''1. What week of development do the palatal shelves fuse?'''&lt;br /&gt;
&lt;br /&gt;
The palatal shelves fuse in week 9 of development. This process requires the a growth and elevation of the palatal shelves before fusing in the midline [[Lecture - Head Development]]&lt;br /&gt;
&lt;br /&gt;
'''2. What animal model helped elucidate the neural crest origin and migration of cells?'''&lt;br /&gt;
&lt;br /&gt;
Chicken embryo model. Neural crest development has been best studied in avian embryos as they can be subject to &amp;quot;surgical manipulation, cell marking techniques, cell culture, and transgenesis by electroporation and retrovirally mediate gene transfer&amp;quot; [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/u46w7212h56h6m1g/#section=86104&amp;amp;page=2&amp;amp;locus=0] &lt;br /&gt;
&lt;br /&gt;
'''3. What abnormality results from neural crest not migrating into the cardiac outflow tract? '''&lt;br /&gt;
&lt;br /&gt;
Cranial neural crest cells extending from the auditory placode to somite 3 migrate to the outflow tract of the heart to participate in aorticopulmonary and truncal septation in the chick embryo. Surgical removal of these premigratory cells results in a high incidence of&lt;br /&gt;
persistent truncus arteriosus [http://circ.ahajournals.org/content/75/1/255.full.pdf]&lt;br /&gt;
Failure of the outflow septum to form results in persistent truncus arteriosus, a condition in which there is a single outflow vessel with a single valve. [http://circres.ahajournals.org/content/77/2/211.full]&lt;br /&gt;
&lt;br /&gt;
==Lab 7==&lt;br /&gt;
&lt;br /&gt;
'''1. Are satellite cells (a) necessary for muscle hypertrophy and (b) generally involved in hypertrophy?'''&lt;br /&gt;
&lt;br /&gt;
Satellite cells are generally involved in muscle hypertrophy but they are not necessary&lt;br /&gt;
&lt;br /&gt;
'''2. Why does chronic low frequency stimulation cause a fast to slow fibre type shift?'''&lt;br /&gt;
&lt;br /&gt;
Chronic Low Frequency Stimulation (CLFS) is a standard, reproducible model of muscle training that parallels the stimulation of slow-twitch muscles by slow motoneurons. This artificial type of nerve innervation induces the sequential transitions in myosin heavy chain (MHC)expression, ultimately resulting in the transition of fast twitch to slow twitch fibres. [http://www.springerlink.com/content/p284hw46x8772683/] Fast-to-slow fibre-type transitions are associated with increases in satellite cell activation, content and fusion to transforming fibres. CLFS stimulates satellite cell proliferation and hence causing a fast to slow fibre type shift. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779649/?tool=pubmed]&lt;br /&gt;
&lt;br /&gt;
'''Trisomy 21 Peer assessment'''&lt;br /&gt;
*hyper-link words to glossary is useful, this should be done for Aneuploidy instead of listing it in the intro&lt;br /&gt;
* Down Syndrome is the historic name used for this condition identified by Down, J.L.H. in a 1866 paper[1] where he described the &amp;quot;phenotypic features that includes mental retardation and characteristic facies&amp;quot;. --this sentence could be incorporated in the opening paragraph so intro can flow better&lt;br /&gt;
*Maybe recent findings could go toward the end, just so we get more of an idea of what the features of Trisomy 21 are first, also quotes directly from the article shouldn't be the main focus of this section, it would be better to summarise the findings in your own words    &lt;br /&gt;
*Some of the images need to be referenced properly, some contain no copyright clearance statement&lt;br /&gt;
*More info needed for Associated Congenital Abnormalities section, not just a list&lt;br /&gt;
*heart defects section has not been referenced, where have the figures come from?, more description of these conditions are needed not just the definition, maybe include what how this abnormality is manifested, also percentages could be better displayed in a table, the same could be done for the limb defects section&lt;br /&gt;
*Image of John Langdon Down appears to be in an odd place, should go around intro when he is mentioned &lt;br /&gt;
*Prevalence could appear toward the beginning, the definition of prevalence could also be a hyper-link to glossary instead of including it in the body of project, might want to include the prevalence of down syndrome in Australia, this may be better formatted in a table&lt;br /&gt;
*American College of Obstetricians and Gynecologists Recommendations section has some good information, however, it may be better to put this under a broader subheading (e.g. management/or diagnosis) maybe a good idea to combine it with Down syndrome screening&lt;br /&gt;
*Screening could also be better formatted in a table with a little more description about how these screenings are conducted&lt;br /&gt;
*Miosis I and II shouldn't really be a heading on its own, maybe better to incorporate it with recent findings. &lt;br /&gt;
*Aneuploidy also should not be a heading on its own this can be included as a glossary term&lt;br /&gt;
*Again a whole section dedicated to growth charts doesn't seem right, good info but could be incorporated into a broader heading&lt;br /&gt;
* I also feel there's info missing from the page, like maybe some the physical characteristics of Trisomy 21 i.e facial abnormalities&lt;br /&gt;
*reference list: i like the idea of splitting up the different kinds of sources used, however this needs to be refined as it is a bit confusing&lt;br /&gt;
&lt;br /&gt;
==Lab 8==&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessments'''&lt;br /&gt;
&lt;br /&gt;
GROUP 1: Turner Syndrome &lt;br /&gt;
*Introduction is informative and well summarised, however a few sentences are a bit lengthy and can be better structured so paragraphs flow easily. e.g. &amp;quot;It is caused by complete or partial X monosomy in some or all cells and occurs in approximately 1 in 2000 live female births, however the morbidity rate of spontaneous abortions is 10% and only about 1% of fetuses survive to term.&amp;quot; can be better structured. In addition there are several spelling mistakes that are distracting e.g. &amp;quot;The affected organ systems and tissues may are effected to a lesser or greater extent amongst that are affected by turner syndrome&amp;quot; - this sentence doesn't make sense at all&lt;br /&gt;
*You may also want to incorporate an image to break up the text in the intro&lt;br /&gt;
*One of the requirements for the group project is to include the history of the disease, the intro contains very minimal background information but besides this there's no evidence of research into how this disease was discovered and developments in its understanding&lt;br /&gt;
*The image beside epidemiology is obstructing the  break up of the introduction and epidemiology, you may want to fix this. This image may also be better if made a little bigger &lt;br /&gt;
*The prevalence is repeated in both intro and epidemiology, maybe just mention it in just one section&lt;br /&gt;
*Epidemiology info is very informative but really needs to be proof read, this lets down the whole section. Some of the sentences contain spelling mistakes and grammar needs to be reviewed e.g. &amp;quot;The phenotype of Turner Syndrome is varies but it involves anomalies of the sex chromosome&amp;quot; and &amp;quot;Turner Syndrome can be transmitted from mother to daughter, and thus can it could be described as a heredity linked syndrome&amp;quot;&lt;br /&gt;
*&amp;quot;The remaining third have structural abnormalities of the X chromosomes, and two thirds are mosaics. Whereby, the maternal X is retained in two-thirds of women and the paternal X in the remainder.&amp;quot; - sentences like this need to be fixed to make more sense &lt;br /&gt;
*Some sentences are also very abrupt and short, could be revised so they flow more&lt;br /&gt;
*The Karyotype image is incorrectly referenced and does not contain the copyright clearance statement, this needs to be fixed &lt;br /&gt;
*The abnormalities graph really needs fixing, not correctly referenced, no copyright clearance statement and title isn't very descriptive&lt;br /&gt;
*I really like how the words relevant to this syndrome are linked to the glossary, this really helps the reader, saving us from having to scroll down to the bottom of the page. This could be applied to the whole page&lt;br /&gt;
*The non-disjunction image is informative but needs to be properly referenced&lt;br /&gt;
*The info in etiology is very informative and comprehensive, but again grammar is a problem e.g. &amp;quot;When an uneven distribution is such that one of the gametes does not have any of a chromosome&amp;quot; -consider revising this sentence&lt;br /&gt;
*The image 22+23=45 could be better placed so that it doesn't overlap into the next section&lt;br /&gt;
*The clinical manifestations section has an extensive list, but could be improved by maybe having a paragraph or two describing these not just a link to a reference, an image of some of these manifestations may also enhance this section&lt;br /&gt;
*The diagnosis section has a good balance of text and image and there is great use of tables. Also the links to the glossary again is helpful&lt;br /&gt;
*maybe consider making the images in the table a little smaller&lt;br /&gt;
*Student drawn images are included and comprehensive&lt;br /&gt;
*Treatment and research sections are succinct and informative, easy to go through&lt;br /&gt;
* I really like the way the glossary is formatted, makes it very easy to access&lt;br /&gt;
*The extensive reference list is impressive and indicative that a lot of research has gone into this page &lt;br /&gt;
  &lt;br /&gt;
Over all:&lt;br /&gt;
*There really needs to be thorough proof reading to correct grammar, better structure your sentences, and generally make better sense of some sentences, this particularly applies to epidemiology section&lt;br /&gt;
*You should also fix the referencing of the images, copyright statements are missing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 2: DiGeorge Syndrome&lt;br /&gt;
*I don't know if the congenital disorder definition is needed in the intro, maybe you can included in the glossary instead&lt;br /&gt;
*The image in the intro could use a legend&lt;br /&gt;
*Info in the intro is comprehensive and informative&lt;br /&gt;
*History section has got good, succinct information and i like the fact that it goes up to 2011, however maybe you can consider putting the timeline in a table. Image could also have a legend &lt;br /&gt;
*Epidemiology has been researched relatively well, info is comprehensive and flows well, however, could be improved with a graph of some sort to accompany info with a visual&lt;br /&gt;
*Etiology contains very descriptive, informative info, could be improved with an image of the chromosome and the area of deletion &lt;br /&gt;
*It would be a good idea if the acronyms are included in the glossary&lt;br /&gt;
*It is evident that the Pathogenesis/Pathophysiology section has been very well researched, maybe the &amp;quot;genes involved in DiGeorge syndrome&amp;quot; section could be formatted in a table&lt;br /&gt;
*The use of a table in Diagnostic tests is succinct and informative. You should check for spelling mistakes (Dianostic Tests is spelt wrong), images to accompany these tests are useful, however, again a legend for each of these would be help&lt;br /&gt;
*Image missing in the Amniocentesis part of diagnosis &lt;br /&gt;
*I don't know if the image link for BACS- on beads technology is really helpful&lt;br /&gt;
*Clinical manifestations has clearly been researched extesively, however, this section is very overwhelming,too much text in my opinion. It would be easier to read if it was summarised more, a graph may be helpful&lt;br /&gt;
*Treatment section is comprehensive and summarised well&lt;br /&gt;
*I have found that incidence has been mentioned in quite a few sections, is this really necessary? Can it just be mentioned in epidemiology?&lt;br /&gt;
*Current and future has got some good info but it is quite lengthy and could be better to summerise it a bit more so u don't lose the reader &lt;br /&gt;
*The last two images need to be referenced properly, with the template and correct referencing  &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*The whole project has been researched very well&lt;br /&gt;
*Some of the images could use legends to describe what they are about and you could also consider moving the images around a bit so there's variety and making some of them a little bigger so their features can be seen&lt;br /&gt;
*Maybe acronyms could be included in the glossary&lt;br /&gt;
*some sections could be reviewed and info could be condensed &lt;br /&gt;
*references need to be reviewed and correctly structured (some work on this is required)&lt;br /&gt;
*You could improve this project by also linking the glossary terms to the text to make it easier to access, also some graphs could be used&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 3: Klinefelter's Syndrome&lt;br /&gt;
*I feel that the introduction is too lengthy, it should be summarised a little more. Although the info is informative, its structure needs some work- grammar and punctuation should be reviewed and sentence structure could be improved&lt;br /&gt;
*Figure 1 could use a more descriptive legend&lt;br /&gt;
*Historical information is ok, maybe could be improved by extending the timeline to a more resent years, also an image wouldn't hurt, just to break up the text a little&lt;br /&gt;
*epidemiology could use some proof reading to correct minor grammar mistakes e.g. &amp;quot;Males born with Klinefelter syndrome often fail to produce sperm, and have very low testosterone levels due to largely to them having small testes&amp;quot;, sentence structure could also be reviewed so this section flows better (some sentences are short, but other than this, this section is informative&lt;br /&gt;
*Incidence is repeated twice, maybe could stick to one section, and it's different in each section (1 in 50 000 or 1 of every 1000 male births?)&lt;br /&gt;
*Aetiology (don't really know what this means), and the subheading &amp;quot;genetics&amp;quot; could be a better choice for the whole section, but info here is informative and understandable &lt;br /&gt;
*I do like the links made in Aetiology, the picture in this section could use a better legend and needs to be referenced properly (no copyright statement?)&lt;br /&gt;
*There is overlapping info in the Aetiology and Pathogenesis sections (both have Non-disjunction as subheading), and both have the same sort of images&lt;br /&gt;
*Table in signs and symptoms is too small should be a lot bigger so detail can be seen, it also needs to be referenced properly&lt;br /&gt;
*The info for signs and symptoms is good in a table, but it would be better if the table had colour so the reader can distinguish each section of the table&lt;br /&gt;
*diagnosis is informative &lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Reference list needs some work, some of the references have been repeated &lt;br /&gt;
*Project could be improved by finalising the glossary and maybe linking the words in the body to the glossary itself&lt;br /&gt;
*Images need to be referenced properly and some need more informative legends  &lt;br /&gt;
*I feel some of the information is a little repetitive, maybe could read through and edit so it flows better &lt;br /&gt;
*subheadings and headings could be reviewed and re-organised so page flows better &lt;br /&gt;
*I do like the feature of links added throughout, maybe more would make it better&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 4: Huntington's Disease&lt;br /&gt;
*Intro has good summary of the disease, however the first paragraph is a little too technical, could you maybe simplify it a little so you don't lose the reader right at the start (reference 5 is missing though)&lt;br /&gt;
*History is succinct and summarised well, i like the quote included, could you have gone a little further with the timeline? (maybe include some of the more recent developments), maybe the timeline could be better formatted in a table&lt;br /&gt;
*Good info from a variety of sources in epidemiology, good use of tables, I like how prevalence has been compared and how the table is explained (one little thing: could you maybe find more statistics for Australia?)&lt;br /&gt;
*Inheritance image needs student template added and maybe made a little bigger so detail can be seen&lt;br /&gt;
*Genetics section is informative but could use an image of the gene maybe&lt;br /&gt;
*Molecular Mechanisms &amp;amp; Pathogenesis section is well researched and good summary is provided. I like how key words have been highlighted. images need fixing (more descriptive legend is needed for the first image and what happened to the second image?&lt;br /&gt;
*I don't think you need to explain what the disease is again in the clinical manifestation segment (don't want to sound repetitive), image in this section isn't very clear, I feel that this section is a tad incomplete-maybe some expansion is needed e.g. classes 2 and 3 could be expanded on more &lt;br /&gt;
*I feel that diagnosis section could go further up? This section is very informative, but could be summarised a little more Some of the images in this section need better explaining, good balance of text and images in this section&lt;br /&gt;
*good use of table in treatment section, however more info could be provided as to how these drugs help the disorder &lt;br /&gt;
*Current/Future Research is very up to date, images here again need more description&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*it is evident that this project has been extensively researched&lt;br /&gt;
*good use of subheadings and headings&lt;br /&gt;
*maybe include the acronyms in the glossary and it would be good if glossary words were linked to text&lt;br /&gt;
*make sure all images include the student template required and legends of some images need to be expanded (more info on what the image is about)&lt;br /&gt;
*fix repetitive sentences&lt;br /&gt;
*good balance of images and text, good use of tables&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 5: Fragile X Syndrome &lt;br /&gt;
*Info in the intro is ok but could be improved by maybe including more of an explanation of the CGG codon (some may not know what a codon is and what this implicates) and a small sentence on FMR1 gene &lt;br /&gt;
*The placement of the two images in the introduction is a bit weird, it disrupts the end of this paragraph. Consider just putting them on the same side or putting one of them in a different section &lt;br /&gt;
*I don't think the first sentence of the history section is history related, looks like it could be better placed in the intro &lt;br /&gt;
*Timeline is ok but could possibly be researched more to include more dates, but it's good that it goes up to 2010&lt;br /&gt;
*I don't know if Screening/Population testing goes under epidemiology, i think it's more part of management/diagnosis &lt;br /&gt;
*Etiology info appears clear and concise, maybe the image of the gene would be better placed in this section&lt;br /&gt;
*I find the section development of disease informative and summarised well. I like the way it's structured (subheadings are fitting), an image could improve this section &lt;br /&gt;
*Signs and symptoms looks like its been researched extensively, info is comprehensive and summarised well, a graph or another image could improve this section and balance out the text &lt;br /&gt;
*Physical phenotype has no referencing (where did this info come from?)&lt;br /&gt;
*Diagnosis is very underdeveloped, a lot more explanation is needed for these diagnostic techniques, images could also help improve this section &lt;br /&gt;
*Treatment is well researched, use of a table here is suitable, however maybe you could break up the writing by splitting up the Treatment Option and Description into two different sections of the table&lt;br /&gt;
*Recent Research is ok, a good intro paragraph may improve this section, maybe provide more recent developments&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*Glossary is incomplete and many words need explaining, consider linking the highlighted words to the glossary as an improvement, also it might be a good idea to include acronyms in the glossary as well &lt;br /&gt;
*legends of images could be expanded a little more &lt;br /&gt;
*Reference list needs some work, I don't think links to websites are the proper way to reference&lt;br /&gt;
&lt;br /&gt;
GROUP 6:Tetralogy of Fallot&lt;br /&gt;
*Info in the intro is succinct and informative but sentence structuring and punctuation lets this down e.g. &amp;quot;These genetic mutations contribute to the four characteristic defects, in the heart of a patient having TOF&amp;quot; - comma is misplaced here &lt;br /&gt;
*&amp;quot;disease that occurs in 3 in every 10000 live births&amp;quot; -consider rephrasing this&lt;br /&gt;
*Intro needs an image to draw attention of reader&lt;br /&gt;
*While I appreciate the sectioning of the history section, i think that a chronological timeline may be more comprehensive for the reader, I feel that some of the dates are all over the place, also the history of this disease seams to stop at 1950s, could you maybe find more recent findings or contributions&lt;br /&gt;
*History images are good but need to be properly referenced and student template is missing from the first image&lt;br /&gt;
*I feel epidemiology section is a little underdeveloped, could you possibly find some more stats and compare incidence in several countries?&lt;br /&gt;
*Signs and symptoms has good info, but i feel that some sections could be expanded more&lt;br /&gt;
*signs and symptoms could use more images to accompany info&lt;br /&gt;
*I like the audio links to the heart signs&lt;br /&gt;
*Genetics/Aetiology section looks like it has been thoroughly researched, i like the structure of how each gene is dealt with, however, this info could be better formatted in a table and summarised a little more (if you are going to include all this technical info make sure it's explained in glossary maybe), also images in this section need better descriptions in the legends&lt;br /&gt;
*Pathophysiology and Abnormalities (I'm not sure if this is the best heading, could maybe be associated conditions or associated abnormalities or even just Cardiac abnormalities), info here is good but could be expanded a little more seeing as cardiac abnormalities seem to be a major manifestation of this anomaly&lt;br /&gt;
*Diagnostic tests section could be better placed further up? appears to have some info missing, and in some parts too much text, maybe could be summarised a little. Images could help break up the text, use of a table here is suitable but colour for the side headings  could make it stand out a bit more. Referencing really needs to be fixed for this section&lt;br /&gt;
*Treatment and management is well researched, however Palliative Procedures could use more referencing esp. at the beginning. Table included is good but could be improved with colour and sectioning&lt;br /&gt;
*Prognosis has good inf but lacks referencing&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to balance out text&lt;br /&gt;
*Reference list needs work, don't think it's sufficient to just provide links to websites&lt;br /&gt;
*proof reading is needed to fix spelling mistakes, grammar issues and general sentence structure &lt;br /&gt;
*Glossary needs finishing, consider linking glossary words to the text and adding any acronyms used &lt;br /&gt;
*referencing of some images need to be fixed and student templates are missing in some&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 7: Angelman Syndrome&lt;br /&gt;
*Intro is very succinct and to the point, could use an image here to grab attention of the reader&lt;br /&gt;
*History has been fairly well researched few minor adjustments to sentence structure could be made to make it flow better, an image could also help enhance this section&lt;br /&gt;
*&amp;quot;However it was only when he stumbled upon an oil painting called ‘a Boy with a Puppet” while on a holiday in Italy he was able to connect the symptoms&amp;quot; -sentence could be restructured to flow better&lt;br /&gt;
*timeline in well formatted in a table, however i feel that more could be added and &amp;quot;current&amp;quot; isn't a year, could you maybe include a year for when these four different genetic abnormalities for AS were confirmed and maybe include what these are&lt;br /&gt;
*Epidemiology and Aetiology look like they could use some more info. In Aetiology, more info on the genes would be helpful, like what they're responsible for and their implications&lt;br /&gt;
*Most of the first paragraph of Pathogenesis could be better placed in history section, image in this section is way too big and it's description could be better placed (more closely associated with it)&lt;br /&gt;
*The legend for the graph in pathogenesis shouldn't really include the link to the source&lt;br /&gt;
*Table in signs and symptoms is a bit confusing, doesn't really indicate where it starts and stops, no margins&lt;br /&gt;
*diagnosis is very detailed and very informative, i feel like the images, while good, disrupt some of the text (too many gaps created) and so info doesn't flow well, maybe reformat them and make them smaller (maybe make the first one a thumb)&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*general formatting of some images needs to be fixed, some of them are too big, interfere with the flow of some section's text, some images need to properly be referenced&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 8: Friedreich’s Ataxia&lt;br /&gt;
*Contenets section not visible&lt;br /&gt;
*Info in both intro and history is very cohesive and informative, however, i feel the timeline could use a bit more work, there's large gaps in between dates (did anything happen in between these dates?) also it would be good if it also included fairly recent advances&lt;br /&gt;
*Epidemiology has been sectioned well, info is informative, however, it could be better if it was in the form of a table&lt;br /&gt;
*The chromosome image is a little faded and not really easy to see, could you maybe fix this so it's clearer &lt;br /&gt;
*Aetiology has been researched well, subheadings are suitable and fit in well, good balance of text and images, info is detailed and understandable, however, some sections could use more referencing (Genetic Instability &amp;amp; Inheritance particularly)&lt;br /&gt;
*Again the pedigree student drawn image could be a little more clearer &lt;br /&gt;
*The Gene expression responses of Friedreich's ataxia image needs to be referenced properly and student template should be added  &lt;br /&gt;
*Pathogenesis image could use a more informative legend&lt;br /&gt;
*Pathogenesis has concise and understandable info, the subheading Cardiomyopathy could be also included in glossary as some may not know what this is &lt;br /&gt;
*some words in Neuropathology need explaining in the glossary e.g. neuropathological, dorsal nuclei of Clarke, Schwann cells, oligodendrocyte etc.)&lt;br /&gt;
*A better description of the spinal cord image is needed&lt;br /&gt;
*Neuropathology has been research extensively and info is very informative and well explained, however, more referencing may be needed &lt;br /&gt;
*some of the info at the beginning of Clinical Presentation could be better as part of the history section&lt;br /&gt;
*Table in this section could be defined a little more with boundaries to differentiate one section form another&lt;br /&gt;
*Current research could be expanded on more by explaining the findings not just lists and links&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*very good structuring of headings and subheadings&lt;br /&gt;
*Glossary seems fine, words could be linked to the glossary as an improvement so the reader doesn't have to be scrolling down, some words could use more explaining (e.g. DRG, CNS etc.)&lt;br /&gt;
*Student drawn images could be clearer and some images need to be referenced properly&lt;br /&gt;
*good use of external links&lt;br /&gt;
*tables could be formatted better (better defined boundaries) &lt;br /&gt;
*good balance between text and images throughout most of page&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 10: Duchenne Muscular Dystrophy&lt;br /&gt;
*Title of the whole page should just be Duchenne Muscular Dystrophy, not Introduction...&lt;br /&gt;
*The intro is very descriptive and comprehensive &lt;br /&gt;
*Image in intro needs proper referencing  &lt;br /&gt;
*consider rephrasing this sentence &amp;quot;In DMD the protein dystrophin is not produced, when it is an important structural component for muscle tissue during contraction&amp;quot;&lt;br /&gt;
*History has good info, but could this be better formatted in a table? this section is text heavy and could maybe use an image, it also could be extended into more recent years&lt;br /&gt;
*Epidemiology is summarised well and contains good statistics&lt;br /&gt;
*I feel that Aetiology - Genetics section has good info, easy to understand and informative but maybe it could be researched a little more &lt;br /&gt;
*General Signs and Symptoms of Duchenne’s Muscular Dystrophy section needs a lot more work, the list of symptoms i don't feel is enough, more expansion on these is needed. An image would improve this section too&lt;br /&gt;
*&amp;quot;diarrhoea&amp;amp;&amp;amp;&amp;amp;.&amp;quot; -this needs to be fixed&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*More images are needed to break up the text&lt;br /&gt;
*glossary needs a bit more work, consider linking glossary words to text&lt;br /&gt;
*I feel that the page overall needs some more work, some sections are lacking content&lt;br /&gt;
*Proof reading to fix grammar and sentence structure&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
GROUP 11: Cleft Palate and Lip&lt;br /&gt;
*Introduction i feel needs more content, too short. more referencing is needed&lt;br /&gt;
*History could be better formatted in a table&lt;br /&gt;
*diagnosis is well researched , good use of tables&lt;br /&gt;
*Syndromes and Anomalies associated with cleft section needs to be completed, good information so far, however conditions could be described more&lt;br /&gt;
*Development has good info but really needs more referencing &lt;br /&gt;
*I feel more description is needed for Types of Cleft Palate/Lip&lt;br /&gt;
*Current and Future Research should be explained more&lt;br /&gt;
*Neuroembryology and functional anatomy of craniofacial clefts has very detailed and informative info&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Overall:&lt;br /&gt;
*ok balance between text and images&lt;br /&gt;
*headings could be better placed&lt;br /&gt;
*some images could be better placed so text isn't disrupted &lt;br /&gt;
*glossary needs to be finished, and you could improve this by linking the glossary term&lt;br /&gt;
&lt;br /&gt;
==Lab 10==&lt;br /&gt;
&lt;br /&gt;
'''1. Besides fetal alcohol syndrome, identify another environmental teratogen that can lead to hearing loss.'''&lt;br /&gt;
&lt;br /&gt;
The Rubella Virus has a teratogenic effect that causes an array of congenital malformations including Perceptive or sensorineural deafness [http://www.ncbi.nlm.nih.gov/pubmed/4992488]&lt;br /&gt;
&lt;br /&gt;
'''2. Identify 3 factors that contribute to poor neonatal drainage of the middle ear.'''&lt;br /&gt;
&lt;br /&gt;
The Eustachian/auditory tube that connects the middle ear to the nasopharynx, is short, narrow and runs almost horizontal at birth. These 3 factors contribute to poor neonatal drainage of the middle ear. [[Lecture - Sensory Development]]&lt;br /&gt;
&lt;br /&gt;
'''3. Identify 1 genetic abnormality that affects hearing development and link to the OMIM record. (Your individual abnormality should be different from all other students)'''&lt;br /&gt;
&lt;br /&gt;
Pendred syndrome, the most common syndrome that causes deafness. It is associated with developmental defects in the cochlea and sensorineural hearing loss. [http://omim.org/entry/274600 OMIM entry 274600:PENDRED SYNDROME; PDS]&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77856</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77856"/>
		<updated>2011-10-13T02:33:59Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Other problems */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary [[#Glossary | '''Stenosis''']] and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs [[#Glossary | '''(Mb)''']] on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
*Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
*Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
*A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
*Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|&lt;br /&gt;
*Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
*Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
*Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
*Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|&lt;br /&gt;
*Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
*The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
*A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), [[#Glossary | '''Mitral Valve Disease''']], [[#Glossary | '''Atrial Septal Defect''']] and [[#Glossary | '''Ventricular Septal Defect''']]. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased [[#Glossary | '''intracardiac pressure''']], [[#Glossary | '''myocardial hypertrophy''']], heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through [[#Glossary | '''2-dimensional echocardiography''']] that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary [[#Glossary | '''mitral valve leaflets''']], more elongated [[#Glossary | '''chordae tendineae''']] and [[#Glossary | '''myxomatous degeneration''']] of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once [[#Glossary | '''diastole''']] has finished and so [[#Glossary | '''mitral regurgitation of blood''']] back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and [[#Glossary | '''ultrasonography''']], [[#Glossary | '''Colour Doppler''']] has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and [[#Glossary | '''urinalysis''']]. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, [[#Glossary | '''hypothyroidism''']], and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the [[#Glossary | '''lamina propria''']] in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the [[#Glossary | '''metasarsophalangeal joint''']] inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the [[#Glossary | '''paleocerebellum''']] and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. Event-related potential [[#Glossary | '''(ERP)''']] studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surface and temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. [[#Glossary | '''Heschl’s gyrus''']] has been found to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in relation to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*[[#Glossary | '''Ophthalmologic''']] evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as [[#Glossary | '''angioplasty''']] and [[#Glossary | '''stent insertion''']] are also practiced, but are highly susceptible to [[#Glossary | '''aneurysm''']], rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a [[#Glossary | '''nephrologist''']] in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
[[#Glossary | '''Osteopenia''']] can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay [[#Glossary | '''menarche''']] with the use of a gonadotropin-releasing hormone such as [[#Glossary | '''leuprolide''']]. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an [[#Glossary | '''antianxiety agent''']]. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as [[#Glossary | '''Zoloft''']] and [[#Glossary | '''Prozac''']].&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Acknowledgement==&lt;br /&gt;
&lt;br /&gt;
The creators of this page would like to sincerely thank Dr. Stephen Palmer of the School of Medical Sciences at the University of New South Wales for his assistance and guidance over the duration of this project. His willingness to help and teaching were greatly appreciated by all members of the group.&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''2-dimensional echocardiography:''' Cross-sectional echocardiography, ultrasound-based diagnostic method.&lt;br /&gt;
&lt;br /&gt;
'''Aneurysm:''' Blood-filled dilation of a blood vessel, caused by a weakening of the vessel wall.&lt;br /&gt;
&lt;br /&gt;
'''Angioplasty:''' A medical procedure where a small balloon is inserted into the narrowed or obstructed blood vessel, inflated, and then removed once the blood flow through the vessel is normal.&lt;br /&gt;
&lt;br /&gt;
'''Antianxiety agent:''' Drugs used for the treatment of anxiety, and its related psychological and physical symptoms (also referred to as Anxiolytics).&lt;br /&gt;
&lt;br /&gt;
'''Atrial Septal Defect:''' A congenital heart defect in which the wall that separates the upper heart chambers (atria) does not close completely.&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked.&lt;br /&gt;
&lt;br /&gt;
'''Chordae Tendineae:''' Cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart .&lt;br /&gt;
&lt;br /&gt;
'''Colour Doppler:''' Ultrasound technique allowing simultaneous grey scale imaging and a dynamic colour flow vascular image.&lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Diastole:''' The period of time when the heart fills with blood during relaxation after systole.&lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''ERP:''' Event-related potential.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Heschl's gyrus:''' The transverse temporal gyrus which is found in the area of the primary auditory cortex. &lt;br /&gt;
&lt;br /&gt;
'''Hypothyroidism:''' A condition in which the thyroid gland does not make enough thyroid hormone.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause.&lt;br /&gt;
&lt;br /&gt;
'''Intracardiac pressure:''' Pressure within the heart.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA.&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lamina Propria:'''&lt;br /&gt;
&lt;br /&gt;
'''Leuprolide:''' An injectable, man-made hormone that is used for treating prostate cancer, endometriosis, central precocious puberty, and fibroids. It is similar to but stronger than human gonadotropin releasing hormone (GnRH).&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta.&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed.&lt;br /&gt;
&lt;br /&gt;
'''Menarche:''' The first menstrual cycle in female human beings.&lt;br /&gt;
&lt;br /&gt;
'''Metasarsophalangeal joint:'''&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Mitral regurgitation of blood:''' A disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. It is the abnormal leaking of blood from the left ventricle, through the mitral valve, and into the left atrium, when the left ventricle contracts.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Disease:''' A degeneration of the heart's mitral valve resulting in backflow.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Leaflets:''' Leaflets of the mitral valve composed of tissue whose sole purpose is to open and close tightly in order to ensure the correct flow of blood through the heart.&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues.&lt;br /&gt;
&lt;br /&gt;
'''Myocardial hypertrophy:''' Increase in size of myocardial muscle due to increase in size of individual myocardial cells, usually in response to an added afterload&lt;br /&gt;
&lt;br /&gt;
'''Myxomatous degeneration:''' A pathological weakening of connective tissue.&lt;br /&gt;
&lt;br /&gt;
'''Nephrologist:''' Someone who studies the function and diseases of the kidney.&lt;br /&gt;
&lt;br /&gt;
'''NAHR:''' Nonallelic homologous recombination is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''Ophthalmology:''' The branch of medicine that deals with the anatomy, functions, pathology, and treatment of the eye.&lt;br /&gt;
&lt;br /&gt;
'''Osteopenia:''' A condition where bone mineral density is lower than normal.&lt;br /&gt;
&lt;br /&gt;
'''Paleocerebellum:'''&lt;br /&gt;
&lt;br /&gt;
'''PPS:''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Prozac:''' A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
'''Stenosis:''' An abnormal narrowing in a blood vessel or other tubular organ or structure.&lt;br /&gt;
&lt;br /&gt;
'''Stent Insertion:''' The insertion of an artificial cylinder into an artery in order to prevent flow constriction.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle.&lt;br /&gt;
&lt;br /&gt;
'''Ultrasonography:''' An ultrasound-based diagnostic imaging technique used for visualizing subcutaneous body structures including tendons, muscles, joints, vessels and internal organs for possible pathology or lesions.&lt;br /&gt;
&lt;br /&gt;
'''Urinalysis:''' An array of tests performed on urine.&lt;br /&gt;
&lt;br /&gt;
'''Ventricular Septal Defect:''' One or more holes in the wall that separates the right and left ventricles of the heart.&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them.&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Zoloft:''' An antidepressant drug used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77851</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77851"/>
		<updated>2011-10-13T02:32:20Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Thyroid */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary [[#Glossary | '''Stenosis''']] and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs [[#Glossary | '''(Mb)''']] on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
*Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
*Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
*A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
*Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|&lt;br /&gt;
*Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
*Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
*Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
*Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|&lt;br /&gt;
*Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
*The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
*A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), [[#Glossary | '''Mitral Valve Disease''']], [[#Glossary | '''Atrial Septal Defect''']] and [[#Glossary | '''Ventricular Septal Defect''']]. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased [[#Glossary | '''intracardiac pressure''']], [[#Glossary | '''myocardial hypertrophy''']], heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through [[#Glossary | '''2-dimensional echocardiography''']] that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary [[#Glossary | '''mitral valve leaflets''']], more elongated [[#Glossary | '''chordae tendineae''']] and [[#Glossary | '''myxomatous degeneration''']] of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once [[#Glossary | '''diastole''']] has finished and so [[#Glossary | '''mitral regurgitation of blood''']] back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and [[#Glossary | '''ultrasonography''']], [[#Glossary | '''Colour Doppler''']] has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and [[#Glossary | '''urinalysis''']]. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, [[#Glossary | '''hypothyroidism''']], and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the [[#Glossary | '''lamina propria''']] in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the [[#Glossary | '''metasarsophalangeal joint''']] inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the [[#Glossary | '''paleocerebellum''']] and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. Event-related potential [[#Glossary | '''(ERP)''']] studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surface and temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. [[#Glossary | '''Heschl’s gyrus''']] has been found to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in relation to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*[[#Glossary | '''Ophthalmologic''']] evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as [[#Glossary | '''angioplasty''']] and [[#Glossary | '''stent insertion''']] are also practiced, but are highly susceptible to [[#Glossary | '''aneurysm''']], rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a [[#Glossary | '''nephrologist''']] in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
[[#Glossary | '''Osteopenia''']] can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay [[#Glossary | '''menarche''']] with the use of a gonadotropin-releasing hormone such as [[#Glossary | '''leuprolide''']]. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an [[#Glossary | '''antianxiety agent''']]. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as [[#Glossary | '''Zoloft''']] and [[#Glossary | '''Prozac''']].&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Acknowledgement==&lt;br /&gt;
&lt;br /&gt;
The creators of this page would like to sincerely thank Dr. Stephen Palmer of the School of Medical Sciences at the University of New South Wales for his assistance and guidance over the duration of this project. His willingness to help and teaching were greatly appreciated by all members of the group.&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''2-dimensional echocardiography:''' Cross-sectional echocardiography, ultrasound-based diagnostic method.&lt;br /&gt;
&lt;br /&gt;
'''Aneurysm:''' Blood-filled dilation of a blood vessel, caused by a weakening of the vessel wall.&lt;br /&gt;
&lt;br /&gt;
'''Angioplasty:''' A medical procedure where a small balloon is inserted into the narrowed or obstructed blood vessel, inflated, and then removed once the blood flow through the vessel is normal.&lt;br /&gt;
&lt;br /&gt;
'''Antianxiety agent:''' Drugs used for the treatment of anxiety, and its related psychological and physical symptoms (also referred to as Anxiolytics).&lt;br /&gt;
&lt;br /&gt;
'''Atrial Septal Defect:''' A congenital heart defect in which the wall that separates the upper heart chambers (atria) does not close completely.&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked.&lt;br /&gt;
&lt;br /&gt;
'''Chordae Tendineae:''' Cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart .&lt;br /&gt;
&lt;br /&gt;
'''Colour Doppler:''' Ultrasound technique allowing simultaneous grey scale imaging and a dynamic colour flow vascular image.&lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Diastole:''' The period of time when the heart fills with blood during relaxation after systole.&lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''ERP:''' Event-related potential.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Heschl's gyrus:''' The transverse temporal gyrus which is found in the area of the primary auditory cortex. &lt;br /&gt;
&lt;br /&gt;
'''Hypothyroidism:''' A condition in which the thyroid gland does not make enough thyroid hormone.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause.&lt;br /&gt;
&lt;br /&gt;
'''Intracardiac pressure:''' Pressure within the heart.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA.&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lamina Propria:'''&lt;br /&gt;
&lt;br /&gt;
'''Leuprolide:''' An injectable, man-made hormone that is used for treating prostate cancer, endometriosis, central precocious puberty, and fibroids. It is similar to but stronger than human gonadotropin releasing hormone (GnRH).&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta.&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed.&lt;br /&gt;
&lt;br /&gt;
'''Menarche:''' The first menstrual cycle in female human beings.&lt;br /&gt;
&lt;br /&gt;
'''Metasarsophalangeal joint:'''&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Mitral regurgitation of blood:''' A disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. It is the abnormal leaking of blood from the left ventricle, through the mitral valve, and into the left atrium, when the left ventricle contracts.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Disease:''' A degeneration of the heart's mitral valve resulting in backflow.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Leaflets:''' Leaflets of the mitral valve composed of tissue whose sole purpose is to open and close tightly in order to ensure the correct flow of blood through the heart.&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues.&lt;br /&gt;
&lt;br /&gt;
'''Myocardial hypertrophy:''' Increase in size of myocardial muscle due to increase in size of individual myocardial cells, usually in response to an added afterload&lt;br /&gt;
&lt;br /&gt;
'''Myxomatous degeneration:''' A pathological weakening of connective tissue.&lt;br /&gt;
&lt;br /&gt;
'''Nephrologist:''' Someone who studies the function and diseases of the kidney.&lt;br /&gt;
&lt;br /&gt;
'''NAHR:''' Nonallelic homologous recombination is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''Ophthalmology:''' The branch of medicine that deals with the anatomy, functions, pathology, and treatment of the eye.&lt;br /&gt;
&lt;br /&gt;
'''Osteopenia:''' A condition where bone mineral density is lower than normal.&lt;br /&gt;
&lt;br /&gt;
'''Paleocerebellum:'''&lt;br /&gt;
&lt;br /&gt;
'''PPS:''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Prozac:''' A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
'''Stenosis:''' An abnormal narrowing in a blood vessel or other tubular organ or structure.&lt;br /&gt;
&lt;br /&gt;
'''Stent Insertion:''' The insertion of an artificial cylinder into an artery in order to prevent flow constriction.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle.&lt;br /&gt;
&lt;br /&gt;
'''Ultrasonography:''' An ultrasound-based diagnostic imaging technique used for visualizing subcutaneous body structures including tendons, muscles, joints, vessels and internal organs for possible pathology or lesions.&lt;br /&gt;
&lt;br /&gt;
'''Urinalysis:''' An array of tests performed on urine.&lt;br /&gt;
&lt;br /&gt;
'''Ventricular Septal Defect:''' One or more holes in the wall that separates the right and left ventricles of the heart.&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them.&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Zoloft:''' An antidepressant drug used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77845</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77845"/>
		<updated>2011-10-13T02:30:37Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Genitourinary Treatment */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary [[#Glossary | '''Stenosis''']] and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs [[#Glossary | '''(Mb)''']] on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
*Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
*Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
*A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
*Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|&lt;br /&gt;
*Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
*Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
*Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
*Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|&lt;br /&gt;
*Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
*The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
*A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), [[#Glossary | '''Mitral Valve Disease''']], [[#Glossary | '''Atrial Septal Defect''']] and [[#Glossary | '''Ventricular Septal Defect''']]. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased [[#Glossary | '''intracardiac pressure''']], [[#Glossary | '''myocardial hypertrophy''']], heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through [[#Glossary | '''2-dimensional echocardiography''']] that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary [[#Glossary | '''mitral valve leaflets''']], more elongated [[#Glossary | '''chordae tendineae''']] and [[#Glossary | '''myxomatous degeneration''']] of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once [[#Glossary | '''diastole''']] has finished and so [[#Glossary | '''mitral regurgitation of blood''']] back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and [[#Glossary | '''ultrasonography''']], [[#Glossary | '''Colour Doppler''']] has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and [[#Glossary | '''urinalysis''']]. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, [[#Glossary | '''hypothyroidism''']], and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the [[#Glossary | '''lamina propria''']] in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the [[#Glossary | '''metasarsophalangeal joint''']] inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the [[#Glossary | '''paleocerebellum''']] and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. Event-related potential [[#Glossary | '''(ERP)''']] studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surface and temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. [[#Glossary | '''Heschl’s gyrus''']] has been found to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in relation to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*[[#Glossary | '''Ophthalmologic''']] evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as [[#Glossary | '''angioplasty''']] and [[#Glossary | '''stent insertion''']] are also practiced, but are highly susceptible to [[#Glossary | '''aneurysm''']], rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a [[#Glossary | '''nephrologist''']] in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
[[#Glossary | '''Osteopenia''']] can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay [[#Glossary | '''menarche''']] with the use of a gonadotropin-releasing hormone such as [[#Glossary | '''leuprolide''']]. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an [[#Glossary | '''antianxiety agent''']]. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as [[#Glossary | '''Zoloft''']] and [[#Glossary | '''Prozac''']].&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Acknowledgement==&lt;br /&gt;
&lt;br /&gt;
The creators of this page would like to sincerely thank Dr. Stephen Palmer of the School of Medical Sciences at the University of New South Wales for his assistance and guidance over the duration of this project. His willingness to help and teaching were greatly appreciated by all members of the group.&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''2-dimensional echocardiography:''' Cross-sectional echocardiography, ultrasound-based diagnostic method.&lt;br /&gt;
&lt;br /&gt;
'''Aneurysm:''' Blood-filled dilation of a blood vessel, caused by a weakening of the vessel wall.&lt;br /&gt;
&lt;br /&gt;
'''Angioplasty:''' A medical procedure where a small balloon is inserted into the narrowed or obstructed blood vessel, inflated, and then removed once the blood flow through the vessel is normal.&lt;br /&gt;
&lt;br /&gt;
'''Antianxiety agent:''' Drugs used for the treatment of anxiety, and its related psychological and physical symptoms (also referred to as Anxiolytics).&lt;br /&gt;
&lt;br /&gt;
'''Atrial Septal Defect:''' A congenital heart defect in which the wall that separates the upper heart chambers (atria) does not close completely.&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked.&lt;br /&gt;
&lt;br /&gt;
'''Chordae Tendineae:''' Cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart .&lt;br /&gt;
&lt;br /&gt;
'''Colour Doppler:''' Ultrasound technique allowing simultaneous grey scale imaging and a dynamic colour flow vascular image.&lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Diastole:''' The period of time when the heart fills with blood during relaxation after systole.&lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''ERP:''' Event-related potential.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Heschl's gyrus:''' The transverse temporal gyrus which is found in the area of the primary auditory cortex. &lt;br /&gt;
&lt;br /&gt;
'''Hypothyroidism:''' A condition in which the thyroid gland does not make enough thyroid hormone.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause.&lt;br /&gt;
&lt;br /&gt;
'''Intracardiac pressure:''' Pressure within the heart.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA.&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lamina Propria:'''&lt;br /&gt;
&lt;br /&gt;
'''Leuprolide:''' An injectable, man-made hormone that is used for treating prostate cancer, endometriosis, central precocious puberty, and fibroids. It is similar to but stronger than human gonadotropin releasing hormone (GnRH).&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta.&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed.&lt;br /&gt;
&lt;br /&gt;
'''Menarche:''' The first menstrual cycle in female human beings.&lt;br /&gt;
&lt;br /&gt;
'''Metasarsophalangeal joint:'''&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Mitral regurgitation of blood:''' A disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. It is the abnormal leaking of blood from the left ventricle, through the mitral valve, and into the left atrium, when the left ventricle contracts.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Disease:''' A degeneration of the heart's mitral valve resulting in backflow.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Leaflets:''' Leaflets of the mitral valve composed of tissue whose sole purpose is to open and close tightly in order to ensure the correct flow of blood through the heart.&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues.&lt;br /&gt;
&lt;br /&gt;
'''Myocardial hypertrophy:''' Increase in size of myocardial muscle due to increase in size of individual myocardial cells, usually in response to an added afterload&lt;br /&gt;
&lt;br /&gt;
'''Myxomatous degeneration:''' A pathological weakening of connective tissue.&lt;br /&gt;
&lt;br /&gt;
'''Nephrologist:''' Someone who studies the function and diseases of the kidney.&lt;br /&gt;
&lt;br /&gt;
'''NAHR:''' Nonallelic homologous recombination is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''Ophthalmology:''' The branch of medicine that deals with the anatomy, functions, pathology, and treatment of the eye.&lt;br /&gt;
&lt;br /&gt;
'''Osteopenia:''' A condition where bone mineral density is lower than normal.&lt;br /&gt;
&lt;br /&gt;
'''Paleocerebellum:'''&lt;br /&gt;
&lt;br /&gt;
'''PPS:''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Prozac:''' A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
'''Stenosis:''' An abnormal narrowing in a blood vessel or other tubular organ or structure.&lt;br /&gt;
&lt;br /&gt;
'''Stent Insertion:''' The insertion of an artificial cylinder into an artery in order to prevent flow constriction.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle.&lt;br /&gt;
&lt;br /&gt;
'''Ultrasonography:''' An ultrasound-based diagnostic imaging technique used for visualizing subcutaneous body structures including tendons, muscles, joints, vessels and internal organs for possible pathology or lesions.&lt;br /&gt;
&lt;br /&gt;
'''Urinalysis:''' An array of tests performed on urine.&lt;br /&gt;
&lt;br /&gt;
'''Ventricular Septal Defect:''' One or more holes in the wall that separates the right and left ventricles of the heart.&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them.&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Zoloft:''' An antidepressant drug used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77840</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77840"/>
		<updated>2011-10-13T02:29:06Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Stenoses */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary [[#Glossary | '''Stenosis''']] and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs [[#Glossary | '''(Mb)''']] on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
*Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
*Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
*A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
*Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|&lt;br /&gt;
*Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
*Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
*Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
*Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|&lt;br /&gt;
*Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
*The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
*A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), [[#Glossary | '''Mitral Valve Disease''']], [[#Glossary | '''Atrial Septal Defect''']] and [[#Glossary | '''Ventricular Septal Defect''']]. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased [[#Glossary | '''intracardiac pressure''']], [[#Glossary | '''myocardial hypertrophy''']], heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through [[#Glossary | '''2-dimensional echocardiography''']] that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary [[#Glossary | '''mitral valve leaflets''']], more elongated [[#Glossary | '''chordae tendineae''']] and [[#Glossary | '''myxomatous degeneration''']] of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once [[#Glossary | '''diastole''']] has finished and so [[#Glossary | '''mitral regurgitation of blood''']] back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and [[#Glossary | '''ultrasonography''']], [[#Glossary | '''Colour Doppler''']] has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and [[#Glossary | '''urinalysis''']]. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, [[#Glossary | '''hypothyroidism''']], and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the [[#Glossary | '''lamina propria''']] in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the [[#Glossary | '''metasarsophalangeal joint''']] inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the [[#Glossary | '''paleocerebellum''']] and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. Event-related potential [[#Glossary | '''(ERP)''']] studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surface and temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. [[#Glossary | '''Heschl’s gyrus''']] has been found to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in relation to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*[[#Glossary | '''Ophthalmologic''']] evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as [[#Glossary | '''angioplasty''']] and [[#Glossary | '''stent insertion''']] are also practiced, but are highly susceptible to [[#Glossary | '''aneurysm''']], rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a [[#Glossary | '''nephrologist''']] in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
[[#Glossary | '''Osteopenia''']] can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay [[#Glossary | '''menarche''']] with the use of a gonadotropin-releasing hormone such as [[#Glossary | '''leuprolide''']]. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an [[#Glossary | '''antianxiety agent''']]. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as [[#Glossary | '''Zoloft''']] and [[#Glossary | '''Prozac''']].&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Acknowledgement==&lt;br /&gt;
&lt;br /&gt;
The creators of this page would like to sincerely thank Dr. Stephen Palmer of the School of Medical Sciences at the University of New South Wales for his assistance and guidance over the duration of this project. His willingness to help and teaching were greatly appreciated by all members of the group.&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''2-dimensional echocardiography:''' Cross-sectional echocardiography, ultrasound-based diagnostic method.&lt;br /&gt;
&lt;br /&gt;
'''Aneurysm:''' Blood-filled dilation of a blood vessel, caused by a weakening of the vessel wall.&lt;br /&gt;
&lt;br /&gt;
'''Angioplasty:''' A medical procedure where a small balloon is inserted into the narrowed or obstructed blood vessel, inflated, and then removed once the blood flow through the vessel is normal.&lt;br /&gt;
&lt;br /&gt;
'''Antianxiety agent:''' Drugs used for the treatment of anxiety, and its related psychological and physical symptoms (also referred to as Anxiolytics).&lt;br /&gt;
&lt;br /&gt;
'''Atrial Septal Defect:''' A congenital heart defect in which the wall that separates the upper heart chambers (atria) does not close completely.&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked.&lt;br /&gt;
&lt;br /&gt;
'''Chordae Tendineae:''' Cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart .&lt;br /&gt;
&lt;br /&gt;
'''Colour Doppler:''' Ultrasound technique allowing simultaneous grey scale imaging and a dynamic colour flow vascular image.&lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Diastole:''' The period of time when the heart fills with blood during relaxation after systole.&lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''ERP:''' Event-related potential.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Heschl's gyrus:''' The transverse temporal gyrus which is found in the area of the primary auditory cortex. &lt;br /&gt;
&lt;br /&gt;
'''Hypothyroidism:''' A condition in which the thyroid gland does not make enough thyroid hormone.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause.&lt;br /&gt;
&lt;br /&gt;
'''Intracardiac pressure:''' Pressure within the heart.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA.&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lamina Propria:'''&lt;br /&gt;
&lt;br /&gt;
'''Leuprolide:''' An injectable, man-made hormone that is used for treating prostate cancer, endometriosis, central precocious puberty, and fibroids. It is similar to but stronger than human gonadotropin releasing hormone (GnRH).&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta.&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed.&lt;br /&gt;
&lt;br /&gt;
'''Menarche:''' The first menstrual cycle in female human beings.&lt;br /&gt;
&lt;br /&gt;
'''Metasarsophalangeal joint:'''&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Mitral regurgitation of blood:''' A disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. It is the abnormal leaking of blood from the left ventricle, through the mitral valve, and into the left atrium, when the left ventricle contracts.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Disease:''' A degeneration of the heart's mitral valve resulting in backflow.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Leaflets:''' Leaflets of the mitral valve composed of tissue whose sole purpose is to open and close tightly in order to ensure the correct flow of blood through the heart.&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues.&lt;br /&gt;
&lt;br /&gt;
'''Myocardial hypertrophy:''' Increase in size of myocardial muscle due to increase in size of individual myocardial cells, usually in response to an added afterload&lt;br /&gt;
&lt;br /&gt;
'''Myxomatous degeneration:''' A pathological weakening of connective tissue.&lt;br /&gt;
&lt;br /&gt;
'''Nephrologist:''' Someone who studies the function and diseases of the kidney.&lt;br /&gt;
&lt;br /&gt;
'''NAHR:''' Nonallelic homologous recombination is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''Ophthalmology:''' The branch of medicine that deals with the anatomy, functions, pathology, and treatment of the eye.&lt;br /&gt;
&lt;br /&gt;
'''Osteopenia:''' A condition where bone mineral density is lower than normal.&lt;br /&gt;
&lt;br /&gt;
'''Paleocerebellum:'''&lt;br /&gt;
&lt;br /&gt;
'''PPS:''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Prozac:''' A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
'''Stenosis:''' An abnormal narrowing in a blood vessel or other tubular organ or structure.&lt;br /&gt;
&lt;br /&gt;
'''Stent Insertion:''' The insertion of an artificial cylinder into an artery in order to prevent flow constriction.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle.&lt;br /&gt;
&lt;br /&gt;
'''Ultrasonography:''' An ultrasound-based diagnostic imaging technique used for visualizing subcutaneous body structures including tendons, muscles, joints, vessels and internal organs for possible pathology or lesions.&lt;br /&gt;
&lt;br /&gt;
'''Urinalysis:''' An array of tests performed on urine.&lt;br /&gt;
&lt;br /&gt;
'''Ventricular Septal Defect:''' One or more holes in the wall that separates the right and left ventricles of the heart.&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them.&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Zoloft:''' An antidepressant drug used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77828</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77828"/>
		<updated>2011-10-13T02:25:35Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary [[#Glossary | '''Stenosis''']] and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs [[#Glossary | '''(Mb)''']] on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
*Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
*Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
*A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
*Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|&lt;br /&gt;
*Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
*Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
*Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
*Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|&lt;br /&gt;
*Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
*The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
*A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;Morris&amp;quot;&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), [[#Glossary | '''Mitral Valve Disease''']], [[#Glossary | '''Atrial Septal Defect''']] and [[#Glossary | '''Ventricular Septal Defect''']]. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased [[#Glossary | '''intracardiac pressure''']], [[#Glossary | '''myocardial hypertrophy''']], heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through [[#Glossary | '''2-dimensional echocardiography''']] that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary [[#Glossary | '''mitral valve leaflets''']], more elongated [[#Glossary | '''chordae tendineae''']] and [[#Glossary | '''myxomatous degeneration''']] of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once [[#Glossary | '''diastole''']] has finished and so [[#Glossary | '''mitral regurgitation of blood''']] back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and [[#Glossary | '''ultrasonography''']], [[#Glossary | '''Colour Doppler''']] has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and [[#Glossary | '''urinalysis''']]. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, [[#Glossary | '''hypothyroidism''']], and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the [[#Glossary | '''lamina propria''']] in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the [[#Glossary | '''metasarsophalangeal joint''']] inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the [[#Glossary | '''paleocerebellum''']] and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. Event-related potential [[#Glossary | '''(ERP)''']] studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surface and temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. [[#Glossary | '''Heschl’s gyrus''']] has been found to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in relation to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*[[#Glossary | '''Ophthalmologic''']] evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as [[#Glossary | '''angioplasty''']] and [[#Glossary | '''stent insertion''']] are also practiced, but are highly susceptible to [[#Glossary | '''aneurysm''']], rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a [[#Glossary | '''nephrologist''']] in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
[[#Glossary | '''Osteopenia''']] can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay [[#Glossary | '''menarche''']] with the use of a gonadotropin-releasing hormone such as [[#Glossary | '''leuprolide''']]. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an [[#Glossary | '''antianxiety agent''']]. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as [[#Glossary | '''Zoloft''']] and [[#Glossary | '''Prozac''']].&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Acknowledgement==&lt;br /&gt;
&lt;br /&gt;
The creators of this page would like to sincerely thank Dr. Stephen Palmer of the School of Medical Sciences at the University of New South Wales for his assistance and guidance over the duration of this project. His willingness to help and teaching were greatly appreciated by all members of the group.&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''2-dimensional echocardiography:''' Cross-sectional echocardiography, ultrasound-based diagnostic method.&lt;br /&gt;
&lt;br /&gt;
'''Aneurysm:''' Blood-filled dilation of a blood vessel, caused by a weakening of the vessel wall.&lt;br /&gt;
&lt;br /&gt;
'''Angioplasty:''' A medical procedure where a small balloon is inserted into the narrowed or obstructed blood vessel, inflated, and then removed once the blood flow through the vessel is normal.&lt;br /&gt;
&lt;br /&gt;
'''Antianxiety agent:''' Drugs used for the treatment of anxiety, and its related psychological and physical symptoms (also referred to as Anxiolytics).&lt;br /&gt;
&lt;br /&gt;
'''Atrial Septal Defect:''' A congenital heart defect in which the wall that separates the upper heart chambers (atria) does not close completely.&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked.&lt;br /&gt;
&lt;br /&gt;
'''Chordae Tendineae:''' Cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart .&lt;br /&gt;
&lt;br /&gt;
'''Colour Doppler:''' Ultrasound technique allowing simultaneous grey scale imaging and a dynamic colour flow vascular image.&lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Diastole:''' The period of time when the heart fills with blood during relaxation after systole.&lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''ERP:''' Event-related potential.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Heschl's gyrus:''' The transverse temporal gyrus which is found in the area of the primary auditory cortex. &lt;br /&gt;
&lt;br /&gt;
'''Hypothyroidism:''' A condition in which the thyroid gland does not make enough thyroid hormone.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause.&lt;br /&gt;
&lt;br /&gt;
'''Intracardiac pressure:''' Pressure within the heart.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA.&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lamina Propria:'''&lt;br /&gt;
&lt;br /&gt;
'''Leuprolide:''' An injectable, man-made hormone that is used for treating prostate cancer, endometriosis, central precocious puberty, and fibroids. It is similar to but stronger than human gonadotropin releasing hormone (GnRH).&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta.&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed.&lt;br /&gt;
&lt;br /&gt;
'''Menarche:''' The first menstrual cycle in female human beings.&lt;br /&gt;
&lt;br /&gt;
'''Metasarsophalangeal joint:'''&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Mitral regurgitation of blood:''' A disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. It is the abnormal leaking of blood from the left ventricle, through the mitral valve, and into the left atrium, when the left ventricle contracts.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Disease:''' A degeneration of the heart's mitral valve resulting in backflow.&lt;br /&gt;
&lt;br /&gt;
'''Mitral Valve Leaflets:''' Leaflets of the mitral valve composed of tissue whose sole purpose is to open and close tightly in order to ensure the correct flow of blood through the heart.&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues.&lt;br /&gt;
&lt;br /&gt;
'''Myocardial hypertrophy:''' Increase in size of myocardial muscle due to increase in size of individual myocardial cells, usually in response to an added afterload&lt;br /&gt;
&lt;br /&gt;
'''Myxomatous degeneration:''' A pathological weakening of connective tissue.&lt;br /&gt;
&lt;br /&gt;
'''Nephrologist:''' Someone who studies the function and diseases of the kidney.&lt;br /&gt;
&lt;br /&gt;
'''NAHR:''' Nonallelic homologous recombination is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''Ophthalmology:''' The branch of medicine that deals with the anatomy, functions, pathology, and treatment of the eye.&lt;br /&gt;
&lt;br /&gt;
'''Osteopenia:''' A condition where bone mineral density is lower than normal.&lt;br /&gt;
&lt;br /&gt;
'''Paleocerebellum:'''&lt;br /&gt;
&lt;br /&gt;
'''PPS:''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Prozac:''' A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
'''Stenosis:''' An abnormal narrowing in a blood vessel or other tubular organ or structure.&lt;br /&gt;
&lt;br /&gt;
'''Stent Insertion:''' The insertion of an artificial cylinder into an artery in order to prevent flow constriction.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality.&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle.&lt;br /&gt;
&lt;br /&gt;
'''Ultrasonography:''' An ultrasound-based diagnostic imaging technique used for visualizing subcutaneous body structures including tendons, muscles, joints, vessels and internal organs for possible pathology or lesions.&lt;br /&gt;
&lt;br /&gt;
'''Urinalysis:''' An array of tests performed on urine.&lt;br /&gt;
&lt;br /&gt;
'''Ventricular Septal Defect:''' One or more holes in the wall that separates the right and left ventricles of the heart.&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them.&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Zoloft:''' An antidepressant drug used to treat depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77532</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77532"/>
		<updated>2011-10-12T14:51:58Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Glossary */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats, a single copy gene region with repetitive sequences&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''(PPS):''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77531</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77531"/>
		<updated>2011-10-12T14:49:31Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Glossary */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract, portion of the left ventricle of the heart through which blood passes to get pumped out by the aorta&lt;br /&gt;
&lt;br /&gt;
'''Malocclusion:''' the abnormal positioning of the teeth when the jaw is closed&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance&lt;br /&gt;
&lt;br /&gt;
'''MRI:''' Magnetic resistance imaging, a diagnostic technique that uses a magnetic field and radio waves to provide computerized images of internal body tissues&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''(PPS):''' Peripheral Pulmonary Stenosis, an obstruction anywhere in the pulmonary artery caused by vessel wall thickening as a result of elastin abnormality&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)caused by vessel wall thickening as a result of elastin abnormality&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle&lt;br /&gt;
&lt;br /&gt;
'''Visualspatial construction:''' the ability of a person to perceive, analyze, and understand visual information taken in from the world around them&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77518</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77518"/>
		<updated>2011-10-12T14:28:06Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Glossary */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies/malformations:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Idiopathic infantile hypercalcemia:''' Abnormally high levels of calcium in the blood at childhood arising from an unknown cause&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT)&lt;br /&gt;
&lt;br /&gt;
'''Systolic murmurs:''' Murmur or sound occurring during the contraction of the heart and pumping of blood out of the ventricle&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77510</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77510"/>
		<updated>2011-10-12T14:16:03Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* History of the disease */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, [[#Glossary | '''idiopathic infantile hypercalcemia''']] and [[#Glossary | '''Supravalvular Aortic Stenosis(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved idiopathic infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of [[#Glossary | '''congenital malformations''']]. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and [[#Glossary | '''systolic murmurs''']] of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the [[#Glossary | '''left ventricular outflow tract (LVOT)''']], Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and [[#Glossary | '''malocclusion''']] of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be ''&amp;quot;indicative of a previously unrecognised syndrome.&amp;quot;'' &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of [[#Glossary | '''Peripheral Pulmonary Stenosis (PPS)''']] and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional [[#Glossary | '''MRI''']] of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in [[#Glossary |'''visualspatial construction''']]. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
*BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
*TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
*Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
*Unique personality&lt;br /&gt;
&lt;br /&gt;
*Intellectual disability &lt;br /&gt;
&lt;br /&gt;
*Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
*Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
*Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
*Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
*Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Figure 7: Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 8: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 9: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 10: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 11: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 12: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 13: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 14: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 15: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
*Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
*Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
*Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
*Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
*Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
*Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
*Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
*Urinalysis&lt;br /&gt;
&lt;br /&gt;
*Calcium determinations&lt;br /&gt;
&lt;br /&gt;
*Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
*FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
*To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
*To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
*To provide information on current research &lt;br /&gt;
&lt;br /&gt;
*To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
*To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Induced chromosome deletion in a Williams-Beuren syndrome mouse model causes cardiovascular abnormalities''' - published in 2011, this study involved the deletion of the elastin gene ELN and what effect it had on cardiovascular abnormalities found in Williams syndrome. Results of this deletion were measured through ELN transcript levels, blood pressure, histological sectioning and M-mode ultrasound to determine circumferential cyclic strain. The results showed that ELN transcript levels were reduced by 38-41% in WS mice who had only one copy of the ELN gene instead of the normal two. These same mice showed an increase in mean blood pressure and also a reduced circumferential cyclic strain. The histological sections showed disorganised and fragmented elastic sheets. The paper concluded that the deletion of ELN in mice with Williams syndrome results in lower gene expression, hypertension, reduced cyclic strain and fragmented elastin sheets. Due to no change in medial lamella units in mice with Williams syndrome, the study suggests other genes may be involved in vascular development. &lt;br /&gt;
&lt;br /&gt;
'''Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome''' - published in 2011, this article suggests that a reduced expression of the LIM kinase1 gene involved in the regulation of the motile responses of cochlear outer hair cells and cochlear amplification results in and is the cause of hyperacusis and progressing hearing loss as observed in patients with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism''' - published in 2010, this study shows “the existence of a negative autoregulatory mechanism that controls the level of GTF2IRD1 transcription via direct binding of the GTF2IRD1 protein to a highly conserved region of the GTF2IRD1 promoter containing an array of three binding sites. This protein-DNA interaction is dependent upon multiple interactions between separate domains of the protein and at least two of the DNA binding sites. This mechanism leads to dosage compensation of GTF2IRD1 transcription”, resulting in the craniofacial dysmorphology, hypersociability, and visuospatial deficits displayed in Williams syndrome patients.&lt;br /&gt;
&lt;br /&gt;
'''Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile''' - published in 2010, this study concludes that after revealing low expression levels of all the typical and atypical genes through lymphoblastoid cell lines,  the “functional hemizygosity of both GTF2I and GTF2IRD1 genes is the main cause of the neurocognitive profile” seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits''' - published in 2010, this article states that through comparing the transcriptome profile of lymphoblastoid cell lines from various patients, 47 genes had been deregulated in WS patients. The pathways that were affected the most included glycolysis and neuronal migration. Genes involved in microtubule formation were also deregulated in patients with the common deletion. This abnormal regulation of gene pathways may be related to the cognitive, visuospatial and metabolic disturbances as seen in WS patients.&lt;br /&gt;
&lt;br /&gt;
'''Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith, '''Hearing and Hypersensitivity to Sound''', Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
Professors Janette Atkinson &amp;amp; Oliver Braddick, '''Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome''' &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
*Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
*Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77485</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77485"/>
		<updated>2011-10-12T13:43:49Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Introduction */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;Genetics Home Reference 2011, Williams Syndrome, U.S. National Library of Medicine, viewed 10 October 2011, &amp;lt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77482</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77482"/>
		<updated>2011-10-12T13:35:16Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Other Associated Medical Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77480</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77480"/>
		<updated>2011-10-12T13:31:51Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Mouse Models */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;National Human Genome Research Institute 2010, ''Knockout Mice'', The National Human Genome Research Institute, viewed 11 October 2011, &amp;lt;http://www.genome.gov/12514551&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77476</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77476"/>
		<updated>2011-10-12T13:23:00Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Thyroid */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77472</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77472"/>
		<updated>2011-10-12T13:19:59Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Facial Characteristics */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&lt;br /&gt;
 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77469</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77469"/>
		<updated>2011-10-12T13:16:56Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Introduction */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;[http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; With regard to sex, it has been noted that the severity of SVAS and total cardiovascular disease is significantly greater in males than in females with WS, proving that the severity of elastin arteriopathy is indeed affected by sex. This difference, as hypothesised, may be related to prenatal hormone effects.&amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Genetically, 90%–95% of patients clinically diagnosed with the syndrome have an approximate 1.55-Mb deletion associated with the loss of 26–28 genes on the 7q11.23 chromosome; 5%–8% of those diagnosed have a slightly larger deletion of approximately 1.84-Mb pair deletion associated with the loss of 28 genes.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. The facial phenotype also changes with time as the child develops. This makes it harder to diagnose Williams Syndrome based on facial characteristics in adults. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth and Nose'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and held open.[[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel. Teeth present are misshaped, often with a screwdriver shape  and are smaller that normal teeth. Malocclusion, the misalignment of teeth is caused by the abnormal shape and size of the teeth.&lt;br /&gt;
&lt;br /&gt;
•	A long philltrum is also present in the majority of cases.&lt;br /&gt;
&lt;br /&gt;
•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes and Ears'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.[[File:Williams Syndrome eye.jpg|thumb|200px|'''Stellate Iris. This image shows a typical eye of an individual with Williams Syndrome showing the stellate iris.''']]&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially.&lt;br /&gt;
&lt;br /&gt;
•	Hyperopia, vertical strabismuth or esotropia, inward strabismuth is present in most cases of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Craniofacial Skeleton'''&lt;br /&gt;
&lt;br /&gt;
|•	Cranial base is shorter in length on both the anterior and posterior halves but maintain the same cranial base angle as a normally developing individual.&lt;br /&gt;
&lt;br /&gt;
•	The saggital length of the maxillary is shorter and more inclined anteriorly.&lt;br /&gt;
&lt;br /&gt;
•	A retrusive mandible is present as the mandible is at a higher plane angle and the chin is deficit. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://www.lds.no/stream_file.asp?iEntityId=13482&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Many individuals diagnosed with Williams syndrome show the symptoms associated with hypercalcemia. For instance, in infants, these symptoms are most commonly irritability, vomiting and constipation, whereas in adults there are more commonly urinary infections and petic ulcer disease. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&lt;br /&gt;
 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hallux Valgus'''&lt;br /&gt;
| Hallux Valgus is the result of the musculoskeletal deviation seen in Williams syndrome. &lt;br /&gt;
| This results in the projection of the metasarsophalangeal joint inward to the inner foot. It is reported that in approximately 78% of individuals diagnosed with Williams syndrome have a big toe which is displaced under or over their other toes. &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Developmental delay in height and weight'''&lt;br /&gt;
| This delay, as well as many of the other abnormalities seen in Williams syndrome has been associated with the lack of connective tissue, due to the deletion of the ELN gene. &lt;br /&gt;
| Individuals with Williams syndrome often present smaller than others without Williams syndrome at the same gestational age, and grow to have a short stature. A study by Pankau et al in 1992, found intrauterine growth retardation in 35% of females with Williams Syndrome and 22% in males. &amp;lt;ref name=&amp;quot;PMID1425797&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1425797 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Early onset of puberty'''&lt;br /&gt;
| It has been suggested that the early onset of puberty could be related to a disruption in hormonal secretions associated with Williams syndrome. There has also been evidence to implicate the hypothalamic-pituitary mediated activation. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| It has been found that individuals with Williams syndrome are more likely to have an earlier onset of puberty. With females beginning their menstrual cycle and males showing Tanner III pubic hair development under the age of 12. &amp;lt;ref name=&amp;quot;PMID10319200&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10319200 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77252</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77252"/>
		<updated>2011-10-12T09:22:31Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Genitourinary Treatment */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77247</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77247"/>
		<updated>2011-10-12T09:19:17Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Other problems */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77246</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77246"/>
		<updated>2011-10-12T09:17:06Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Stenoses */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77244</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77244"/>
		<updated>2011-10-12T09:14:23Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref&amp;gt;Morris, C 2006, ‘Williams Syndrome’, in RA Pagon et.al (ed.), Gene Reviews, University of Washington, Seattle&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77232</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77232"/>
		<updated>2011-10-12T08:57:44Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77229</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77229"/>
		<updated>2011-10-12T08:54:56Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Genitourinary Treatment */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia.&lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77216</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77216"/>
		<updated>2011-10-12T08:41:03Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Mouse Models */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following is an example of a research study conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed Article] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F2/ Phenotypes of Gtf2ird1 and Gtf2i mutant mouse embryos] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F3/ Morphological analysis of the head in mutant embryos and expression of Gtf2i and Gtf2ird1] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/figure/F4/ Reduced growth, craniofacial and pigmentation defects in heterozygous Gtf2ird1 and Gtf2i animals] |&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77204</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77204"/>
		<updated>2011-10-12T08:20:51Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cognitive, Behavioural and Neurological Phenotype */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 12: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 13: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 14: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following are examples of research studies conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77203</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77203"/>
		<updated>2011-10-12T08:17:37Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cognitive, Behavioural and Neurological Phenotype */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 11: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following are examples of research studies conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77200</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77200"/>
		<updated>2011-10-12T08:14:30Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Structural Differences in the Brain */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 10: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following are examples of research studies conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77198</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77198"/>
		<updated>2011-10-12T08:12:50Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Renal Tract Abnormalities */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 9: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following are examples of research studies conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2011_Group_Project_9&amp;diff=77195</id>
		<title>Talk:2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:2011_Group_Project_9&amp;diff=77195"/>
		<updated>2011-10-12T08:10:48Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Images */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[2011_Group_Project_9|'''Group 9''']]: [[User:z3331469]] | [[User:z3331556]] | [[User:z3332178]] | [[User:z3332183]]&lt;br /&gt;
&lt;br /&gt;
{{2011GroupDiscussionMH}}&lt;br /&gt;
&lt;br /&gt;
'''Page Edits 30 Sep'''&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
File:2011_Project_Group_9_edits.jpg|Project Page&lt;br /&gt;
File:2011_Project_Group_1-11_edits.jpg|All Groups (1-11) Project&lt;br /&gt;
File:2011_Talk_Group_9_edits.jpg|Discussion Page&lt;br /&gt;
File:2011 Talk Group 1-11 edits.jpg|All Groups (1-11) Discussion&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Images==&lt;br /&gt;
&lt;br /&gt;
Here's another image guys, i don't know where to put it so feel free to add it to any of your sections&lt;br /&gt;
&lt;br /&gt;
[[File:Characteristic facial features of a child with Willams Syndrome.jpg|500px]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hey guys...so ive gone through the articles which we originally used for our lab assessments and ive found quite a few other images we can use. Im gonna upload them all and put them here for now..so they're all together and then we can go through and choose which ones we want to use and where to put include them on the page! :] &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|z3332183]] 21:21, 4 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|500px]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Schematic diagram detailing genes deleted in probands.jpeg|500px]]&lt;br /&gt;
&lt;br /&gt;
==Peer Review==&lt;br /&gt;
&lt;br /&gt;
'''Group 9 Review'''&lt;br /&gt;
*Intro – don’t need the word ‘Ever’ at the beginning of the 2nd para. The intro needs to be proof-read/edited so it flows well and is not too colloquial. &lt;br /&gt;
*Intro/History – would look better if it was broken up with a picture or some colour. Maybe the timeline in a coloured table? Other groups have done this and it looks quite good. &lt;br /&gt;
*Genetic factors – can you explain the picture you have used, refer to it in the text?&lt;br /&gt;
*Diagnosis – should come after all the epidemiology, phenotype etc, just before specialised facilities I think? It is your project so do what you want, but I think that having it so close to the beginning is a bit funny. I think treatment should then come after the diagnosis. &lt;br /&gt;
*Cognitive, behavioural and neurological phenotype – as each of these subheadings and the text in them come only from one research paper, perhaps refer directly to the researcher’s names and year in an intro sentence into each? I think it would be better than just putting in a reference number at the end. &lt;br /&gt;
*Current Research – is it the WS Association or Foundation?&lt;br /&gt;
*Glossary needs work, just define everything – don’t assume people know what everything means.&lt;br /&gt;
 &lt;br /&gt;
--[[User:Z3332824|z3332824]] 14:51, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Peer Review'''&lt;br /&gt;
* Introduction is well referenced and nicely detailed, outlining each of the facets of the topic that follow.&lt;br /&gt;
* Relevant information presented in the history, outlining in enough detail the sequence that led to recognition of the syndrome. The timeline may be superfluous though.&lt;br /&gt;
* Good balance between table, text and pictures in Genetic Factors/Etiology; the table in particular presents complex information in a very understandable form, but it could contain more references.&lt;br /&gt;
* Each subheading in Diagnosis is thoroughly researched, however each segment of Diagnosis requires more references.&lt;br /&gt;
* The subheadings of Epidemiology are a bit peculiar. Management and Treatment wouldn’t usually be listed under these headings.&lt;br /&gt;
* I would have placed Phenotype earlier on the page, probably after Etiology. This section could also use some more free text, even if to explain the table. The table itself is very comprehensive though.&lt;br /&gt;
* I would have probably linked Phenotype and Cardiac/Genitourinary Conditions, Endocrine and Other Associated Medical Conditions together. Also, the “other problems” subheading seems like it should be a main heading, with all the afore-mentioned segments following it as subheadings themselves.&lt;br /&gt;
* In Renal Tract Abnormalities, a subheading is introduced by a colon following a sentence in a free paragraph; very strange. The information presented however is very in-depth.&lt;br /&gt;
* Cognitive etc section needs many more references. Peculiar sentence structure (“as having a cognitive variety of relative strengths and weaknesses”). Incorrect grammar is evident in places. The Sociability and Anxiety both seems to have redundancies.&lt;br /&gt;
* The glossary is insufficient.&lt;br /&gt;
* Structural differences needs many more references.&lt;br /&gt;
* Specialised etc can’t start with “Here in Australia” (welcome to the internet). Also, the information presented about the support groups is entirely too detailed; a link would be preferable&lt;br /&gt;
--[[User:Z3290689|z3290689]] 14:42, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Group 9: &lt;br /&gt;
Obviously a lot of effort has been placed in this page. But it lacks of images in some sections like history or introduction.  &lt;br /&gt;
It is nice to know the history of the disease but It would be better it is summarised. &lt;br /&gt;
Epidmiology seems to have many subheading under it. Perhaps a separate headings for each and more info on the epidmiolgy not one sentence only. &lt;br /&gt;
The image of phenotype of Williams Syndrome can  be in a separate box ( as an image ). &lt;br /&gt;
Finally, Amazing work on all the details ( associations and medical conditions). Just be aware that references referring to 23 are empty.  &lt;br /&gt;
--[[User:Z3284061|z3284061]] 11:52, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessment'''&lt;br /&gt;
&lt;br /&gt;
* Introduction is good but an image would be good&lt;br /&gt;
* History and Timeline is a little text heavy&lt;br /&gt;
* Genetic Factors and Etiology section is very good, well written, good use of tables and images&lt;br /&gt;
* Epidemiology is a little text heavy, a image might be good to break it up&lt;br /&gt;
* Structural Differences in the Brain section needs more references&lt;br /&gt;
* Glossary needs more work&lt;br /&gt;
* No references in Phenotype&lt;br /&gt;
* Maybe reorganise headings so it flows better&lt;br /&gt;
* Overall it is a well researched project but could do with some more images &lt;br /&gt;
--[[User:Z3292953|z3292953]] 11:02, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''''Williams Syndrome (Group 9) Peer Review:'''''&lt;br /&gt;
&lt;br /&gt;
Introduction: The content is interesting, however try adding an image to interest the reader. &lt;br /&gt;
&lt;br /&gt;
History of the Disease: This is possibly too much information- may bore the reader. Otherwise, it is very well researched. Once again a picture would help to break up the huge slab of information. &lt;br /&gt;
&lt;br /&gt;
Genetic Factors and Etiology: This section is impressive. The image is good and contains all of the relevant information. Well done. Also the table is a nice touch. &lt;br /&gt;
&lt;br /&gt;
Diagnosis: This section needs many more references. The picture is good. The information is written well. &lt;br /&gt;
&lt;br /&gt;
Epidemiology: This section is good, however I am not too sure about merging management and treatment within the epidemiology subheading? Just a thought. Also, a picture is necessary to break up the information. &lt;br /&gt;
&lt;br /&gt;
Phenotype of William Syndrome: I like the use of the table – helps to organize the information. Referencing needs to be completed as currently there are no references in this section. &lt;br /&gt;
&lt;br /&gt;
Cardiac/ Genitourinary Conditions: It seems like a huge slab of information that needs more images to help balance it out. Information is extensive though, well done. &lt;br /&gt;
&lt;br /&gt;
Endocrine: Good use of subheadings. Thyroid subheading has no references? &lt;br /&gt;
&lt;br /&gt;
Other Associated Medical Conditions: Great use of table. Could you add a picture into this section? &lt;br /&gt;
&lt;br /&gt;
Cognitive, Behavioural and Neurological Phenotype: Wow, a lot of detail has gone into this section. Not enough references. Image is interesting.  Possibly cut down on some of the information in this section, or add more pictures as there is too much text and you may lose the reader as a result. &lt;br /&gt;
&lt;br /&gt;
Structural Differences in the Brain: Not enough references in this section. It is a slab of text, try breaking it up more. Insert more spaces within the paragraphs. &lt;br /&gt;
&lt;br /&gt;
Specialised Facilities and Supportive Associations: Is this section necessary?&lt;br /&gt;
 &lt;br /&gt;
Current research and developments: Good summary of the research however seems a bit brief. &lt;br /&gt;
Glossary: Could be a bit more extensive. &lt;br /&gt;
&lt;br /&gt;
Overall, good job and good luck with the editing process! --[[User:Z3290808|z3290808]] 10:52, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams – Beuren Syndrome – Group 9&lt;br /&gt;
&lt;br /&gt;
*	Introduction seems very conscise and clear. Use of an image would improve this section. &lt;br /&gt;
*	History of the disease is great. Seems well detailed and reference. Use of the timeline is great. This could be put into a table so it can be centered and improve the overall look of the project. Another image could be included in this section as well, maybe of J. Williams?&lt;br /&gt;
*	I thought the Genetic Factors and Etiology section was great. Well written and good use of images. Table was fantastic. I though maybe another section dealing the pathogenesis and pathophysiology would be more informative. &lt;br /&gt;
*	Some of your images don’t have a good detailed explanation of what they are showing. I think this would greatly improve your use of images. &lt;br /&gt;
*	Epidemiology seems good, covers all the necessary information. I thought an image here could be good, maybe a graph of incidence rates in certain countries. &lt;br /&gt;
*	Phenotype is very informative and well written however doesn’t seem to be any referencing. Is this information reliable?&lt;br /&gt;
*	Cardiac Conditions is incomplete, “other problems” subheading. &lt;br /&gt;
*	More images in Genitourinary and Endocrine headings., and a few others This will help break up the text. Seems quite text heavy in a few sections. &lt;br /&gt;
*	Current research and future developments seems incomplete. Not much is mentioned about future research prospects in regards to what we are trying to discover and what direction it is taking etc. This would improve this section. The projects that are mentioned could be elaborated on and their importance explained. &lt;br /&gt;
*	Glossary needs completing.&lt;br /&gt;
*	Otherwise very well done. Looks like a lot of work has been put in with some very interesting information presented. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3288196|Z3288196]] 10:48, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessment'''&lt;br /&gt;
&lt;br /&gt;
*Introduction; well written. Concise and to the point, requires an image.&lt;br /&gt;
*The history is too text heavy and is hard to follow. The timeline needs to summarized, includes too much of information. Try to include an image to make it look more appealing.&lt;br /&gt;
*Really like the table and image in the genetic factors/etiology section. They break up the text nicely and makes it easier to understand and follow.&lt;br /&gt;
*Epidemiology section should come above diagnosis. Why is treatment and management included as sub headings in the epidemiology section? It would make more sense to have them as separate sections further down. The information on epidemiology needs to be expanded a little it more.&lt;br /&gt;
*Phenotype; good layout. &lt;br /&gt;
*The 'other problems' subheading under cardiac conditions has no information.&lt;br /&gt;
*The layout of headings and subheadings needs to be fixed. It's a bit confusing and hard to follow at the moment. For example, try to combine Genitourinary, cardiac conditions and endocrine under one heading rather than 3 separate sections. &lt;br /&gt;
*The &amp;quot;Cognitive, Behavioural and Neurological Phenotype&amp;quot; sections needs images to break up the text. Try and summarize some of the information. This section looks a bit mundane compared with the rest.  Requires more referencing, there only one reference per sub section at the moment.&lt;br /&gt;
*Not sure if you need to include the &amp;quot;Specialised Facilities and Supportive Associations&amp;quot; section. Maybe add a link to these websites instead.&lt;br /&gt;
*Current research and development is too brief, needs more information.&lt;br /&gt;
*Glossary: Needs to be expanded.&lt;br /&gt;
--[[User:Z3291622|Z3291622]] 10:46, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Peer Review'''&lt;br /&gt;
&lt;br /&gt;
This wiki shows a lot of promise and a lot of energy has been used into it, just needs a little more polish&lt;br /&gt;
&lt;br /&gt;
:*Very text heavy, most notably in sections:Genitourinary Conditions, Cognitive, Behavioural and Neurological Phenotype, Structural Differences in the Brain.&lt;br /&gt;
&lt;br /&gt;
:*You should refrain from using the words &amp;quot;mental retardation&amp;quot; as this could be deemed offensive. Use &amp;quot;intellectual disability&amp;quot; as that is a more common term now used in Australia. Also use &amp;quot;learning difficulty&amp;quot; or &amp;quot;developmental delay&amp;quot;. We should also encourage the use of person-first language e.g., &amp;quot;a child with an intellectual disability&amp;quot; rather than &amp;quot;intellectually disabled child&amp;quot;. This promotes the idea that a person comes before their disability.&lt;br /&gt;
&lt;br /&gt;
:*Some sections could do with images just so it breaks up the info and text.&lt;br /&gt;
&lt;br /&gt;
:*Structural Differences in the Brain has only one reference, yet all that info. Could you have found more references to back the section?&lt;br /&gt;
&lt;br /&gt;
:*Specialised Facilities and Supportive Associations could do without. I find it distracting and could better suited as External Links or Queries.&lt;br /&gt;
&lt;br /&gt;
:*Glossary needs a lot of work.&lt;br /&gt;
&lt;br /&gt;
:*Current Research in comparison to the text heavy sections is lacking and in doing also in bullet point form seems out of place. Needs an overhaul.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3293267|z3293267]] 10:18, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Peer Review&lt;br /&gt;
&lt;br /&gt;
Some places for improvement. &lt;br /&gt;
&lt;br /&gt;
:*Double spacing of paragraphs looks awkward.&lt;br /&gt;
&lt;br /&gt;
:*History section would benefit by placing the information into the timeline rather than paragraphs as it is a bit hard to follow.&lt;br /&gt;
&lt;br /&gt;
:*In the diagnosis section each of the hallmark symptoms could be further explained rather than just listed.  &lt;br /&gt;
&lt;br /&gt;
:*The management steps could be explained rather than just listed. Not enough information in this section. Treatment is very choppy, should be written in paragraphs not sentences. &lt;br /&gt;
&lt;br /&gt;
:*Research could be summarised and papers talked about rather than just listing papers of current research or individuals that are researchers.&lt;br /&gt;
&lt;br /&gt;
:*Glossary needs to be finished. If you didn’t have time, should have gotten rid of terms.&lt;br /&gt;
&lt;br /&gt;
:*References need to be fixed. There are many that are just a web address. Full citation is needed. Several different styles of referencing used, just have one.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3217043|z3217043]] 09:57, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Group 9 Peer Review&lt;br /&gt;
&lt;br /&gt;
*Introduction is well written however a simple image would make this more appealing&lt;br /&gt;
*Epidemiology should be earlier in the page&lt;br /&gt;
*Needs an image in history to break up the text. Even the timeline put into a table would help&lt;br /&gt;
*Some headings could be more general as not to confuse the reader with scientific jargon&lt;br /&gt;
*Text/image ratio is not quite balance. Less text and more images would be better&lt;br /&gt;
*Phenotype section is well written-well done&lt;br /&gt;
*Glossary needs to be extended&lt;br /&gt;
*Referencing is fine&lt;br /&gt;
*Overall, a well researched project however better organisation of text and images will help with the presentation of this information&lt;br /&gt;
--[[User:Z3308965|Fleur McGregor]] 09:44, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*Intro: Clear and concise information but you definitely need an image.&lt;br /&gt;
&lt;br /&gt;
*History: Stick to the timeline, no need for long paragraphs. &lt;br /&gt;
&lt;br /&gt;
*Genetics: Love th atble and the colour is excellent. The  information above the table needs to be broken down with sub-headings.&lt;br /&gt;
&lt;br /&gt;
*Diagnosis:  The image needs more explanation or referred to in the writings to get a better understanding. &lt;br /&gt;
&lt;br /&gt;
*Epidemiology:Confused as to why this sections is positioned here. It should be one of the initial sections. Only one line for the entire section, because obviously management and treatment need their own section. &lt;br /&gt;
&lt;br /&gt;
*Phenotype: The student drawn image is excellent and very well suited.&lt;br /&gt;
&lt;br /&gt;
*Cardiac conditions: difficult to follow the large blocks of text.&lt;br /&gt;
&lt;br /&gt;
*Current research: Poorly done in comparison to the rest of the project. Needs more work.&lt;br /&gt;
&lt;br /&gt;
*Glossary: There is many more words that need to be in this section. A lot of terminology has been used in the previous parts.&lt;br /&gt;
&lt;br /&gt;
*Overall, great job (some parts more than others), need to make the page more cohesive by using a common formatting style, add plenty more words to the glossary and revise and trim some of the longer segments.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3290270|z3290270]] 02:20, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Group 9&lt;br /&gt;
&lt;br /&gt;
Hey, your page has a lot of very interesting content and some unique self drawn images. I thoroughly enjoyed this page, thanks&lt;br /&gt;
&lt;br /&gt;
#The key points relating to the topic that your group allocated are clearly described. &lt;br /&gt;
#* Introduction: Inclusion of incidence would be nice&lt;br /&gt;
#* History: very informative and a nice simple timeline&lt;br /&gt;
#* Genetics: Good, succinct section, especially liked the table&lt;br /&gt;
#* Diagnosis: needs referencing. Is diagnosis only postnatal? What is the average age of diagnosis for this disease?&lt;br /&gt;
#* Management and Treatment: Seems a little out of place under epidemiology, I think it should be place later on &lt;br /&gt;
#* Phenotype:Reference?&lt;br /&gt;
#* Cardiac conditions: maybe give explanations for atrial and ventricular septal defect, just brief descriptions would suffice. Why is it so that males are more likely to suffer CVD than females?&lt;br /&gt;
#The choice of content, headings and sub-headings, diagrams, tables, graphs show a good understanding of the topic area. &lt;br /&gt;
#* good subheadings, interesting self drawn images. However, this page needs to find a balance in text and images&lt;br /&gt;
#Content is correctly cited and referenced.&lt;br /&gt;
#* needs to work on referencing&lt;br /&gt;
#The wiki has an element of teaching at a peer level using the student's own innovative diagrams, tables or figures and/or using interesting examples or explanations.&lt;br /&gt;
#Evidence of significant research relating to basic and applied sciences that goes beyond the formal teaching activities. &lt;br /&gt;
#* research done is evident, just need to reference&lt;br /&gt;
#Relates the topic and content of the Wiki entry to learning aims of embryology. &lt;br /&gt;
#Clearly reflects on editing/feedback from group peers and articulates how the Wiki could be improved (or not) based on peer comments/feedback. Demonstrates an ability to review own work when criticised in an open edited wiki format. Reflects on what was learned from the process of editing a peer's wiki. &lt;br /&gt;
#Evaluates own performance and that of group peers to give a rounded summary of this wiki process in terms of group effort and achievement. &lt;br /&gt;
#The content of the wiki should demonstrate to the reader that your group has researched adequately on this topic and covered the key areas necessary to inform your peers in their learning. &lt;br /&gt;
#* very interesting content, informative&lt;br /&gt;
#Develops and edits the wiki entries in accordance with the above guidelines&lt;br /&gt;
&lt;br /&gt;
&amp;quot;What would improve this project....&amp;quot; &lt;br /&gt;
&lt;br /&gt;
* referencing&lt;br /&gt;
* more images&lt;br /&gt;
* glossary; lacking a lor of terms&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3291643|z3291643]] 00:10, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Peer Review for Group 9'''&lt;br /&gt;
&lt;br /&gt;
*Introduction gives a well rounded view of the syndrome&lt;br /&gt;
*Maybe in the history of the syndrome you can find images of the 2 historic people for the syndrome, i.e. one for william and one for beuren.&lt;br /&gt;
*In the timeline, isn’t there any important contributions made between ’93 and ’06. Other than that it was well made.&lt;br /&gt;
*In the table found in the genetics part of the page, Elastin row and GTF2I row has no referencing to the information presented. Please add them.&lt;br /&gt;
*I think the treatment under epidemiology should have its own title as it only refers to epidemiology slightly&lt;br /&gt;
*The phenotype of Williams syndrome has no referencing in this section. Also i don’t think you need a table to sort this information as it is, rather have them under little subheadings&lt;br /&gt;
*The other problems subheading under cardiac conditions has no info, either put some in or remove it later.&lt;br /&gt;
*Under the endocrine section, the thyroid part hasd no referencing please include it.&lt;br /&gt;
*Some information in the table found in the ‘other abnormalities section lacks some referencing aswell.&lt;br /&gt;
*In the structural differences of the brain section, the top 2 paragraphs lack referencing.&lt;br /&gt;
*The Cognitive, Behavioural and Neurological Phenotype section was interesting to read.&lt;br /&gt;
*The information under Specialised Facilities and Supportive Associations seems a bit unnecessary for this style of assignment. Rather have links to these organisations rather than having them explained on the page.&lt;br /&gt;
*More current literature in regards to the syndrome could also be presented to give the reader a sense of direction in which way the research is heading&lt;br /&gt;
*Glossary must be updated and expanded, many words are used that are not explained&lt;br /&gt;
*Referencing is done very well&lt;br /&gt;
*Need to balance picture to words ratio as it is heavy on the word side. I understand its hard to obtain, thus maybe drawing them would be better alternative. &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3291317|Z3291317]] 23:56, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
peer review: &lt;br /&gt;
 	&lt;br /&gt;
*Intro and history are great lead ins to your project, but id really appreciate a picture or two for those who can't visualise what you are trying to say.&lt;br /&gt;
&lt;br /&gt;
*No glossary for those verbose words such as haploinsufficiency?&lt;br /&gt;
&lt;br /&gt;
*The order of your headings is really out of order, how can you go from aetiology to diagnosis and then back to epidemiology? &lt;br /&gt;
&lt;br /&gt;
Introduction and history: These sections need pictures. It is difficult to read such a large block of text.&lt;br /&gt;
&lt;br /&gt;
*management and treatment should be well explained, not everyone knows how a urine analysis shows a person has Williams-Beuren Syndrome&lt;br /&gt;
&lt;br /&gt;
*how about subheadings under treatment? &lt;br /&gt;
	&lt;br /&gt;
*I think your headings are really confusing, no logical order or why one follows the next.  &lt;br /&gt;
&lt;br /&gt;
*nothing under other problems section of the cardiac conditions..?&lt;br /&gt;
&lt;br /&gt;
*combine Genitourinary, cardiac conditions and endocrine under one heading.&lt;br /&gt;
&lt;br /&gt;
*Cognitive, Behavioural and Neurological Phenotype needs to have some pictures to break up the tonne of writing! &lt;br /&gt;
&lt;br /&gt;
*whilst Specialised Facilities and Supportive Associations is a good idea, maybe just include a link instead of actually listing so much. This isn't a major part of the project so i don't think so much detail needs to be into it.&lt;br /&gt;
&lt;br /&gt;
*current research should describe what is happening..not just listing the new articles.&lt;br /&gt;
&lt;br /&gt;
* very little glossary&lt;br /&gt;
--[[User:Z3291423|Jasjit Walia]] 23:42, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
&lt;br /&gt;
Introduction and history: These sections need pictures. It is difficult to read such a large block of text.&lt;br /&gt;
&lt;br /&gt;
Genetics: Good section overall. The genetics could be explained in a bit more detail and the pictures could be a bit bigger.&lt;br /&gt;
&lt;br /&gt;
Diagnosis: Good section- well written and clearly explained.&lt;br /&gt;
&lt;br /&gt;
Epidemiology: Would be better in paragraphs not dot points.&lt;br /&gt;
&lt;br /&gt;
Phenotype table: I think it would look better if the colours were changed so that it looks more professional.&lt;br /&gt;
&lt;br /&gt;
Cardiac/genitourinary/endocrine: These sections need more pictures to break up all the text.&lt;br /&gt;
&lt;br /&gt;
Cognitive phenotype: This section is by far the most detailed and well explained section. It would be much better with pictures though. Great work.&lt;br /&gt;
--[[User:Z3291324|z3291324]] 23:26, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''' Group 9 Peer Review'''&lt;br /&gt;
&lt;br /&gt;
* Interesting introduction, however it's difficult to appreciate without a diagram of sorts. The introduction is succinct and leads well into the project. The history of the disease is also well presented, and the timeline quite clear - in general, these sections only require an image (if possible) to be complete!&lt;br /&gt;
* The section on genetic factors and etiology is well explained, and the variation of formats makes the information easy to obtain. &lt;br /&gt;
* Diagnosis section is also well laid out; perhaps more referencing in this section could explore different methods (if there are any?). &lt;br /&gt;
* Epidemiology is outlined well, although I don't think you want to put management and treatment in the same section as epidemiology; they should be on their own independent sections. I think you may have slightly misunderstood epidemiology (occurrence, bias to sex/age/gender/race, etc.). &lt;br /&gt;
* Phenotype is well set out, and the student-drawn image has been well chosen for this section! &lt;br /&gt;
* Cardiac Conditions, Genitourinary conditions, Endocrine, Other Associated Medical Conditions etc. &amp;lt;-- make these sections subsections of Clinical presentation, etc. In general these sections might benefit from the occasional table, as well as diagrams to help break up the information; large blocks of text are difficult to read and maintain interest of the readers.&lt;br /&gt;
* Current research and developments section, compared to the rest of the project is not of the same standard; it could do with some well-placed research! Try to place some emphasis on this section as these areas outline whether we can hope for a cure in the future and give the reader some direction as to where the condition/disease is heading.&lt;br /&gt;
* Glossary is still incomplete; but this is obvious and something which (I'm sure) everyone needs to complete! The references are generally well used; see if you implement more in your research. &lt;br /&gt;
* Overall, a pleasing product; try for more images, but otherwise there is more than enough information required for the project. Try to distribute it over the sections and ensure the information presented under each subheading is relevant; you may want to also consider absorbing some sections and re-classifying them as sub-sections. &lt;br /&gt;
--[[User:Z3288827|Leonard Tiong]] 22:15, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
&lt;br /&gt;
*The introduction is easy to read and brief. It has been referenced well.&lt;br /&gt;
*The history section however is difficult to read because there is so much information. Maybe including an image would help and formatting the timeline into a table as well.&lt;br /&gt;
*Maybe it would be a good idea to place epidemiology after history for the flow of the page&lt;br /&gt;
*And the sub-headings underneath epidemiology deserve its own heading such as treatment and management as it has nothing to do with epidemiology&lt;br /&gt;
*Phenotype of Williams Syndrome - nice piece of extra information however it is not referenced at all&lt;br /&gt;
*Nothing follows after other problems...&lt;br /&gt;
*Other Associated Medical Conditions - so much is dedicated to this section! maybe reduce the amount of info.&lt;br /&gt;
*Furthermore the glossary is incomplete&lt;br /&gt;
*However overall it is a good start. There were some good images used and the information was understandable&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3330313|z3330313]] 00:57, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
&lt;br /&gt;
'''*The key points relating to the topic that your group allocated are clearly described.'''&lt;br /&gt;
main points are there but may not be very well structured. Management and treatment are the same (even with repeated text) and i think it can be made into one section. It should also be on its own (big heading) and not under epidemiology. Also, epidemiology by itself is very limited. Treatment section is poorly structured with different sentences talking about different things.&lt;br /&gt;
&lt;br /&gt;
'''*The choice of content, headings and sub-headings, diagrams, tables, graphs show a good understanding of the topic area.'''&lt;br /&gt;
In Endocrine section, include information such as why individuals with william's symdrome is prone to such disorders. What does it relate to? Key information is there but perhaps not well structured.&lt;br /&gt;
&lt;br /&gt;
'''*Content is correctly cited and referenced.'''&lt;br /&gt;
Structural Differences in the Brain should have more references. Cognitive, Behavioural and Neurological Phenotype needs more references for that amount of text. where did you base File:House drawings Williams.jpg off?&lt;br /&gt;
&lt;br /&gt;
'''*The wiki has an element of teaching at a peer level using the student's own innovative diagrams, tables or figures and/or using interesting examples or explanations.'''&lt;br /&gt;
Image showing typical phenotype is good with adequate explanation.&lt;br /&gt;
&lt;br /&gt;
'''*Evidence of significant research relating to basic and applied sciences that goes beyond the formal teaching activities.'''&lt;br /&gt;
extensive use of research papers evident in the references but more in-text referencing would be good.&lt;br /&gt;
&lt;br /&gt;
'''*Relates the topic and content of the Wiki entry to learning aims of embryology.'''&lt;br /&gt;
Genitourinary Conditions could be related to embryological development as most of these conditions are traced back to fetal development.&lt;br /&gt;
&lt;br /&gt;
'''*Develops and edits the wiki entries in accordance with the above guidelines.'''&lt;br /&gt;
Mostly developed by the guidelines but some changes would be beneficial.&lt;br /&gt;
&lt;br /&gt;
--z3329495 21:25, 28 September 2011 (EST) &lt;br /&gt;
&lt;br /&gt;
'''Group 9: Peer assessment'''&lt;br /&gt;
* The introduction is good&lt;br /&gt;
* The history section is informative but may be could be kept a little shorter&lt;br /&gt;
* The start of the page is quite text heavy, may be you can brake it up with a picture&lt;br /&gt;
* Rearrange you page, so that you have the epidemiology section right after the history section&lt;br /&gt;
* Genetic and aetiology sections are well done&lt;br /&gt;
* There are no references in the Phenotype section&lt;br /&gt;
* May be the detail in the foundations is a little over the top. Why not put a simple link to their web side instead?&lt;br /&gt;
* The research section could be a little more detailed&lt;br /&gt;
* It would be good to put more of the terms used into your glossary&lt;br /&gt;
* Overall the page is interesting to read. A few more images would be nice. --z3279511 17:15, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
&lt;br /&gt;
*You don’t have a very good image/text ratio. More images are needed to break up the text.&lt;br /&gt;
*Good information in your introduction although you need an image&lt;br /&gt;
*Maybe try and condense your history just into a timeline?&lt;br /&gt;
*Genetic factors and etiology and diagnosis are good and have a nice flow&lt;br /&gt;
*I think the section epidemiology should closer to the beginning of your project- also not sure why management and treatment are mentioned here.&lt;br /&gt;
*Phenotypes should be organised better&lt;br /&gt;
*Good table for associated medical conditions&lt;br /&gt;
*A few of your headings should be reformatted&lt;br /&gt;
*Specialised facilities and supportive associations seems a little unnecessary&lt;br /&gt;
*Glossary is incomplete&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
&lt;br /&gt;
*Introduction: contend is fine&lt;br /&gt;
&lt;br /&gt;
*History: could be a bit shortened, otherwise good&lt;br /&gt;
&lt;br /&gt;
*Genetic and Etiology: well done&lt;br /&gt;
&lt;br /&gt;
*Diagnosis: looks good&lt;br /&gt;
&lt;br /&gt;
*Epidemiology: treatment doesn’t belong there (own section?), the contend is good&lt;br /&gt;
&lt;br /&gt;
*Phenotype: references missing&lt;br /&gt;
&lt;br /&gt;
*Cardiac conditions: well done, but what’s with other conditions?&lt;br /&gt;
&lt;br /&gt;
*Genitourinary Conditions: the contend is good, but the structure could be clearer, a table for the grading system would be nice&lt;br /&gt;
&lt;br /&gt;
*Endocrine: missing references, otherwise good section&lt;br /&gt;
&lt;br /&gt;
*Other associated conditions: looks fine&lt;br /&gt;
&lt;br /&gt;
*Cognitive, behavioural Phenotype: references missing?&lt;br /&gt;
&lt;br /&gt;
*Structural diff. in the brain: is there really only one resource? Lack of structure and subheadings&lt;br /&gt;
&lt;br /&gt;
*Special Facilities: I don’t think it is necessary to list the addresses of the foundations, and write down all their aims. The online link is enough.&lt;br /&gt;
&lt;br /&gt;
*Research: could have more detailed information&lt;br /&gt;
&lt;br /&gt;
*Glossary: incomplete&lt;br /&gt;
&lt;br /&gt;
*The phenotype sections should be put together&lt;br /&gt;
--[[User:Z3387190|Z3387190]] 23:20, 27 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Comments on Group Project 9===&lt;br /&gt;
'''Strengths:'''&lt;br /&gt;
*Good use of subheadings. It gives the page a structured feel to it.&lt;br /&gt;
*For most part of the references, it is good with the initiative to prevent duplication of references.&lt;br /&gt;
* I really like the “Specialised Facilities and Supportive Associations” section. Parents who just found out about their child’s condition would probably want to know more and seek help and this would be good for them.&lt;br /&gt;
'''Weaknesses:'''&lt;br /&gt;
*The history section looks really overwhelming. &lt;br /&gt;
*The glossary section is poorly done, with missing definitions for some words. There are other words that should be included in the glossary but was not.&lt;br /&gt;
*The image of the typical facial feature of an individual with WS looks similar to the one shown during lecture by Dr Palmer. It would be good to acknowledge what the image drawn was based on.&lt;br /&gt;
'''Specific corrections:'''&lt;br /&gt;
*It will be good to include an image in either the introduction or history section. At least it will be able to grab some attention.&lt;br /&gt;
*Reference 23 is missing its source.&lt;br /&gt;
*It will be good to elaborate more on some of the research studies being done to give the readers a feel of the direction in which the research for Williams Syn is gearing towards.&lt;br /&gt;
&lt;br /&gt;
--Z3389806 06:45, 27 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Group 9: Williams Syndrome&lt;br /&gt;
*First few sections are lacking in images to draw readers attention. &lt;br /&gt;
*Intro: brief but still provides a good overview to the webpage.&lt;br /&gt;
*History: Timeline is a great addition, but maybe consider a table format just to clean up the text a little bit.&lt;br /&gt;
*Genetic factors: Good use of image and table. Also well referenced.&lt;br /&gt;
*Epidemiology: I think this section would benefit from a few paragraphs of information rather than just bullet points.&lt;br /&gt;
*Current research: needs more information here about the research itself, not just the foundations &lt;br /&gt;
*Specialised facilities and supportive associations: is a nice touch the webpage&lt;br /&gt;
*Glossary: could be expanded upon and is incomplete.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332327|z3332327]] 01:36, 29 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Group 9 Peer Assessment'''&lt;br /&gt;
*Introduction has clear explanation of the topic though image would liven the section up&lt;br /&gt;
*History is very informative though have no images, image of the founder would suit this area. While the time line done properly and looks good but bullet points would make look better&lt;br /&gt;
*Genetic factors should incorporate the image used “fig 2”, although the use of the table is well made explaining the cases of genetic transmission.&lt;br /&gt;
*Diagnosis introduction done well though image “fig 3” not mentioned in the text which should also be integrated into the text.&lt;br /&gt;
*Epidemiology should be first before the diagnosis and treatment would be better as its own heading and below near the end.&lt;br /&gt;
*Headings needs to be more organised and some more images which are linked to the text otherwise very bulky with text&lt;br /&gt;
*Current research/ future research done well and separated with sub headings&lt;br /&gt;
*Glossary need to be expanded as most terms not understood without a dictionary&lt;br /&gt;
*Reference 23 and 2 needs to be fixed otherwise all done well&lt;br /&gt;
z3332250 23:57, 26 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Group 9 Critique'''&lt;br /&gt;
&lt;br /&gt;
#•	Introduction is ok. Maybe add a picture or two to make the introduction look a little bit more interesting&lt;br /&gt;
#•	History is pretty good. Nice work on the timeline!&lt;br /&gt;
#•	The table in the section on genetic factors is appropriate. Good job!&lt;br /&gt;
#•	Diagnosis is good&lt;br /&gt;
#•	Epidemiology should be after introduction, not diagnosis, but otherwise ok&lt;br /&gt;
#•	The overall project is quite good, however diagnosis should be at the end and not one of the first sections&lt;br /&gt;
#•	Also, is it necessary to put in information about support groups? Something to think about&lt;br /&gt;
#•	Glossary is unfinished&lt;br /&gt;
#•	The current research and developments section should have more information in it. Two lines of information is not enough detail&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3289991|Robert Klein]] 16:16, 26 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Peer Assessment Group 9 '''Williams-Beuren Syndrome'''&lt;br /&gt;
&lt;br /&gt;
*The introduction could use a simple image of the chromosome 7q11.23 just to make the introduction look a bit more interesting&lt;br /&gt;
*History is too detailed and in a few instances a repetition of the timeline&lt;br /&gt;
*An image in the timeline section will make it a bit more interesting&lt;br /&gt;
*The section 'Genetic factors and Etiology' is a great balance of image, table and text. Interesting information presented simply and clearly&lt;br /&gt;
*Interesting image of the deleted gene location&lt;br /&gt;
*Under Epidemiology you could also talk about prevalence of the condition in certain regions of the world etc. It looks like a one sentence section. &lt;br /&gt;
*The management section looks like it is part of epidemiology. You might want to reformat this to make it look like it is a topic by itself.&lt;br /&gt;
* Too many one sentence paragraphs under 'Treatment'. It might be a good idea to organise the thoughts and bunch them into small paragraphs. Half a line in a paragraph doesn't look great, surely these single lines can relate to another paragraph. &lt;br /&gt;
*The heading 'other problems' don't sound descriptive enough, you might want to call it, 'Associated Abnormalities'.&lt;br /&gt;
*Please add 'Genitourinary Conditions' in addition to a heap of other unexplained terms in the glossary&lt;br /&gt;
*I like the addition of Figure 6. It is an interesting observation.&lt;br /&gt;
*The addition of support groups in Australia and other places is a useful section.&lt;br /&gt;
*Overall the page has been well researched, just find a balance between texts, images and tables and it will be an informative page to refer back to.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Williams-Beuren Syndrome'''&lt;br /&gt;
&lt;br /&gt;
*'Introduction' is good, but need an image to open up the page&lt;br /&gt;
*Can you try to compile all that text in 'History' into the timeline?  Otherwise it's a bit much and a bit repetitive; an image couldn't hurt either&lt;br /&gt;
*Good work with 'Genetics', easy to read and interesting&lt;br /&gt;
*Diagnosis might fit better below the signs and symptoms, ie after we know enough about the syndrome to fully appreciate the diagnosis&lt;br /&gt;
*'Treatment' doesn't really fit in 'Epidemiology', again this would be better towards the end of the page&lt;br /&gt;
*Nice table for 'Phenotype of Williams Syndrome', very clear and informative&lt;br /&gt;
*Your subtitles are a little confusing, you might want to try incorporating all the condions ie cardiac and genitinary into one section&lt;br /&gt;
*Though the information within these sections is very good&lt;br /&gt;
*You seem to be missing a ''lot'' of images, it's difficult to read when it's just blocks of text&lt;br /&gt;
*For 'Cognitive, Behavioural and Neurological Phenotype' you need more references.  You should back up what your saying with at least 2 references; though there seems to be a lot of interesting information here&lt;br /&gt;
*'Structural Differences in Brain' - only 1 reference for all that information? That doesn't seem very reliable&lt;br /&gt;
*I like the topic 'Specialised Facilities and Supportive Associations', really interesting choice. Very good&lt;br /&gt;
*For 'Current Research', instead of just an article reference, make a brief summary of the paper and describe why it is significant?  Otherwise this section is a bit pointless.&lt;br /&gt;
*The glossary can't hurt to be expanded..... and finished.&lt;br /&gt;
*Overall, the page looks good, clearly a lot of research has gone into it.  Just focus on making it more visually appealing, and work on those references&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Group 9- &lt;br /&gt;
* Glossary is incomplete&lt;br /&gt;
* There are very few images on the page to break up the text&lt;br /&gt;
* Introduction needs an image. Other than that the information is good&lt;br /&gt;
* History- not sure if you need the text AND the list of dates. Maybe you could combine it all into one&lt;br /&gt;
* Genetic factors and etiology- really good. Easy to understand and visually appealing&lt;br /&gt;
* Diagnosis is also easy to take in&lt;br /&gt;
* Epidemiology should be up the top before diagnosis&lt;br /&gt;
* Also you need to sort out your subheadings. Management and treatment are not part of epidemiology&lt;br /&gt;
* More information is needed on the actually epidemiology&lt;br /&gt;
* Phenotype should come before treatment so we know why the treatments are necessary &lt;br /&gt;
* Also- cardiac, endocrine and genitourinary conditions are part of the phenotype. Maybe consider including these in the table&lt;br /&gt;
* The whole phenotype section is confusing sorry. It is ALL phenotype but you have put it in different sections. Not really sure why you have done this. It needs to be formatted better.&lt;br /&gt;
* The information is all there it just isn’t organised properly&lt;br /&gt;
* Do you need this? ‘Specialised Facilities and Supportive Associations&lt;br /&gt;
* You have done a great job of researching and the information is all there its just really confusing sorry. You need to find a way of organizing it so that it is more accessible to the reader.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Group 9'''&lt;br /&gt;
* The structure and use of headings and subheadings is good but i think you need to rethink the order of your headings eg epidemiology should be closer to the beginning. &lt;br /&gt;
* Intro informative. maybe you could bullet point the phenotypic characteristics, just make it easier to read. could you add a picture in this section?&lt;br /&gt;
* Nice history, could you maybe put your timeline into a table.&lt;br /&gt;
* good use of the table in genetics and aetiology and nice to see the accompanying picture referenced. &lt;br /&gt;
* I feel treatment should be its own heading and not a subheading.&lt;br /&gt;
* Phenotype of Williams Syndrome- a nice easy to read section breaking up the text. Could you add anymore pictures here?&lt;br /&gt;
* Genitourinary Conditions is very text heavy could you add in some pictures here or tabulate some of the information, just to keep the page flowing nicely. &lt;br /&gt;
* The endocrine section should be renamed, as it does not really explain to the reader what your going to talk about. &lt;br /&gt;
* Other Associated Medical Conditions- is a nice section good use of the table. &lt;br /&gt;
* Cognitive, Behavioural and Neurological Phenotype section is very text heavy it needs to be broken up either by pictures or a table. but it seems like a lot of effort has been put into the research in this section.&lt;br /&gt;
* Im not sure whether this section is necessary for our assessment Specialised Facilities and Supportive Associations??&lt;br /&gt;
* Current research and developments should be above the preceding section and a summary of the information would be nice instead of dot points.&lt;br /&gt;
&lt;br /&gt;
'''Group 9 Assessment'''&lt;br /&gt;
*Great job of linking the same resource to the same reference number in the reference section!&lt;br /&gt;
*The introduction and history are very thorough, but what’s missing are pictures to help it look more appealing.  &lt;br /&gt;
*The timeline- the information it good, but it might look better in a table format.  &lt;br /&gt;
*The genetic factors chart is good, but the last row doesn’t have any referencing… &lt;br /&gt;
*The diagnosis section definitely needs more referencing for all of the information. &lt;br /&gt;
*Epidemiology- This section could also really use some pictures to add to the section. &lt;br /&gt;
*The phenotype chart also needs all of the information referenced…  It might also be helpful to have more pictures, at least one for each subgroup within the chart. &lt;br /&gt;
*The Genitourinary Conditions section is rather wordy… Pictures could definitely be helpful here as well as more bullet lists or possibly another chart to simplify the info.&lt;br /&gt;
*The complete list of problems and associated medical conditions is rather lengthy… It might be a good idea to simplify all of this information as much as possible and simply compile it ALL together into one chart….&lt;br /&gt;
 *The whole “Cognitive, Behavioral and Neurological Phenotype” as well as the “Structural Differences in the Brain” sections definitely need more referencing.  &lt;br /&gt;
*Are support groups really necessary to be included for this project?  &lt;br /&gt;
*Current research could also a picture or two.  &lt;br /&gt;
*Not all the words are defined in the glossary, and it might look better if a bullet list were used here.  Also, it would be nice to have the glossary words linked to the actual words in the wiki page for easy reference.&lt;br /&gt;
*Overall, not bad.  Just work on fixing the overall flow and referencing and you will be fine! &lt;br /&gt;
--[[User:Z3391078|Z3391078]] 16:35, 27 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Peer Assessment: Group Project 9'''&lt;br /&gt;
*The introduction and history of the disease are informative and it is good to have both the detailed historical information in addition to the timeline.&lt;br /&gt;
*It might be good to have an image at the beginning of the page to break up the text, such as of someone prominently involved with the disease findings (John C.P. Williams or Alois J Beuren).&lt;br /&gt;
*The diagnostic section only has one reference which detracts from the reliability of the section and makes the reader wonder where the information was sourced from. It is also good to place it in as if the reader desires to know more about the subject, they are able to look at where certain parts came from.&lt;br /&gt;
*The phenotype section is really clear and well formatted, however there are no references in this section.&lt;br /&gt;
*In general there needs to be more images/figures/graphs to help the ease of reading. For example in sections: Genitourinary Conditions, Other Associated Medical Conditions and Cognitive, Behavioural and Neurological Phenotype.&lt;br /&gt;
*The section on specialised facilities and supportive associations is an additional section that really adds to the page.&lt;br /&gt;
*There needs to be a picture drawn by a student.&lt;br /&gt;
*Some of the definitions of words in the glossary need to be completed.&lt;br /&gt;
--[[User:Z3217345|z3217345]] 10:16, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
*'''Intro''': More info about the syndrome itself needed. Add a picture if you can? The text alone is a bit dry.&lt;br /&gt;
*'''History''': ... 1952 is really not early. I'd call it a rather new syndrome if that's when it was discovered..? Otherwise, lots of info and references, which is good.&lt;br /&gt;
*'''Genetic factors and Etiology''': Looks good.&lt;br /&gt;
*'''Diagnosis''': Seems fine.&lt;br /&gt;
*'''Epidemiology''': Not sure it makes sense to have management and treatment under epidemiology? Content seems fine, though is very text-heavy, maybe find a figure to break it up?&lt;br /&gt;
*'''Phenotype''': I like the table. Gives an easy overview.&lt;br /&gt;
*'''Cardiac Conditions''': Good content. I assume the &amp;quot;other problems&amp;quot; section is still under construction?&lt;br /&gt;
*'''Genitourinary Conditions''': Content seems fine, but it's very text heavy, this really needs to be broken up somehow. Possibly use a table, or include more figures.&lt;br /&gt;
*'''Endocrine''': Endocrine what? Conditions? That title is a bit odd. Otherwise, looks good. How come the thyroid section doesn't have a reference?&lt;br /&gt;
*'''Other Associated Medical Conditions''': Good content, I like the table.&lt;br /&gt;
*'''Cognitive, Behavioural and Neurological Phenotype''': Very impressive amount of (really interesting) information, which however currently mainly consists of text. Some more figures will help break that down a bit. (Watch out with the spatial cognition part - the title is spelled correctly, but within the text it's all &amp;quot;spacial&amp;quot;.) Otherwise, very well done!&lt;br /&gt;
*'''Structural Differences in the Brain''': Not quite sure it makes sense to have this section here - put it before the cognitive phenotype section, instead after? Content is very good.&lt;br /&gt;
*'''Specialised Facilities and Supportive Associations''': Interesting idea. Not quite sure it's needed cause I think we're supposed to focus on the science, but at the same time I don't see why not include it. Though your formatting makes it a very long section - I'd keep it more brief.&lt;br /&gt;
*'''Current research and developments''': A little bit too brief. You could expand a little bit more on what is being done. The links are good, but maybe give a few more examples of recent papers and reviews.&lt;br /&gt;
*'''Glossary''': Poor. MANY more terms need explanations.&lt;br /&gt;
*'''References''': Looks fine in general, though the link might need fixing, and also one reference leads to emptiness?&lt;br /&gt;
*General: From the conditions sections onwards I'm not quite sure the sections and different titles you have chosen make sense, it seems a bit confusing. Maybe rethink that and try and come up with a more clear structure? Also, you need to make your structuring and how you split up a section into subsections more uniform.&lt;br /&gt;
Overall though, you cover an impressive spectrum of information. Well done!&lt;br /&gt;
&lt;br /&gt;
'''Peer Review'''&lt;br /&gt;
&lt;br /&gt;
* interesting &lt;br /&gt;
* a lot of information has been put into it but relevant and not repetive&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3060621|z3060621]] 21:53, 28 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Discussion==&lt;br /&gt;
&lt;br /&gt;
Hey i found this paragraph which i think could go into epidemiology some how...Nobby do you think it could help?&lt;br /&gt;
&lt;br /&gt;
Subsequent characterization of the deleted interval, now referred to as the WBS critical region, reveals the following: (a) 90%–95% of patients clinically diagnosed with WBS have an approximately 1.55-Mb deletion associated with loss of 26–28 genes; (b) 5%–8% of clinically diagnosed WBS patients have a slightly larger, approximately 1.84-Mb pair deletion associated with loss of 28 genes; (c) the deleted intervals are flanked by highly homologous stretches of DNA, organized into a single centromeric duplicon and two telomeric duplicons; (d) each duplicon contains genes, pseudogenes, and clusters of related genes; (e) the duplicons predispose to NAHR through intra- or inter-chromosomal exchange during meiosis; and (f) the deletion arises with equal frequency on either the maternally or the paternally inherited chromosome 7 homolog. &lt;br /&gt;
&lt;br /&gt;
here's the article: http://www.jci.org/articles/view/35309#T1&lt;br /&gt;
&lt;br /&gt;
another site: http://emedicine.medscape.com/article/893149-overview#a0199 &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 14:27, 11 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
hey guys I've got a small paragraph explaining how WS isn't inherited in the majority of cases. I wasn't sure where to put it so i slotted it into the intro...do u think it should go there or somewhere else?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 18:14, 5 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
sorry peeps... i think its a no go... doesnt have a proper clearance... so unless u wanna email her...? but it usually takes a long time to get that... :(&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332178|z3332178]] 20:51, 4 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
hey guys ive found this website that has really good images but i don't know if we can use them cause i can't really find a clearance statement, but it says something about it being a site for educational benefits or something, does that count? can one of you check it out and see if we can use them&lt;br /&gt;
&lt;br /&gt;
http://childrensheartinstitute.org/educate/gallery/williams.htm&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 15:28, 4 October 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey guys...i figured out how to link the words on the page straight to the glossary. Im gonna link all of the ones that we have in the glossary so far, and then as we keep adding words just copy and paste the formatting from the ones already done! :]&lt;br /&gt;
--[[User:Z3332183|z3332183]] 21:34, 30 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
hahaha everyone is commenting on the lack of images. yes guys, we know but there are little to no copyright free images out there.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 14:36, 27 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey, i've got no problem with that, i think it's a fair idea&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 19:06, 18 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey guys ive been thinking that epidemiology isn't really in the right spot.... management and treatment should really go after all the descriptions of the abnormalities and incidence shoukd go at the beginning... so what i'm thinking is that we should split up the subheading and add incidence to the intro and have management and treatment as one heading towards the end...??? what do u guys suggest?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 23:20, 17 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey guys i found this really good article that deals with embryology in WS!! but i don't know where the info fits in...can u please have a quick glance over it and see where you think some of the info can go??? i just don't wanna mess up your parts by adding random info...&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629217/?tool=pubmed&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 17:36, 14 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Yay!!! Yeah thats fine...were just gonna fix our ones up...coz we have another assignment to do tonight...so you n nobby can edit all u want tonight! Ohh and yeah sure...just post up the info you have for the timeline n then ill put it into a table!!&lt;br /&gt;
&lt;br /&gt;
Hey, yeh no worries, im going to be working on it for the rest of the day now that my exams are over....i ll try get as much of it done ASAP. Oh and after i finish typing up the timeline, would one of u guys format it in a table for me??? i seriously tried to do it but I got a bit confused lol&lt;br /&gt;
Oh btw great job on the drawings!!! :)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 13:54, 14 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey sister 1 can you work on cardiac? I'll do other associated instead of sister 3.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332178|Z3332178]] 10:42, 14 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
and also, i just came across this page which is on the unsw embryo page....&lt;br /&gt;
http://embryology.med.unsw.edu.au/embryology/index.php?title=Talk:Williams_Syndrome#Australia_-_Support_Groups&lt;br /&gt;
&lt;br /&gt;
it lists some recent papers and current research, including one of steve palmer's papers.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 08:31, 14 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
hey guys, yes moving epidemiology up is a great idea!!!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 07:25, 14 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1288273/ '''article for the visuospatial construction i.e. not able to draw house, bicycle etc, think this can be for our case studies...'''&lt;br /&gt;
&lt;br /&gt;
yes i think that's a good idea, i was just about to mention that, shall i move it?? I fixed up a bit of the intro, is it ok? Btw I sware i thought i was on another page when i hit save cause all these tables and images came up, then i realised it was laticia and felicia's AWSOME WORK :), it looks really good!!! just thought i should mention that... I've spent hours trying to find images and most of the articles i've found have really good ones but we cant use them!! ahhh it's soo frustrating&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 23:58, 11 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Also, in Marks feedback he said that epidemology should be linked earlier to diagnosis, so shall we just move it up and have it straight after diagnosis before the physical characteristics?&lt;br /&gt;
--[[User:Z3332183|z3332183]] 23:14, 11 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129970/?tool=pubmed Hey guys...heres another open access article that we can use pics from!!!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|z3332183]] 22:48, 11 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
i think we can all use this article http://www.ncbi.nlm.nih.gov/books/NBK1249/ --[[User:Z3331556|z3331556]] 22:06, 11 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://www.nejm.org.wwwproxy0.library.unsw.edu.au/doi/full/10.1056/NEJMra0903074#t=article '''pretty good recent article :) but i don't know if we can use the pics, can someone double check...'''&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 21:46, 11 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1511580/?tool=pubmed] Clinical and molecular cytogenetic (FISH) diagnosis of Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|z3332183]] 13:34, 7 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey guys found this AWESOME article we can get pics off =D Leftward Lateralization of Auditory Cortex Underlies Holistic Sound Perception in Williams Syndrome PMID: 20808792 (forgot how to ref so this'll do for now)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332178|z3332178]] 22:51, 8 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey! Yeah it think its better if they just go under the same heading because they go together and its impossible to separate them anyway...so yeah 'Genetic Factors and Etiology' should be fine...and we can add in any subheadings if we need em later... :D&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|z3332183]] 19:54, 3 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey guys i just changed the etiology, genetic factors/ cause headings, before we had genetic factors and etiology as separate headings with cause as a subheading below genetic factors and it didn't really make sense... so is it ok if we just have the heading 'Genetic Factors and Etiology'???&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 15:44, 3 September 2011 (EST) &lt;br /&gt;
&lt;br /&gt;
Hey guys i just emailed Dr. Steve Palmer, will hope for a quick reply. Apparently he's taking the next lecture or something when we get back, but by then it will be too late, so it's best if we can arrange a meeting. Who wants to come with me to see him..........................................................................................=/&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 17:16, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Here's an article for diagnosis and management of the disease&lt;br /&gt;
&lt;br /&gt;
[http://onlinelibrary.wiley.com/doi/10.1002/ajmg.c.30139/abstract;jsessionid=E69D4793044A7511E77F50CA141F0825.d02t04?systemMessage=Wiley+Online+Library+will+be+disrupted+3+Sep+from+10-12+BST+for+monthly+maintenance]&lt;br /&gt;
&lt;br /&gt;
Hey that's heaps good, we'll compare timetables tomorrow during the lab or something, this page is coming alongggggggggggg!&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 16:00, 31 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Happy sister 1, you are awesome! I'll do Coronary artery stenosis, Pulmonary valve stenosis, Atrial septal defect, Ventricular septal defect if you didnt already start on any... I'm doin my williams research now so hopefully, i'll have my bit up tonight! *crosses fingers* I'm so sick of readin articles... =P Is there a time we can all go meet up with the WS proff?&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332178|Z3332178]] 20:37, 30 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Hey i found out who the researcher of WS at uni is, it's Dr Steve Palmer, here's his email s.palmer@unsw.edu.au, on the course outline it says that we have to make an appointment if we want to see him. We should try get together sometime this week or next week so we can go see him and ask about his current research???&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 18:51, 27 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
So i finally figured out how to reference on this thing, thought you guys might need help.... if you look on the main project page I've started to put some info up, so if you click on the edit button (on the side of each heading) the info and references come up, just copy and paste the ref name....blah blah part after your info BUT REPLACE THE PMID NUMBER WITH THE ONE YOU NEED FOR YOUR ARTICLE. When u save, the reference is automatically made in the reference heading at the bottom of the pages&lt;br /&gt;
&lt;br /&gt;
Hope this makes sense lol&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 17:17, 27 August 2011 (EST) &lt;br /&gt;
&lt;br /&gt;
Hey guys i've posted up some links to articles that may help in your research, they're on the reference list below. Oh and Felicia i think we should further split up the cardiovascular heading so we can research specific types and make them subheadings??? The OMIM clinical synopsis web page [http://omim.org/clinicalSynopsis/194050] has these as abnormalities associated with the heart:&lt;br /&gt;
&lt;br /&gt;
Supravalvular aortic stenosis&lt;br /&gt;
&lt;br /&gt;
Valvular aortic stenosis&lt;br /&gt;
&lt;br /&gt;
Bicuspid aortic valve&lt;br /&gt;
&lt;br /&gt;
Mitral valve prolapse&lt;br /&gt;
&lt;br /&gt;
Mitral regurgitation&lt;br /&gt;
&lt;br /&gt;
Coronary artery stenosis&lt;br /&gt;
&lt;br /&gt;
Pulmonary valve stenosis&lt;br /&gt;
&lt;br /&gt;
Atrial septal defect&lt;br /&gt;
&lt;br /&gt;
Ventricular septal defect&lt;br /&gt;
&lt;br /&gt;
which ones do you want to search???&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 15:22, 27 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
“The behavioral phenotype of Williams syndrome: A recognizable pattern of neurodevelopment” by Colleen A. Morris&lt;br /&gt;
The review article concludes that a person with William syndrome share distinct cognitive and behavioural features. The phenotype of a typical patient will be due to the deleted genes of chromosome 7 q11.23.[http://onlinelibrary.wiley.com.wwwproxy0.library.unsw.edu.au/doi/10.1002/ajmg.c.30286/full]&lt;br /&gt;
&lt;br /&gt;
“Impaired geometric reorientation caused by genetic defect” by Laura Lakusta, Banchiamlack Dessalegn, and Barbara Landau&lt;br /&gt;
By testing participants in a plain or single blue walled chamber, the study was able to show that William syndrome patients show a failure to reconstruct and use geometric representations of the chamber o find hidden objecs.[http://www.ncbi.nlm.nih.gov.wwwproxy0.library.unsw.edu.au/pmc/articles/PMC2840366/?tool=pmcentrez]&lt;br /&gt;
--z3332178 22:42, 9 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://omim.org/entry/194050&lt;br /&gt;
&lt;br /&gt;
Review Article: Research Review: Williams syndrome: a critical review of the cognitive, behavioral, and neuroanatomical phenotype. [http://www.ncbi.nlm.nih.gov/pubmed/18489677]&lt;br /&gt;
&lt;br /&gt;
Research Article: Elevated Ambulatory Blood Pressure in 20 Subjects With Williams Syndrome[http://userwww.service.emory.edu/~erein/research/broder-et-al.pdf]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 21:35, 10 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 13:19, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
The genomic basis of the Williams - Beuren syndrome&lt;br /&gt;
C Schubert. Cellular and Molecular Life Sciences. Basel: Apr 2009. Vol. 66, Iss. 7; p. 1178&lt;br /&gt;
[http://proquest.umi.com/pqdweb?index=0&amp;amp;did=1892633801&amp;amp;SrchMode=1&amp;amp;sid=2&amp;amp;Fmt=6&amp;amp;VInst=PROD&amp;amp;VType=PQD&amp;amp;RQT=309&amp;amp;VName=PQD&amp;amp;TS=1312428336&amp;amp;clientId=25620]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|Z3332183]] 13:28, 4 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
J Hum Genet. 2009 Apr;54(4):193-8. Epub 2009 Mar 13.&lt;br /&gt;
William's syndrome: gene expression is related to parental origin and regional coordinate control.&lt;br /&gt;
Collette JC, Chen XN, Mills DL, Galaburda AM, Reiss AL, Bellugi U, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Division of Neurogenetics, Cedars-Sinai Medical Center and Departments of Human Genetics and Pediatrics, UCLA, Los Angeles, CA, USA.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
&lt;br /&gt;
William's syndrome (WS) features a spectrum of neurocognitive and behavioral abnormalities due to a rare 1.5 MB deletion that includes about 24-28 genes on chromosome band 7q11.23. Study of the expression of these genes from the single normal copy provides an opportunity to elucidate the genetic and epigenetic controls on these genes as well as their roles in both WS and normal brain development and function. We used quantitative RT-PCR to determine the transcriptional level of 14 WS gene markers in a cohort of 77 persons with WS and 48 normal controls. Results reported here: (1) show that the expression of the genes deleted in WS is decreased in some but not all cases, (2) demonstrate that the parental origin of the deletion contributes to the level of expression of GTF2I independently of age and gender and (3) indicate that the correlation of expression between GTF2I and some other genes in the WS region differs in WS subjects and normal controls, which in turn points toward a regulatory role for this gene. Interspecies comparisons suggest GTF2I may play a key role in normal brain development.&lt;br /&gt;
&lt;br /&gt;
PMID:19282872[http://www.ncbi.nlm.nih.gov/pubmed/19282872]  '''hey guys this is one of the articles i found but i've tried getting the whole article to read but sirius doesn't seem to have this particular volume '''&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 18:09, 6 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''Review Article:The genomic basis of the Williams – Beuren syndrome''&lt;br /&gt;
•Williams syndrome is a genomic disorder with symptoms including mental retardation, visuospatial impairment &amp;amp; overfriendliness.&lt;br /&gt;
&lt;br /&gt;
•It is caused due to a hemizygous contiguous gene deletion with regards to chromosome  7q11.23. &lt;br /&gt;
&lt;br /&gt;
•This review article deals with the genomic assembly of the region involved in Williams syndrome as well as the chromosomal mechanisms such as deletions and duplications and the consequences of these.&lt;br /&gt;
&lt;br /&gt;
Reference:&lt;br /&gt;
Schubert, C. The genomic basis of the Williams – Beuren syndrome. Cell, Mol. Life Sci. 66:1178-1197, 2009 [http://www.springerlink.com.wwwproxy0.library.unsw.edu.au/content/r41l072283g5222u/fulltext.pdf]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''Research Article: Functional, structural and metabolic abnormalities of the hippocampl formation in Williams syndrome''&lt;br /&gt;
•In this study, neuroimaging (PET and fMRI) was used to investigate the hippocampal structure, function and metabolic integrity of 12 people with Williams syndrome compared to 12 healthy controls.&lt;br /&gt;
&lt;br /&gt;
•N-acetul aspartate can be seen as a marker for synaptic activity and measures of this were reduced in those with Williams syndrome&lt;br /&gt;
&lt;br /&gt;
•Although regular hippocampal size was maintained in both groups, slight changes in the shape were present.&lt;br /&gt;
&lt;br /&gt;
•Through the results of the investigation, it was suggested that the neurocognitive abnormalities seen in Williams syndrome may be partly due to hippocampal dysfunction.&lt;br /&gt;
&lt;br /&gt;
Reference: &lt;br /&gt;
Meyer-Lindenberg A., et al. Functional, structural and metabolic abnormalities of the hippocampal formation in Williams syndrome. J Clin Invest. 115(7):1888-95, 2005 [http://www.ncbi.nlm.nih.gov.wwwproxy0.library.unsw.edu.au/pubmed/15951840/]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332183|z3332183]] 23:02, 9 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
PLoS One. 2010 Apr 21;5(4):e10292.&lt;br /&gt;
Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.&lt;br /&gt;
Gao MC, Bellugi U, Dai L, Mills DL, Sobel EM, Lange K, Korenberg JR.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component analysis (PCA) of standardized WAIS-R subtests, r = 0.40 (Pearson correlation, Bonferroni corrected p-value = 0.007), accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.&lt;br /&gt;
&lt;br /&gt;
PMID:20422020 [http://www.ncbi.nlm.nih.gov/pubmed/20422020]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
* Williams Syndrome presents with a distinct pattern of intellectual disabilities that differ from normal on subtests of the WAIS-R (Wechsler Adult Intelligence Scale-Revised). Found that relative to their overall performance, WS subjects tended to do well in tests of vocabulary (Vocabulary) and abstract reasoning (Similarities, Picture Arrangement), and poorly in tests of numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design, Object Assembly), and memory (Digit Span)&lt;br /&gt;
&lt;br /&gt;
* Gene expression in the tissue of interest (brain) is not possible so quantitated gene expression in lymphoblastoid (LB) cell lines&lt;br /&gt;
&lt;br /&gt;
* STX1A is best known as an important component of the presynaptic SNARE complex involved in priming of synaptic vesicles for release.&lt;br /&gt;
&lt;br /&gt;
* Data indicate that peripheral STX1A expression levels measured in lymphoblastoid cell lines strictly grown, is related to an emergent property of the CNS, intelligence.&lt;br /&gt;
&lt;br /&gt;
'''here's the actual article''' [http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010292]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''REVIEW ARTICLE'''&lt;br /&gt;
&lt;br /&gt;
Arch Pediatr. 2009 Mar;16(3):273-82. Epub 2008 Dec 18.&lt;br /&gt;
[Williams-Beuren syndrome: a multidisciplinary approach].&lt;br /&gt;
[Article in French]&lt;br /&gt;
Lacroix A, Pezet M, Capel A, Bonnet D, Hennequin M, Jacob MP, Bricca G, Couet D, Faury G, Bernicot J, Gilbert-Dussardier B.&lt;br /&gt;
Source&lt;br /&gt;
&lt;br /&gt;
Laboratoire langage, mémoire et développement cognitif, CNRS, UMR 6215, 99, avenue du Recteur-Pineau, 86000 Poitiers, France. agnes.lacroix@uhb.fr&lt;br /&gt;
&lt;br /&gt;
'''Abstract'''&lt;br /&gt;
Williams-Beuren syndrome (WBS) (OMIM# 194050) is a rare, most often sporadic, genetic disease caused by a chromosomal microdeletion at locus 7q11.23 involving 28 genes. Among these, the elastin gene codes for the essential component of the arterial extracellular matrix. Developmental disorders usually associate an atypical face, cardiovascular malformations (most often supravalvular aortic stenosis and/or pulmonary artery stenosis) and a unique neuropsychological profile. This profile is defined by moderate mental retardation, relatively well-preserved language skills, visuospatial deficits and hypersociability. Other less known or rarer features, such as neonatal hypercalcemia, nutrition problems in infancy, ophthalmological anomalies, hypothyroidism, growth retardation, joint disturbances, dental anomalies and hypertension arising in adolescence or adulthood, should be treated. The aim of this paper is to summarize the major points of WBS regarding: (i) the different genes involved in the deletion and their function, especially the elastin gene and recent reports of rare forms of partial WBS or of an opposite syndrome stemming from a microduplication of the 7q11.23 locus, (ii) the clinical features in children and adults with a focus on cardiovascular injury, and (iii) the specific neuropsychological profile of people with WBS through its characteristics, the brain structures involved, and learning.&lt;br /&gt;
&lt;br /&gt;
PMID:19097873 [http://www.ncbi.nlm.nih.gov/pubmed/19097873]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 19:40, 10 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
'''Here's  the image i showed you guys'''&lt;br /&gt;
&lt;br /&gt;
[[File:Distribution of quantitative transcription of genes deleted in WS.png|Distribution of quantitative transcription of genes deleted in WS]]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 12:23, 12 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|300px]]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 17:33, 16 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The frequency of SD cells for RB1 and SNRPN in WS and control individuals.&lt;br /&gt;
&lt;br /&gt;
[[File:The frequency of SD cells for RB1 and SNRPN in WS and control individuals.jpg|The frequency of SD cells for RB1 and SNRPN in WS and control individuals|400px]]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3332178|z3332178]] 23:22, 16 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
I've found a good case study for WS, maybe we could have a case study sub-heading?? [http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1754.1993.tb03023.x/abstract]&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 13:38, 17 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Suggestions for areas of research==&lt;br /&gt;
I thought I could get the ball rolling, let me know if you want to add or remove anything.&lt;br /&gt;
&lt;br /&gt;
===INTRODUCTION=== &lt;br /&gt;
(z3331556)&lt;br /&gt;
-What is William’s Syndrome? &lt;br /&gt;
&lt;br /&gt;
===History of the disease=== &lt;br /&gt;
(z3331556)&lt;br /&gt;
-How it was discovered &lt;br /&gt;
-Who discovered it? &lt;br /&gt;
-Timeline of how knowledge developed &lt;br /&gt;
&lt;br /&gt;
===Etiology===&lt;br /&gt;
(z3332183)&lt;br /&gt;
- Cause &lt;br /&gt;
- Susceptibility of the patient&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
(z3332183)&lt;br /&gt;
-How it’s detected (tests/examinations)&lt;br /&gt;
-How soon it can be detected?&lt;br /&gt;
&lt;br /&gt;
===Genetic Factors===&lt;br /&gt;
-deletions&lt;br /&gt;
(all)&lt;br /&gt;
&lt;br /&gt;
===Physical Characteristics===&lt;br /&gt;
-Facial characteristics etc.&lt;br /&gt;
(z3332178)&lt;br /&gt;
&lt;br /&gt;
===Associated medical conditions===&lt;br /&gt;
-Cardiac abnormalities (z3331556),(z3332178)&lt;br /&gt;
&lt;br /&gt;
-Renal abnormalities (z3331469) &lt;br /&gt;
&lt;br /&gt;
-other (hoarse voice, inguinal hernia, orthopaedic problems, hypercalcaemia etc.)&lt;br /&gt;
(z3332183)&lt;br /&gt;
&lt;br /&gt;
===Cognitive, Behavioural and Neurological Problems===&lt;br /&gt;
(z3332178)&lt;br /&gt;
&lt;br /&gt;
===Epidemiology===&lt;br /&gt;
-Incidence, distribution, and control of disease&lt;br /&gt;
(z3331469)&lt;br /&gt;
&lt;br /&gt;
===Management/treatment===&lt;br /&gt;
-Treatment of individual symptoms, avoid taking increased levels of calcium and Vitamin D&lt;br /&gt;
(z3331469)&lt;br /&gt;
&lt;br /&gt;
===Specialized Facilities/ supportive associations===&lt;br /&gt;
-Williams Syndrome Foundation (UK), Williams Syndrome Association&lt;br /&gt;
(all)&lt;br /&gt;
&lt;br /&gt;
===Case studies===&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1288273/&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862007/&lt;br /&gt;
&lt;br /&gt;
===Interesting facts===&lt;br /&gt;
(all)&lt;br /&gt;
&lt;br /&gt;
===Current research and developments===&lt;br /&gt;
(all)&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
http://www.cddh.monash.org/assets/williams-synd.pdf&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 18:09, 17 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://books.google.com.au/books?id=qvKaSNg0pUcC&amp;amp;pg=PA158&amp;amp;lpg=PA158&amp;amp;dq=Williams+and+Barrett-Boyes&amp;amp;source=bl&amp;amp;ots=0SIpaamHuh&amp;amp;sig=4ouDsgFvt8XBbuwKPThFGWX9b4Y&amp;amp;hl=en&amp;amp;ei=8F5MTurlGuuNmQWA6eCyAg&amp;amp;sa=X&amp;amp;oi=book_result&amp;amp;ct=result&amp;amp;resnum=7&amp;amp;ved=0CEMQ6AEwBg#v=onepage&amp;amp;q=Williams%20and%20Barrett-Boyes&amp;amp;f=false  &lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 13:09, 18 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome Foundation, accessed 22 August 2011, http://www.williams-syndrome.org.uk/&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome Association, accessed 22 August 2011,  http://williams-syndrome.org/&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331469|z3331469]] 13:12, 22 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
http://omim.org/clinicalSynopsis/194050 '''this is a clinical synopsis that is a good starting point for medical and physical abnormalities, it basically lists all complications associated with WS. I think we can use these as subheadings???'''&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728781/pdf/v080p00205.pdf '''This is a source for cardiac abnormalities'''&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946897/?tool=pmcentrez&lt;br /&gt;
&lt;br /&gt;
http://www.nature.com/ejhg/journal/v18/n1/full/ejhg2009108a.html&lt;br /&gt;
&lt;br /&gt;
'''These last two are basically introductory info on WS and they have info for the Genetics heading'''&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 15:44, 27 August 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://books.google.com.au/books?id=9E9q5112WBgC&amp;amp;pg=PA151&amp;amp;lpg=PA151&amp;amp;dq=hallux+valgus+in+williams+syndrome&amp;amp;source=bl&amp;amp;ots=LdaFmjSds_&amp;amp;sig=QW_9bjbIgo44rXQrwKTh2TF5hSo&amp;amp;hl=en&amp;amp;ei=__teTu2oNMjEmAXCx80B&amp;amp;sa=X&amp;amp;oi=book_result&amp;amp;ct=result&amp;amp;resnum=4&amp;amp;sqi=2&amp;amp;ved=0CCwQ6AEwAw#v=onepage&amp;amp;q&amp;amp;f=false&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 13:38, 1 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/books/NBK1249/ '''another good source'''&lt;br /&gt;
&lt;br /&gt;
--[[User:Z3331556|z3331556]] 14:39, 3 September 2011 (EST)&lt;br /&gt;
&lt;br /&gt;
==Peer Assessments==&lt;br /&gt;
* Intro was good, it was brief and straight to the point&lt;br /&gt;
* The beginning paragraphs of the history could be more summarised especially considering that you have a timeline beneath&lt;br /&gt;
* Your use of a table for the genetics’ component was great. It was easy to read and concise. It was a different approach but it worked well. &lt;br /&gt;
* More information could have been added to the treatment section such as comparisons between key methods/strategies, the pros and cons&lt;br /&gt;
* The phenotype section was well set out although I believe it should have been placed up after the genetics section so that the information flows more consistently&lt;br /&gt;
* The layout of the implications section was slightly unclear. Maybe here you could have large heading for implications, followed by a list (dot point) of the implications occurred then have in paragraph form a description of each. Having headings such as: Other problems and other associated medical conditions tended to drag on this segment.&lt;br /&gt;
* The inclusion of the supportive associations was a nice little touch!&lt;br /&gt;
* Great use of referencing&lt;br /&gt;
--[[User:Z3332629|z3332629]] 15:30, 22 September 2011 (EST)&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77179</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77179"/>
		<updated>2011-10-12T07:52:19Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Mouse Models */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The following are examples of research studies conducted to explore the genotype-phenotype relationship in Williams Syndrome using mouse models:&lt;br /&gt;
&lt;br /&gt;
Enkhmandakh, B et.al, 2009, conducted a mouse model based study on the “essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.” &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; They investigated the little known contributions of the TFII-I transcription factors in embryonic development. &lt;br /&gt;
Through the use of ‘knock-out’ mouse models, this study showed that the homozygous loss in function of either Gtf2ird1 or Gtf2i genes, which code for TFII-I, results in multiple abnormalities in the phenotype of the ‘knock-out’ mouse, including death of the embryo, brain haemorrhage and defects relating to blood vessels, neural tube and craniofacial regions of the embryo. Additional analysis demonstrated that embryo death could be caused by defects in the yolk sac and a subset of the two heterozygous genes presented retarded growth and skeletal and craniofacial defects. This therefore showed that an insufficient production of the TFII-I proteins, resulting from the ‘knock-out’ of Gtf2ird1 and Gtf2i genes in the 7q11.23 critical region of chromosome 7, causes some of the developmental manifestations associated with Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Angiography_image_indicating_Supravalvular_aortic_stenosis.jpg&amp;diff=77159</id>
		<title>File:Angiography image indicating Supravalvular aortic stenosis.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Angiography_image_indicating_Supravalvular_aortic_stenosis.jpg&amp;diff=77159"/>
		<updated>2011-10-12T06:46:02Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Supravalvular Aortic Stenosis in Williams Syndrome==&lt;br /&gt;
&lt;br /&gt;
Original file name: APC-4-213-g001.jpg&lt;br /&gt;
&lt;br /&gt;
This sngiography image shows the most common heart condition that arises in Williams Syndrome, Supravalvular aortic stenosis(SVAS), a narrowing of the ascending aorta caused by the disruption or deletion of the elastin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
Original legend: Left Ventricular Cine angiography picture demonstrating clearly the Supravalvular aortic stenosis in a 12 year old patient. Figure shows pigtail catheter in left ventricle with opacification of aortic sinuses, coronary vessels, ascending aorta with arch, arch vessels and descending aorta. Labelled structures are RCA (right coronary artery), LMCA (left main coronary artery)&lt;br /&gt;
&lt;br /&gt;
===Reference===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pubmed&amp;gt;21976893&amp;lt;/pubmed&amp;gt;| [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180991/ PMC3180991]&lt;br /&gt;
&lt;br /&gt;
Copyright © Annals of Pediatric Cardiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
{{Template:2011 Student Image}}&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77149</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77149"/>
		<updated>2011-10-12T06:25:12Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
&lt;br /&gt;
[[File: Angiography image indicating Supravalvular aortic stenosis.jpg|300px|thumb|'''Figure 8: Left Ventricular Cine angiography picture demonstrating Supravalvular aortic stenosis in a 12 year old Williams Syndrome patient''']]&lt;br /&gt;
&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77144</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77144"/>
		<updated>2011-10-12T06:18:07Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
*'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
*'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Angiography_image_indicating_Supravalvular_aortic_stenosis.jpg&amp;diff=77141</id>
		<title>File:Angiography image indicating Supravalvular aortic stenosis.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Angiography_image_indicating_Supravalvular_aortic_stenosis.jpg&amp;diff=77141"/>
		<updated>2011-10-12T06:12:26Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: Original file name: APC-4-213-g001.jpg

Left Ventricular Cine angiography picture demonstrating clearly the Supravalvular aortic stenosis in a 12 year old patient. Figure shows pigtail catheter in left ventricle with opacification of aortic sinuses, coron&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Original file name: APC-4-213-g001.jpg&lt;br /&gt;
&lt;br /&gt;
Left Ventricular Cine angiography picture demonstrating clearly the Supravalvular aortic stenosis in a 12 year old patient. Figure shows pigtail catheter in left ventricle with opacification of aortic sinuses, coronary vessels, ascending aorta with arch, arch vessels and descending aorta. Labelled structures are RCA (right coronary artery), LMCA (left main coronary artery)&lt;br /&gt;
&lt;br /&gt;
Copyright © Annals of Pediatric Cardiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180991/&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Characteristic_facial_features_of_a_child_with_Willams_Syndrome.jpg&amp;diff=77136</id>
		<title>File:Characteristic facial features of a child with Willams Syndrome.jpg</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=File:Characteristic_facial_features_of_a_child_with_Willams_Syndrome.jpg&amp;diff=77136"/>
		<updated>2011-10-12T06:05:09Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: Original file name: APC-4-213-g002.jpg

Photograph of a child showing the characteristic facial features of Williams Syndrome

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unp&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Original file name: APC-4-213-g002.jpg&lt;br /&gt;
&lt;br /&gt;
Photograph of a child showing the characteristic facial features of Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;br /&gt;
&lt;br /&gt;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180991/&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77129</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77129"/>
		<updated>2011-10-12T05:59:31Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Other problems */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In some cases it can arise as a result of the narrowing of the renal artery (Renal artery stenosis)&amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
Hypertension in Williams syndrome can develop during childhood, however it is more commonly found in adults, with more than half of them developing high blood pressures.&amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Consequences of this condition can be an increased risk of myocardial infarction and stroke. &lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77116</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77116"/>
		<updated>2011-10-12T04:50:16Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Other problems */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77114</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=77114"/>
		<updated>2011-10-12T04:48:40Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Histological analysis of the arterial walls of Williams Syndrome patients with SVAS show a disorganised structure with fragmented elastic fibers and an increase in the size of smooth muscle cells (muscle hypertrophy). &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
Hypertension or high blood pressure is another common cardiac condition that can result from Williams Syndrome. Studies have shown that an increased risk of high blood pressure in Williams Syndrome sufferers is the result of the re-organisation of lamellar structures in large vessel walls and the degeneration of elastic fibers caused by the loss of the ELN allele. &amp;lt;ref name=&amp;quot;PMID20926892&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20926892&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76940</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76940"/>
		<updated>2011-10-11T09:48:53Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Stenoses */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt; PPS is also the cause of vessel arteriopathy, an outcome of deletion or mutation of the ELN gene. &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76939</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76939"/>
		<updated>2011-10-11T09:33:59Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Genetic factors and Etiology */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength. The expression of the ELN gene is largely limited to the third trimester of fetal development and early postnatal years.&amp;lt;ref name=&amp;quot;PMID9819363&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9819363 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76938</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76938"/>
		<updated>2011-10-11T09:23:51Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength.                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76937</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76937"/>
		<updated>2011-10-11T09:22:11Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Stenoses */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength.                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, ''Pediatric Supravalvar Aortic Stenosis: Background'', Webscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. It is a narrowing at the level of the main pulmonary artery, occurring in multiple places along this artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Xiushui, M 2011, ''Pulmonic Stenosis: Pathophysiology'', Medscape Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/157737-overview#a0104&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76935</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76935"/>
		<updated>2011-10-11T08:44:08Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Cardiac Conditions */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength.                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
SVAS can be diagnosed through 2-dimentional echocardiography that allows for multiple views of the heart to be examined. &amp;lt;ref&amp;gt;Krishnan, A 2011, Pediatric Supravalvar Aortic Stenosis: Background, WebMD Reference, viewed 11 October 2011, &amp;lt;http://emedicine.medscape.com/article/892252-overview&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Peripheral Pulmonary Stenosis (PPS)'''&lt;br /&gt;
&lt;br /&gt;
PPS is the second most common cardiac abnormality associated with Williams Syndrome. PPS can occur in multiple places along the Pulmonary artery and can be related to hypoplasia or incomplete development of the pulmonary arterial bed. &amp;lt;ref name=&amp;quot;PMID11331257&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76934</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76934"/>
		<updated>2011-10-11T07:21:28Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* History of the disease */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [http://www.wsf.org/family/news/perspective.pdf John C. P. Williams of Williams-Beuren syndrome]&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength.                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
	<entry>
		<id>https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76933</id>
		<title>2011 Group Project 9</title>
		<link rel="alternate" type="text/html" href="https://embryology.med.unsw.edu.au/embryology/index.php?title=2011_Group_Project_9&amp;diff=76933"/>
		<updated>2011-10-11T06:53:31Z</updated>

		<summary type="html">&lt;p&gt;Z3331556: /* Thyroid */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{2011ProjectsMH}}&lt;br /&gt;
&lt;br /&gt;
{{2011Projects}}&lt;br /&gt;
&lt;br /&gt;
=Williams-Beuren Syndrome=&lt;br /&gt;
&lt;br /&gt;
==Introduction==&lt;br /&gt;
&lt;br /&gt;
[[File:Facial features of four individuals with Willams Syndrome.gif|400px|thumb|'''Figure 1: Facial Characteristics of four individuals with Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome, more commonly known as Williams Syndrome, is a [[#Glossary | '''congenital abnormality''']]  caused by the deletion of genetic material on chromosome 7q11.23, which encompasses 28 neighbouring genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;http://omim.org/entry/194050&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This multisystem developmental genetic disorder implicates psychological, behavioural and medical defects, including diverse phenotypic characteristics such as distinctive facial deformities, cardiovascular abnormalities,intellectual disabilities/mental retardation, growth abnormalities, endocrine abnormalities and a unique personality and cognitive profile. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some or all of these features may be present in varying degrees, with the condition becoming apparent at the onset of birth or in early infancy. &amp;lt;ref name=&amp;quot;PMID21107555&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21107555 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome, in a majority of cases, is not inherited. It can manifest in families with no history of the disorder, this is because Williams Syndrome is the result of a random event that occurs at gamete formation in the parent of a Williams Syndrome patient. Only a single copy of the altered chromosome 7 in each cell is required to cause this syndrome, therefore it is considered to be an autosomal dominant condition. There is only a small percentage of cases where people inherit the chromosomal deletion associated with Williams Syndrome from a parent with the condition. &amp;lt;ref&amp;gt;http://ghr.nlm.nih.gov/condition/williams-syndrome&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Ever since it was discovered that the cause of this genetic abnormality was a [[#Glossary | '''microdeletion''']] in chromosome 7, one of the main focuses of research has been attempting to identify the different responsibilities each gene of the deletion has for the function and development of the brain as well as their role in physical characteristics. These research efforts have the common aim to provide knowledge of how cognitive, behavioural and physical features arise as a result of the gene absence and their interplay with the environment. &lt;br /&gt;
Current research into the links between genes absent in Williams Syndrome and the brain, behaviour and structural and functional abnormalities have been confirmed and are continuously being investigated through the use of mouse models. &amp;lt;ref name=&amp;quot;PMID16272111&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16272111 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; The exact links between the missing genes and the [[#Glossary | '''phenotype''']] of Williams Syndrome is yet to be fully explored.&lt;br /&gt;
&lt;br /&gt;
'''Links:''' [[Williams Syndrome]] | [http://omim.org/entry/194050?search=williams%20syndrome&amp;amp;highlight=william%20syndrome OMIM Entry #194050-Williams-Beuren Syndrome]&lt;br /&gt;
&lt;br /&gt;
==History of the disease==&lt;br /&gt;
&lt;br /&gt;
[[File: Chromosome 7, indicating 7q11.23 region of Williams Syndrome.gif|500px|thumb|'''Figure 2: Chromosome 7 indicating the region,7q11.23, that contains the genes which are deleted in Williams Syndrome''']]&lt;br /&gt;
&lt;br /&gt;
William-Beuren Syndrome is named after John C.P. Williams, a cardiologist from New Zealand, and Alois J Beuren, a German physician and cardiac researcher.&lt;br /&gt;
&lt;br /&gt;
Initial investigation into Williams-Beuren Syndrome came from two apparently different disorders, idiopathic infantile [[#Glossary | '''hypercalcemia''']] and Supravalvular Aortic Stenosis [[#Glossary | '''(SVAS)''']] . With further research, these abnormalities were identified as being aspects of this same syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The first cases related to Williams Syndrome involved Idiopathic Infantile Hypercalcemia. From as early as 1952, research into infantile hypercalcemia, by Falconi et.al, found that children with this disorder had common clinical characteristics such as a short stature and a variety of congenital malformations. &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the years that followed many other studies were conducted in this area revealing additional correlations. For example in 1957 Stapleton and colleagues studied the effects of hypercalcemia in a number of infants and noted several consistencies between them including abnormal facial features, failure to thrive, developmental delay, and systolic murmurs of the heart, all of which have now been associated with Williams Syndrome. &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
J.C.P Williams was one of the first to recognise some of the clinical factors associated with this syndrome. In a study conducted in 1961 of SVAS, an obstruction occurring in the left ventricular outflow tract (LVOT), Williams and his colleagues made the observation that patients suffering from this heart condition had strikingly similar unusual facial features that included broad foreheads, eyes set wider apart than normal, wide mouths with pouting lips and malocclusion of teeth, pointy chin and prominent pointed ears. As well as this they discovered their subjects also presented with mental retardation and a low IQ. Williams and his colleagues suggested that their findings might be indicative of a previously unrecognised syndrome. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In this same year Rashkind and colleagues published a paper detailing the relationship between idiopathic childhood hypercalcemia and cardiac abnormalities &amp;lt;ref name=&amp;quot;PMID13739645&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13739645 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In 1962 AJ Beuren and associates also studied the correlations between SVAS, mental retardation and distinctive facial features of a number of subjects and made similar observations to Williams, particularly pointing out the characteristic “elfin” features of Williams syndrome patients. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID18941598&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18941598 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Beuren also noted the behavioural traits of his subjects suffering from SVAS, describing them as all having a “friendly nature”, something which would later be recognised as one of the unique personality traits of people diagnosed with Williams-Beuren Syndrome. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
In further studies conducted in 1964, Beuren and his colleagues detailed the possible association of Peripheral Pulmonary Stenosis and complex dental malformations with SVAS, mental retardation and certain facial appearance which they examined previously. They too came to the conclusion that these complications were representative of a new syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  &lt;br /&gt;
&lt;br /&gt;
===Timeline===&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Year'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Events'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                         &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1950s'''&lt;br /&gt;
|Increasing awareness and research into infantile idiopathic hypercalcemia &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
                                                          &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1952-1957'''&lt;br /&gt;
|Studies conducted by several researchers on infantile hypercalcemia revealed correlations between it and several defects known to be characteristic of Williams Syndrome today. These included abnormal facies, developmental delay, mental retardation and heart palpitations  &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID12980492&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12980492 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID13469755&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13469755 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''1961'''&lt;br /&gt;
|J.C.P Williams and colleagues from New Zealand were the first to suggest that SVAS may be an element of a previously unidentified syndrome which results in mental retardation and an abnormal facial structure. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID14007182&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14007182 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1962'''&lt;br /&gt;
|A.J Beuren and peers made same observations as Williams detailing links between SVAS, mental retardation and abnormal faces, specifically describing them as “elfin-like.” They were also the first to highlight the “over-friendly nature” of their subjects. &amp;lt;ref name=&amp;quot;PMID13967885&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;13967885 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1963'''&lt;br /&gt;
|Black and Bonham-Carter, from England, drew attention to the fact that those individuals who had been affected by Infantile Hypercalcemia had very similar facial features to those patients with SVAS &amp;lt;ref name=&amp;quot;PMID14055045&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14055045 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1964'''&lt;br /&gt;
|Beuren and colleagues made associations between Peripheral Pulmonary Stenosis and complex dental malformations with SVAS. Like Williams, they too believed these were signs of a common undiscovered syndrome. &amp;lt;ref name=&amp;quot;PMID14136289&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14136289 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
In this same year a further advancement into research that links Idiopathic Hypercalcemia with SVAS was made by R.Garcia and associates. They presented a case which proved that these two conditions were related and proposed both were symptoms of “a newly recognized syndrome.” &amp;lt;ref name=&amp;quot;PMID14148234&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14148234 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1970'''&lt;br /&gt;
|The above reports all contributed to a large series of phenotypes that now became known as 'Williams Syndrome' or 'Williams elfin facies syndrome'. Further research into specific cases continued to reinforce this newly identified syndrome. &amp;lt;ref name=&amp;quot;PMID1133652&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;1133652 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1972'''&lt;br /&gt;
|Beuren presented compelling evidence that “Williams syndrome” and infantile hypercalcemia are the same disorder. &amp;lt;ref&amp;gt;Hagen, J.M. van,2007''Williams Syndrome: from genes to clinical features,''Erasmus University Rotterdam,Rotterdam&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1980s'''&lt;br /&gt;
|Research continued and revealed further disabilities associated with Williams Syndrome, including physical characteristics such as, growth problems, joint limitations, genitourinary problems and other developmental disabilities, &amp;lt;ref name=&amp;quot;PMID2456379&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2456379 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; giving it the title of a multisystem disorder. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''1993'''&lt;br /&gt;
|A major discovery was made by Morris et.al. Genetic research conducted on large and small families affected by Williams Syndrome revealed that the SVAS phenotype was closely linked with several DNA markers, including elastin, along the long arm of Chromosome 7. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
Further research into this concluded that the mutation of the Elastin gene on chromosome 7 was the cause of SVAS. &amp;lt;ref name=&amp;quot;PMID8096434&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8096434 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This was rapidly confirmed in many other studies and led to the first laboratory test of the disorder. &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;|'''2006'''&lt;br /&gt;
|In recent years, studies conducted on Williams Syndrome patients with the use of functional MRI of the brain, demonstrated changes linked to the behavioural characteristics of this condition, for example difficulties in visualspatial construction. &amp;lt;ref name=&amp;quot;PMID21120465&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21120465 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID16760918&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16760918 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genetic factors and Etiology==&lt;br /&gt;
[[File: Distribution of quantitative transcription of genes deleted in WS.png|500px|thumb|'''Figure 3: Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. b: Z-scores (relative to the WS mean) of STX1A expression levels''']]&lt;br /&gt;
&lt;br /&gt;
Williams Syndrome is a multi-system genomic disorder that occurs due to a [[#Glossary | '''hemizygous''']] deletion/nonallelic homologous recombination [[#Glossary | '''(NAHR)''']] .  The sizes of deletion commonly range from 1.55 to 1.84 mega base pairs (Mb) on chromosome 7q11.23 which encompasses 28 genes.&amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2042578&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID19568270&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19568270 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The region associated with Williams syndrome contains a single copy gene region with repetitive sequences or Low Copy Repeats [[#Glossary | '''(LCR)''']] . The deletions that cause Williams syndrome are due to a misalignment of these repetitive sequences or gametes within the Williams-Beuren syndrome critical region. &amp;lt;ref&amp;gt;Morris CA. Williams Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews (Internet). Seattle (WA): University of Washington, Seattle; 1993-.&lt;br /&gt;
1999 Apr 09 (updated 2006 Apr 21). [http://www.ncbi.nlm.nih.gov/pubmed/20301427 PMID: 20301427]&amp;lt;/ref&amp;gt; This occurs during the process of [[#Glossary | '''meiosis''']] and follows an unequal crossing over that is due to a high similarity of LCRs. &lt;br /&gt;
&lt;br /&gt;
A genotype-phenotype correlation has been found for some of the genes within the deletion region. The most well known of these being elastin gene (ELN), whereby elastin [[#Glossary | '''haploinsufficiency''']] is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; CLIP2, GTF2I, GTF2IRD1 and LIMK1 are some of the other genes that are most commonly deleted in individuals with Williams syndrome. Researchers have suggested that the deletion of these genes could help in the explanation of some of the characteristic signs of Williams syndrome including the unique behavioural characteristics and also some of the related cognitive difficulties.&lt;br /&gt;
&lt;br /&gt;
In most cases, Williams syndrome occurs sporadically and the deletions can occur with no reference to the parental origin of the chromosome that transmits the disease. There have been, however, a very small number of cases where [[#Glossary | '''autosomal dominant inheritance''']]  of Williams syndrome has been reported.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Gene'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Normal Function'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Elastin (ELN)'''                         &lt;br /&gt;
| Elastin is a main component of elastic fibres. It also contributes to the structure of connective tissue, particularly its flexibility and strength.                                                                                                               &lt;br /&gt;
| The loss of one copy of this gene reduces the normal production of elastin by half. &lt;br /&gt;
Elastin haploinsufficiency is responsible for a number of abnormalities characteristic of Williams Syndrome, particularly connective tissue abnormalities and cardiovascular disease including arterial stenosis. &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;                                                                                                                  &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''LIM domain kinase 1 (LIMK1)'''&lt;br /&gt;
| Studies, such as Wang et al in 1998 &amp;lt;ref name=&amp;quot;PMID9685409&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9685409 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;  suggest that LIMK1 is involved in the area of the brain that is in control of the visualisation of an object as a set of parts. &lt;br /&gt;
It has also been implicated in other visual tasks such as drawing, making models and writing.&lt;br /&gt;
| Studies differ in regards to the contribution of LIMK1 deletions to the phenotype expressed in Williams syndrome. Some studies have suggested that the loss of this gene leads to the problems with visuo-spatial tasks that are common in Williams syndrome. Other studies suggest that it is involved with the characteristic progressive loss of hearing, &amp;lt;ref name=&amp;quot;PMID21655442&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21655442 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; while other studies have not found these connections.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''General transcription factor IIi (GTF2I)'''&lt;br /&gt;
| This gene is involved in the production of the following two proteins:&lt;br /&gt;
•	BAP-135: involved in the normal function of the immune system&lt;br /&gt;
&lt;br /&gt;
•	TFII-I: helps in the regulation of other genes activity and is therefore active in many tissues of the body, particularly in the brain.&lt;br /&gt;
| It has been suggested that the loss of one copy of this gene may be responsible for the intellectual disability seen in Williams syndrome. It may also be involved in the social characteristics of those with Williams syndrome. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|- &lt;br /&gt;
|bgcolor=&amp;quot;springgreen&amp;quot;| '''General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)'''&lt;br /&gt;
| It was shown in 2005 by Tassabehji et al. &amp;lt;ref name=&amp;quot;PMID16293761&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16293761 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; that the GTF2IRD1 gene is involved in the development of both craniofacial features and cognitive development in mammals.&lt;br /&gt;
It was also shown by Yan et al in 2000 that GTF2IRD1 is involved with the function of the RB1 protein both in vitro and in vivo. &amp;lt;ref name=&amp;quot;PMID10642537&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;10642537 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The deletion of a copy of this gene has been implicated in some of the phenotypic features seen in Williams syndrome through the use of data from human genetic mapping. These features include the hypersociabilty and visuaspatial deficits, but the main implication are the craniofacial abnormalities. &amp;lt;ref name=&amp;quot;PMID19109438&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19109438 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Links:'''&lt;br /&gt;
[http://omim.org/entry/130160?search=elastin&amp;amp;highlight=elastin OMIM Entry #130160 – Elastin (ELN)] | [http://omim.org/entry/601329 OMIM Entry #601329 - LIM domain kinase 1 (LIMK1)] | [http://omim.org/entry/601679?search=General%20transcription%20factor%20IIi%20%28GTF2I%29&amp;amp;highlight=general%20transcription%20gtf2i%20iii%20factor OMIM Entry #601679 - General transcription factor IIi (GTF2I)] |[http://www.omim.org/entry/604318?search=General%20Transcription%20Factor%20II-I%20Repeat%20Domain-containing%20Protein%201%20%28GTF2IRD1%29&amp;amp;highlight=repeat%20transcription%20gtf2ird1%20general%201%20domaincontaining%20factor%20protein%20iii General Transcription Factor II-I Repeat Domain-containing Protein 1 (GTF2IRD1)]&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[File: Genotyping_of_the_five_microsatellites_markers_in_WBS_families.jpg‎|500px|thumb|'''Figure 4: Genotyping of the five microsatellites markers in WBS families. DNA fragments of those affected are always the first column of each gel followed by DNA from the mother and the last column the DNA of the father. Black arrows indicate allelic loss''']]&lt;br /&gt;
There are ways to clinically diagnose Williams Syndrome even though the phenotype varies between individuals. There is not a particular clinical feature that is able to ascertain the diagnosis alone, but there are particular features that individuals with Williams Syndrome may present with. These features include conditions and abnormalities discussed in the associated medical conditions sections, but most commonly include:&lt;br /&gt;
&lt;br /&gt;
•Distinctive facial features&lt;br /&gt;
&lt;br /&gt;
•Unique personality&lt;br /&gt;
&lt;br /&gt;
•Intellectual disability &lt;br /&gt;
&lt;br /&gt;
•Growth abnormalities&lt;br /&gt;
&lt;br /&gt;
•Cardiovascular Disease&lt;br /&gt;
&lt;br /&gt;
•Endocrine Abnormalities &lt;br /&gt;
&lt;br /&gt;
Although these clinical criteria for diagnosis are available, the detection of the contiguous gene deletion responsible for Williams Syndrome is the main form of diagnosis. It has been found that over 99% of individuals that meet the clinical diagnosis criteria for Williams Syndrome also have this contiguous gene deletion. This gene deletion is detected through the use of fluorescent in situ hybridisation (FISH) or through targeted mutation analysis. &amp;lt;ref name=&amp;quot;PMID7693128&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7693128 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File: FISH test used to confirm the deletion of the ELN gene.jpg|300px|thumb|'''Figure 5: FISH test used to confirm the deletion of the EN gene''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Fluorescent in situ hybridisation [[#Glossary | '''(FISH)''']] :''' FISH uses elastin probes for a specialised form of chromosome analysis. This method is commercially available and commonly used to determine if an individual showing the clinical signs of William’s syndrome does have the deletion of the genes in the Williams-Beuren syndrome critical region. If the individual only has one copy of the elastin gene, then a diagnosis of William’s syndrome is confirmed. &amp;lt;ref name=&amp;quot;PMID17180802&lt;br /&gt;
&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;17180802 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Targeted Mutation Analysis:''' these are non FISH methods that are also used to detect the contiguous gene deletion in order to determine whether or not an individual has Williams Syndrome.&lt;br /&gt;
&lt;br /&gt;
•Real-time quantitative PCR: is used to establish the number of copies of three of the genes contained within the Williams-Beuren syndrome critical region. A deletion in this area would mean that only a single copy of one of these genes would be found.&lt;br /&gt;
&lt;br /&gt;
•Genomic microarray analysis: makes use of array genomic hybridisation techniques which involved examining multiple genes simultaneously and comparing them in order to determine whether there are any abnormalities in the amount of chromosomal material.&lt;br /&gt;
&lt;br /&gt;
•Heterozygosity testing: is mostly used to identify the size of the deletions, and involves the testing of short tandem repeats [[#Glossary | '''(STRs)''']] from the Williams-Beuren syndrome critical region. If there is no deletion, than the STR sizes should be different at each of the markers determining heterozygosity. But if only one STR size is found at a marker, than this may indicate that there is a deletion, but may also indicate homozygosity. Quantitive PCR is then needed to determine whether or not the single STR size is dur to a deletion in the critical area or a non-abnormal finding of homozygosity.&lt;br /&gt;
&lt;br /&gt;
==Epidemiology==&lt;br /&gt;
&lt;br /&gt;
===Rate of Incidence===&lt;br /&gt;
&lt;br /&gt;
Williams-Beuren Syndrome occurs in 1 in 7,500-20,000 births.&amp;lt;ref name=&amp;quot;PMID18489677 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18489677  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Many of the clinical manifestations associated with Williams syndrome are globally consistent, however some studies have shown that some symptoms are less common in certain countries. A study conducted in the Hong Kong Chinese population showed that SVAS, the most common defect associated with Williams syndrome in the West, is less common than peripheral pulmonary stenosis in the study area.&amp;lt;ref name=&amp;quot;PMID14967851&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;14967851 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Another study showed that the prevalence of cardiovascular defects in a group of Williams syndrome patients in Greece was lower than that documented in the majority studies performed (8/50 rather than half or more of the study group).&amp;lt;ref name=&amp;quot;PMID15774842&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15774842 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Facial Characteristics==&lt;br /&gt;
&lt;br /&gt;
Most physical musculoskeletal abnormalities result from the absence of elastin due to the elastin gene deletion. [[File:WS girl labelled.jpg|thumb|300px|'''Figure 6: Shorter and upturned nose, long philtrum, full and prominent lips and hypoplastic teeth commonly seen in the Williams syndrome phenotype''']]&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Features'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mouth'''&lt;br /&gt;
| &lt;br /&gt;
•	Lips are full and prominent. Often wide and help open.&lt;br /&gt;
&lt;br /&gt;
•	Teeth are often missing and/or hypoplastic, has thin enamel.&lt;br /&gt;
&lt;br /&gt;
•	Long philltrum also present in the majority of cases.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Nose'''&lt;br /&gt;
|•	Flat nasal bridge with a shorter, upturned nose and anterverted nares.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Eyes'''&lt;br /&gt;
|•	Eyes often have a stellate arrangement of the iris.&lt;br /&gt;
&lt;br /&gt;
•	Eyebrows flare medially&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Ears'''&lt;br /&gt;
|•	Ears are lower than the normal height on the face and have prominent ear lobes.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Cardiac Conditions==&lt;br /&gt;
&lt;br /&gt;
[[File: Scans of Supravalvular Aortic Stenosis and Pulmonary Stenosis.jpg|300px|thumb|'''Figure 7: Scans indicating Supravalvular aortic stenosis (arrows on C) and combined valvar (arrow on D) and subvalvar (arrowheads on D) pulmonary stenoses in 9-month-old boy with Williams syndrome''']]&lt;br /&gt;
&lt;br /&gt;
One of the major manifestations of Williams Syndrome is cardiac abnormalities, 80% of those diagnosed with this syndrome show some form of heart condition. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Most heart defects result from the mutation or deletion of the Elastin (ELN) gene on chromosome 7. Damage or loss of this gene causes its subsequent loss in function, no longer providing the necessary elasticity in tissues like the lungs, the dermis and larger blood vessels, with one of the major results being elastin arteriopathy. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID7726172&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;7726172&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This is present in about 75% of affected individuals and may be present in any artery, the most common of them being in the aorta causing a condition known as Supravalvular Aortic Stenosis (SVAS). &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
Other cardiac anomalies include Hypertension, Peripheral Pulmonic Stenosis (PPS), Mitral valve disease, Atrial septal defect and Ventricular septal defect. These conditions and their severity varies from patient to patient. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
It is reported that males diagnosed with Williams syndrome are more likely to suffer from cardiovascular disease than females who are diagnosed with this same disorder. &amp;lt;ref name=&amp;quot;PMID11743512&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11743512 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Stenoses===&lt;br /&gt;
Stenoses are the typical types of cardiovascular disorders in Williams Syndrome. This manifestation is characterised by the narrowing of arteries due to the thickening of these blood vessels caused by smooth-muscle overgrowth. Stenoses may be isolated or may occur simultaneously in numerous places, in both medium and large arteries such as the aorta (in SVAS) and pulmonary artery (in PPS) &amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
The most prevalent classes of stenoses are SVAS and PPS, with 70-75% and 39% of people with Williams syndrome reporting to suffer from SVAS and PPS respectively. &amp;lt;ref name=&amp;quot;PMID20808633&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808633 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other stenoses occur in peripheral vessels such as renal, carotid, coronary, subclavian and mesenteric arteries.&amp;lt;ref name=&amp;quot;PMID20089974&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20089974 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been found that PPS is more common in infancy and tends to improve over time. On the other hand, SVAS affects Williams Syndrome sufferers of any age and is most likely to worsen over time if not treated. &amp;lt;ref name=&amp;quot;PMID20301427&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Supravalvular Aortic Stenosis (SVAS)'''&lt;br /&gt;
&lt;br /&gt;
SVAS is the most common condition in Williams Syndrome, and was one of the first to be associated with this anomaly. It is characterised by elastin arteriopathy in the ascending aorta causing its narrowing. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; This condition is caused by the loss of function of the Elastin (ELN) gene as a result of a mutation or intragenic deletions within this gene. &amp;lt;ref name=&amp;quot;PMID11701637&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11701637&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; SVAS is the dominant cause of morbidity and mortality for this syndrome’s patients &amp;lt;ref name=&amp;quot;PMID20425781&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425781&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; because when left uncorrected, it may lead to increased intracardiac pressure, myocardial hypertrophy, heart failure, and eventually death. &amp;lt;ref name=&amp;quot;PMID8475063&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8475063 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Other problems===&lt;br /&gt;
Some of the other cardiac abnormalities that can arise from Williams Syndrome include:&lt;br /&gt;
&lt;br /&gt;
'''Hypertension'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Mitral valve disease'''&lt;br /&gt;
&lt;br /&gt;
The Mitral valve, or bicuspid valve, between the left atrium and ventricle is another structure of the heart that can be affected in Williams Syndrome. The most common abnormality associated with this syndrome is mitral valve prolapse(MVP)which results in multiple, unnecessary mitral valve leaflets, more elongated chordae tendineae and myxomatous degeneration of the leaflet tips. These characteristics lead to the leaflets of the valves bulging into the left atrium during systole and the inability of the leaflet tips to join together. The mitral valve isn't able to function in closing the left ventricle off from the right atrium once diastole has finished and so mitral regurgitation of blood back into the atrium occurs when blood is trying to be pumped out. &amp;lt;ref name=&amp;quot;PMID21545515&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;21545515&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;    &lt;br /&gt;
&lt;br /&gt;
'''Atrial septal and Ventricular septal defects'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Table showing &amp;quot;the prevalence of CV abnormalities in 423 patients from nine selected international series published in the last two decades&amp;quot; &amp;lt;ref name=&amp;quot;PMID18452001&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18452001&amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''CV abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Prevalence (%)'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen                                                                                                                &lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''All CV diseases'''&lt;br /&gt;
| 84&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''SVAS'''&lt;br /&gt;
|69&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''PPS'''&lt;br /&gt;
|34&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Hypertension'''&lt;br /&gt;
|17&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Mitral valve disease'''&lt;br /&gt;
|15&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Pulmonary Valve disease'''&lt;br /&gt;
|5&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; |'''Aortic valve disease'''&lt;br /&gt;
|3&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Genitourinary Conditions==&lt;br /&gt;
&lt;br /&gt;
===Renal Tract Abnormalities===&lt;br /&gt;
[[File:X-ray Abdomen bilateral nephrocalcinosis.jpg|300px|thumb|'''Figure 8: Abdominal X-ray showing extensive bilateral nephrocalcinosis''']]&lt;br /&gt;
In a study of 40 patients with Williams Syndrome, some form of renal abnormality was detected in 7 of the patients from the study group. This study provided the foundation for the statistic stating that 18% of people with Williams Syndrome have some form of renal tract abnormality.&amp;lt;ref name=&amp;quot;PUBMED8488870&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8488870 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Some of these abnormalities include: &lt;br /&gt;
&lt;br /&gt;
*'''Renal Agenesis'''&lt;br /&gt;
&lt;br /&gt;
Renal agenesis is a disorder involving the absence of one or both of the kidneys, categorised into unilateral or bilateral respectively. In this case, renal agenesis is a secondary condition to the developmental genetic disorder that is Williams Syndrome. &lt;br /&gt;
&lt;br /&gt;
Bilateral renal agenesis is fatal and most infants die within the first four hours following birth. This is due to the noticeable deficiency of amniotic fluid (oligohydramnios) after 12-13 weeks causing pulmonary hypoplasia.&lt;br /&gt;
&lt;br /&gt;
It is diagnosed firstly by the absence of amniotic fluid followed by the absence of the bladder and kidneys. &amp;lt;ref name=&amp;quot;PMID8066039&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8066039 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Following diagnostic tests such as CT scans and ultrasonography, Colour Doppler has been found to be useful in detecting and identifying vascular anomalies related to renal agenesis. &amp;lt;ref name=&amp;quot;PMID8610763&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8610763 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Unilateral renal agenesis results in mostly normal development. Patients must be examined periodically as there is an increased incidence of urinary tract infections amongst those affected. Elevated blood pressure may result in kidney damage. Patients are advised to not participate in contact sports in order to protect the sole remaining kidney.&lt;br /&gt;
Unilateral/Bilateral renal agenesis results from a lack of induction of the metanephric blastema by the ureteral bud. &amp;lt;ref name=&amp;quot;PMID9763817&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;9763817 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Duplicated kidneys'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Also known as duplex kidneys, duplicated collecting systems and duplex collecting systems. This is defined as the doubling of the renal units; either containing 2 pyelocaliceal systems in relation to a single ureter or with double ureters. The 2 ureters may empty separately into the bladder or fuse to form a single ureteral orifice. As with renal agenesis, duplicated kidneys may be classified as unilateral or bilateral. In general, patients usually have complete ureteric duplication in which results in a greater tendency for the ureters to develop obstructions, reflux, and infections. &amp;lt;ref name=&amp;quot;PMID11110565&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11110565 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
 &lt;br /&gt;
A duplex kidney with either a bifid renal pelvis or bifid ureter results when a single ureteral bud bifurcates before the ampulla bifurcates. &amp;lt;ref name=&amp;quot;PMID2117358&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;2117358 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Vesicourinary reflux'''&lt;br /&gt;
&lt;br /&gt;
Vesicourinary (vesicoureteral) reflux is the reverse flow of urine from the bladder to the ureters or even the kidneys. It results as a failure of the ureteric openings which store and void urine.&lt;br /&gt;
&lt;br /&gt;
The International Reflux Grading system classifies VUR into 5 grades, depending on the degree of retrograde filling and dilatation of the renal collecting system.&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Grading'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Characteristics'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade I'''                          &lt;br /&gt;
| Urine backs up into the ureter only, and the renal pelvis appears healthy, with sharp calyces.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade II'''&lt;br /&gt;
| Urine backs up into the ureter, renal pelvis, and calyces. The renal pelvis appears healthy and has sharp calyces.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade III'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear mildly dilated, and the calyces are mildly blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade IV'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The ureter and pelvis appear moderately dilated, and the calyces are moderately blunted.&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Grade V'''&lt;br /&gt;
| Urine backs up into the ureter and collecting system. The pelvis is severely dilated, the ureter appears tortuous, and the calyces are severely blunted. &amp;lt;ref name=&amp;quot;PMID3975102&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;3975102 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
In most cases, vesicourinary reflux presents with no symptoms. When symptoms are present, the most common is a urinary tract infection (UTI). Bacteria thrive in this suitable habitat as the urine remains in the child’s urinary tract, thus causing the urinary tract infection. Studies estimate that 30 percent of children and up to 70 percent of infants that present with a urinary tract infection have vesicourinary reflux. &amp;lt;ref name=&amp;quot;PMID6333147&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;6333147 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''Nephrocalcinosis'''&lt;br /&gt;
&lt;br /&gt;
Nephrocalcinosis occurs in less than 5% of patients with WS. Although relatively rare, it is one symptom which presents in infant, child and adult life. It is the deposition of excess calcium in the kidneys which may lead to kidney failure, kidney stones or obstructive uropathy. Nephrocalcinosis may be diagnosed by abdominal CT scans, ultrasounds of the kidney and urinalysis. &amp;lt;ref name=&amp;quot;PMID8723124&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;8723124 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Endocrine Conditions==&lt;br /&gt;
&lt;br /&gt;
===Hypercalcemia===&lt;br /&gt;
&lt;br /&gt;
Hypercalcemia refers to elevated levels of calcium in the bloodstream. It is not always observed in individuals with Williams syndrome but it is more common among children with infantile hypercalcemia being reported in approximately 15% of infants diagnosed with Williams syndrome. Most of these cases are reported within the first four years of age, but cases of recurrence in puberty have also been reported. Typically, the infantile hypercalcemia is transient and found only in mind forms, but in rare cases it can also be life-threateningly severe. &amp;lt;ref name=&amp;quot;PMID15466114&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diabetes Mellitus===&lt;br /&gt;
It is reported that approximately 75% of adult individuals with Williams syndrome suffer from a form of pre-diabetes, such as impaired glucose tolerance, or diabetes mellitus. &amp;lt;ref name=&amp;quot;PMID20425788&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425788 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; In the Williams-Beuren syndrome critical region, one of the genes is syntaxin-1A (STX-1A). This gene codes for a protein that is involved in exocytosis of insulin granules in pancreatic beta-cells. Lam et al in 2005 &amp;lt;ref name=&amp;quot;PMID16123365&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;16123365 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; used a mouse model and an intraperitoneal glucose challenge to show that an overproduction of this syntaxin-1A gene resulted in hyperglycemia (described above) as well as a lower secretary level of insulin.&lt;br /&gt;
&lt;br /&gt;
===Thyroid===&lt;br /&gt;
The prevalence of thyroid abnormalities is increased in individuals diagnosed with Williams syndrome. Some of these abnormalities include thyroid-gland hypoplasia, hypothyroidism, and morpho-volumetric abnormalities in the thyroid gland. Thyroid-gland hypoplasia, which is present in 75% of Williams syndrome individuals has been impicated as a cause of the congenital hypothyroidism, a form of thyroid dydgenesis,  seen in 35% of these individuals. Also, there is a 67.5% prevalence of morpho-volumetric abnormalities in the thyroid gland associated with Williams syndrome.&lt;br /&gt;
&lt;br /&gt;
==Other Associated Medical Conditions==&lt;br /&gt;
&lt;br /&gt;
'''Other Abnormalities'''&lt;br /&gt;
&lt;br /&gt;
There are a number of other abnormalities associated with Williams Syndrome including a hoarse voice, inguinal hernias and joint abnormalities. These abnormalities vary in severity between different individuals and elastin haploinsufficiency is responsible for a number of these abnormalities characteristic of Williams Syndrome.&amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{|style=&amp;quot;background:white&amp;quot; border=&amp;quot;1px&amp;quot; cellspacing=&amp;quot;1&amp;quot; align=&amp;quot;centre&amp;quot; cellpadding=&amp;quot;4&amp;quot;&lt;br /&gt;
&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Abnormality'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Cause'''&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot; | '''Effect and Relation to Williams Syndrome'''&lt;br /&gt;
|- style=&amp;quot;background:springgreen&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Joint Abnormalities'''                          &lt;br /&gt;
| The elastin deficiency seen in Williams syndrome is the cause of the lax joints and other joint abnormalities.                                                                                                                &lt;br /&gt;
| Individuals with Williams syndrome typically have loose joints during infancy which then get worse with age and towards later childhood, they may develop joint contractures.&lt;br /&gt;
The lax joints that young children with Williams syndrome suffer from often lead to compensatory measures of posture, resulting in mild [[#Glossary | '''lordosis''']] and [[#Glossary | '''kyphosis''']] .  &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &lt;br /&gt;
These joint abnormalities occur in the lower limbs more often than anywhere else in the body.                                                                                                                &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Ingiunal Hernias'''&lt;br /&gt;
| Although further research needs to be done, it is suggested that mutations in the SERPINA1 gene, could play a role in the prevalence of direct inguinal hernias in individuals with Williams syndrome. This is due to the fact that this particular gene, encodes for the elastase inhibitor - alpha-1-antitrypsin (AAT). .&lt;br /&gt;
| Inguinal hernias are more common in individuals with Williams syndrome. They occur in approximately 40% of individuals with Williams syndrome, but only in approximately 5% of individuals that are not diagnosed with Williams syndrome. These inguinal hernias are usually diagnosed when the individual is an infant and they are more common in males then females, with an approximate ratio of 10:1. &amp;lt;ref name=&amp;quot;PMID18267160&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18267160 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID20425789&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425789 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Auditory Abnormalities'''&lt;br /&gt;
| Chronic otitis media or chronic ear infections occur more commonly in children with Williams syndrome. Children in the average population have an average occurrence rate of 41% while those with Williams have an occurrence rate of 50%. &amp;lt;ref name=&amp;quot;PMID12949276&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12949276 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| Hearing loss is widely seen in adults with Williams syndrome and although not as extensive, it is also commonly seen in school-aged children with Williams syndrome. There is previous research that suggests that the hearing loss that is associated with Williams syndrome begins early and is likely to be progressive with age. &amp;lt;ref name=&amp;quot;PMID20425785&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425785 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;springgreen&amp;quot;| '''Hoarse Voice'''&lt;br /&gt;
| Due to a connective tissue abnormality, where the lamina propria in the vocal folds has a decreased amount of elastic fibres. &amp;lt;ref name=&amp;quot;PMID12784297&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12784297 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
| The hoarse voice is present in 98% of people with Williams Syndrome.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Structural Differences in the Brain==&lt;br /&gt;
[[File:Auditory Cortex Location - Comparison Between Control Subject and WS Subject.jpg|200px|thumb|'''Figure 9: Auditory Cortex Location - Comparison Between Control Subject and WS Subject.''']]&lt;br /&gt;
&lt;br /&gt;
Williams syndrome has been characterized by the smaller brain mass, but relative enlargement of particular areas of the brain. The [[#Glossary | '''neocellebellar vermis''']] has been shown to be larger in Williams syndrome individuals and a differential development of the paleocerebellum and other areas of the brain was found. &lt;br /&gt;
&lt;br /&gt;
===Language===&lt;br /&gt;
&lt;br /&gt;
The abnormal language expressed in Williams syndrome has been related to the abnormal functioning of the brain during processing. The normal left-anterior asymmetry in language processing has been lost and a more diverse arrangement has been found. ERP studies have shown the functioning of a different pathway to that of a normal person in language processing. This abnormal organization of the neural network is what has allowed for the relative sparing of the language processing in Williams syndrome. &lt;br /&gt;
&lt;br /&gt;
===Cognitive Abilities===&lt;br /&gt;
A reduction in the size of the parietal occipital region has been found in the majority of Williams syndrome patients. This reduction in the posterior cerebral area has been predicted to contribute to the visuospatial processing difficulty found in the syndrome. The isthmus and splenium are the major white matter tracts which connect the visual processing and associated processing areas of the brain. This would result in the impaired visospatial processing of visual information in the brains of Williams syndrome individuals. The areas of language and affect have been shown to be relatively preserved as the frontal lobe is correctly proportioned in William syndrome individuals. The hypersociability of Williams syndrome individuals may be attributed to the enlargement of the neocerebellar vermis. The social and emotional functions of the posterior cerebellum has been the area thought to be responsible for these phenotypes.&lt;br /&gt;
There has been a consistently long central sulcus found in William syndrome individuals. There is an unusual configuration of the central sulcus which is associated with abnormal behavior. There is also an overall unusual configuration of the other gyri on the medial surfaceand temporal lobes. There is brain asymmetry and cingulate cortex dysfunctioning has been attributed to the abnormal social engagement expressed by William syndrome individuals. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Auditory===&lt;br /&gt;
&lt;br /&gt;
The amygdala has been related to the lateral nucleus and contributes to the inhibited fear response to new faces. &lt;br /&gt;
The auditory centres are known to be the thalamus and cortex, however, the visual cortex has been shown to activate in Williams syndrome individuals when stimulated by music. At a cortival level, There seems to be a hyperactivity when a musical stimuli is present. This is the result of a more excitable auditory response formed by hyperexcitable neurons which form irregular neural systems with other functional areas of the brain. Heschl’s gyrus has been sound to be duplicated in William syndrome individuals who present with 2-4 pairs of Heschl’s gyrus. The auditory cortex of these individuals has been shown to be relatively larger than an average human, 2.2 times in the left hemisphere and 1.2 in the right. &amp;lt;ref name=&amp;quot;PMID20808792&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20808792 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Cognitive, Behavioural and Neurological Phenotype==&lt;br /&gt;
[[File:House drawings Williams.jpg|300px|thumb|'''Figure 10: Drawings of a house by a child with Williams syndrome and a child without Williams syndrome''']]&lt;br /&gt;
Williams syndrome patients have been described as having a cognitive variety of relative strengths and weaknesses. Relative strengths include the social use of language, facial recognition and attraction to music. However there are deficits in visuospatial learning, use of vocabulary, onset of words in infancy and arithmetic. There is also a distinct behavioural characteristic of Williams syndrome, hyper sociability. These individuals are overly enthusiastic and socially interactive to an abnormal extent. Over 90% of Williams Syndrome cases also present with some form of anxiety or an anxiety disorder. Ironically, phobias often present themselves despite the affiliation for other people. Individuals with Williams syndrome also typically have poor coordination as well as a low IQ. Their average IQ is 55, ranging from 40-90, whereas average IQ is 90 and above. This means that these individuals will show a failure to thrive during infancy, especially in realtion to language and motor development.&lt;br /&gt;
&lt;br /&gt;
===Spatial cognition===&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams syndrome typically have a deficiency in spatial cognition.  An adult with Williams will function at a 5 year olds level of spatial cognition. This is often seen as the result of the attention paid to detail at the expense of the whole. There is often a bias present to carefully note the local aspects of the visual stimuli thus overlooking the global picture. An example of this is the replication of the letter Z constructed by a number of letter z’s. A Williams syndrome individual will draw a number of the smaller, local z as opposed to the complete structure. When asked to draw freehand images of a house, William syndrome adolescents were unable to present a logical arrangement of the building. Compared to a normal control of the same age, Williams syndrome individuals are highly impaired in spatial cognitive functions. Spatial cognition follows a specific path throughout development which remains impaired as the individual matures.[[File:Z diagram Williams.jpg|300px|thumb|'''Figure 11: A replication of the &amp;quot;Z&amp;quot; figure by a Williams syndrome individual and a control.''']]&lt;br /&gt;
These spatial insufficiencies also extend to influence speech negatively. An example of this would be describing the tree relative to the house as behind the house when the tree is in fact next to the house. There is an obstruction of language expressed to the poor spacial skills exhibited in Williams syndrome. Williams Syndrome individuals often have difficulty with spatial representations and this effectively impairs other cognitive functions which require such spacial skills. &amp;lt;ref name=&amp;quot;PMID20425784&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20425784 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Language Representations===&lt;br /&gt;
&lt;br /&gt;
Many studies have been performed on the effects of Williams syndrome on individuals language abilities as it is one of the relative strengths in cognitive functioning. One area of interest is the expressive language used by individuals with Williams syndrome. A key feature of Williams syndrome is the incorrect use of sophisticated words in expressive language. The choice of such erroneous words is the result of selecting the right semantic field however failing to select for the appropriate context. This is possibly due to the presence of a different wiring mechanism of neurons in semantic processing.&lt;br /&gt;
Adolescents and adults are often articulate and very talkative which prevents other individuals engaged in conversation with them to recognise any cognitive abnormalities.&lt;br /&gt;
&lt;br /&gt;
During infancy, there is a stunted development of language  as the onset of the first word is later than normal infants. All aspects of the behavioural phenotype of Williams syndrome is delayed heavily during the earlier years, this includes language. Although the onset of words is delayed, it is followed by a rapid acquisition words. However, the meaning of words may not be fully understood by the developing child saying them. For example, a 4 year old child could repeat long and often complex words such as encyclopaedia, proficiency and accomplishment without understanding the meaning of the word. The development of strong grammar during childhood years is followed by the rapid development of language. It is this rapid development of grammar that allows Williams syndrome to be distinguished from other forms of mental retardation. The acquisition of proper grammar allows adolescents and adults with Williams syndrome to form complex grammatical forms thus having greater language production compared to others with various forms of mental retardation. &amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Use of social evaluation cues for WS and non WS individuals.jpg|300px|thumb|'''Figure 12: Use of social evaluation cues for WS and non WS individuals.''']]&lt;br /&gt;
&lt;br /&gt;
===Sociability===&lt;br /&gt;
Williams Syndroms is a distinct disorder which is characterised by the individuals hypersociability and need for social interactions. Unlike most other disorders, individuals are remarkably social, empathetic and friendly. Williams syndrome individuals perceive others as friends rather than strangers. Across various studies, it has been found that individuals with Williams syndrome rate unfamiliar faces more approachable than most other normal controls. This finding is consistent with their interest in approaching strangers and their social phenotype. An early emergence of this social behaviour is present in infants with Williams syndrome. Whilst conducting tests on infants, an obstacle to retrieving accurate results is the tendency for the child to pay more attention to the people present than the task at hand. One theory is that the social behaviour is a mechanism by which the child can avoid the difficult task at hand. &amp;lt;ref name=&amp;quot;PMID18211726&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18211726 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Individuals with Williams Syndrome use language to effectively communicate with other on a social level. They not only engage in conversation with others, but also maintain the conversation by the extensive use of linguistic devices. There is an over use of lexical evaluative devices and vocal prosody to construct coherent and complex stories. The hypersocial phenotype of Williams syndrome is characterised by the individuals use of expressive devices over various linguistic settings to engage and maintain their audiences attention during conversation. This skill is developed throughout childhood and perfected during adolescents once grammar is established firmly in the individual. &amp;lt;ref name=&amp;quot;PMID18924169&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;18924169 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Musicality===&lt;br /&gt;
There is relatively less known about the musicality of Williams syndrome, however it has been marked as a relatively spared cognitive function. This could be explained by the multisensory processing which occurs when listening to music. Williams syndrome patients exhibit increased sensitivity towards auditory stimuli. There is known hypercusis, phonophobia and auditory fascination. 80% of Williams syndrome patients shows an aversion toward everyday noises, as the individuals find such stimuli as painfully strong. Phonophobia has been diagnosed in 91% of the Williams syndrome individuals. This fear of normal sounds and aversion to everyday noises have been shown to be the result of an abnormalities in the limbic system aswell as the autonomic system. This avoidance and anxiety towards everyday noises and normal sounds are seen in younger children peaking at about 5-8 years and slowly reduces. This initial fear toward sounds however, is thought to be the start of auditory fascination.&lt;br /&gt;
William Syndrome individuals are captivated by music and their strong emotional response to it. There is uniform and holistic sound perception found in the majority of Williams syndrome individuals. There is a high rate of rhythmic creativity found and a particular liking for rhythmic and percussion instruments. &amp;lt;ref name=&amp;quot;PMID20733255&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20733255 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Anxiety and Phobias===&lt;br /&gt;
It has been found that when compared to the general population, children with Williams syndrome have a significantly higher rate of anxiety related disorders. They particularly showed a higher occurrence of generalised anxiety disorder and specific phobia disorder. &lt;br /&gt;
Children with Williams syndrome often present with various anxiety disorders and phobias that carry-on through to adulthood. A study using the diagnostic and statistical manual of psychiatric disorders(DSM-IV) showed that 5% of these children expressed sever psychological disorders. 80.7% of the individuals were shown to have been diagnosed with at least one of the diagnosed disorders in the dsm-IV. Of the many disorders, Attention Deficit/Hyperactivity Disorder and specific phobias were the highest occurrences. AD/HD was the most common disorder affecting almost 65% of the Williams syndrome children. Specific phobias, most commonly a phobia towards loud noises, was present in 54% of the individuals. A few other notable disorders were separation anxiety (7%), obsessive compulcive disorder (3%), social phobias (2%), post traumatic stress disorder (1%) and panic disorders (1%). &amp;lt;ref name=&amp;quot;PMID20161441&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20161441 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Facial processing===&lt;br /&gt;
&lt;br /&gt;
Despite deficits in spacial cognition, facial representations are an area of sparing in Williams syndrome. There is a remarkable ability to remember, discriminate between and recognise between both familiar and unfamiliar faces. This strength of facial recognition extends to the perception of faces in various contexts. Changing the lighting, orientation and background does not affect the identification of faces in Williams syndrome. Williams syndrome individuals are just as skilled as normal individuals of the same age in facial perception if not, better. Younger individuals with Williams syndrome are shown to have superior facial recognition abilities compared to age-matched individuals. &amp;lt;ref name=&amp;quot;PMID19047076&amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;19047076 &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;[[File:Cognitive performance in WS subjects (n = 67) versus normal controls.png|450px|thumb|'''Figure 13: Cognitive performance in Williams syndrome subjects (n = 67) versus normal controls.png''']]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Other cognitive functions===&lt;br /&gt;
&lt;br /&gt;
William syndrome individuals show moderate to mild forms of mental retardation with an IQ average of 55 for the population. The IQ ranges from 40-90, which means some individuals have the IQ of a normal person. By adulthood, there is a failure to successfully perform piagetian seriation and conservation tasks normally achieved by 8 years of age. The cognitive impairment of Williams syndrome has been shown to be similar to that of Down syndrome. There is little difference shown between the verbal and performance IQ scores of the two groups. Arithmatics is shown to be the greatest challenge for the syndrome and language to be a relative strength. A severe impairment with the use of arithmetics and its implications to daily life has been shown to be expressed in Williams syndrome individuals. This can be shown by their preference for a hundred 5c as opposed to a $5 note. Some individuals however, are known to have adequately learn addition, subtraction and even division. Adults are also shown to have difficulty estimating quantities a normal developing child can do. For example, the length of a bus can be estimated to be as small as 1cm or as large as 100m when a normal child would say about 11m.&lt;br /&gt;
Reading is a more variable function as some find it difficult to reading whilst others read particular topics of interests. Williams syndrome presents an uneven cognitive profile with specific strengths and various deficits unlike most forms of mental retardation where there is a general deficiency in all aspects of cognitive function.&lt;br /&gt;
&amp;lt;ref&amp;gt;Bellugi, U. et al, 2001, ''Journey From Cognition to Brain to Gene: Perspectives From Williams Syndrome,'' Massachusetts Institute of Technology,the United States of America &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams-Beuren Syndrome as it is a complex multisystem medical condition. As symptoms of Williams-Beuren Syndrome involve multiple disciplines, treatment of those symptoms requires a large clinical team of doctors and nurses. With this team, a number of periodical assessments and systemic evaluations must be made if WS is diagnosed. This includes:&lt;br /&gt;
&lt;br /&gt;
•	Complete physical and neurological examination&lt;br /&gt;
&lt;br /&gt;
•	Growth parameters plotted on WS growth charts (see: [http://www.williams-syndrome.org/growth-charts/growth-charts])&lt;br /&gt;
&lt;br /&gt;
•	Cardiological evaluation&lt;br /&gt;
&lt;br /&gt;
•	Genitourinary system evaluation&lt;br /&gt;
&lt;br /&gt;
•	Ophthalmologic evaluation&lt;br /&gt;
&lt;br /&gt;
•	Multidisciplinary developmental evaluation (if patient is over 2 years of age)&lt;br /&gt;
&lt;br /&gt;
•	Ultrasonography of bladder and kidneys&lt;br /&gt;
&lt;br /&gt;
•	Urinalysis&lt;br /&gt;
&lt;br /&gt;
•	Calcium determinations&lt;br /&gt;
&lt;br /&gt;
•	Thyroid function tests&lt;br /&gt;
&lt;br /&gt;
•	FISH to determine ELN deletion &amp;lt;ref&amp;gt;AMERICAN ACADEMY OF PEDIATRICS Committee on Genetics (2001) Health Care Supervision for Children With Williams Syndrome Pediatrics Vol. 107 No. 5 May 1, 2001 pp. 1192 -1204&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
Currently, there is no cure for Williams Syndrome as it is a complex multisystem medical condition. The treatment of conditions brought about by Williams-Beuren Syndrome can be difficult depending on the number of recognised conditions. &lt;br /&gt;
&lt;br /&gt;
===Cardiac Treatment===&lt;br /&gt;
&lt;br /&gt;
Surgery is generally required to repair supravalvular aortic stenosis if the severity of the condition is notable. &amp;lt;ref name=&amp;quot;PMID11167112 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11167112  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; Other procedures such as angioplasty and stent insertion are also practiced, but are highly susceptible to aneurysm, rupture or restenosis. &amp;lt;ref name=&amp;quot;PMID11331257 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;11331257  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;PMID15691415 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15691415  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Pulmonary artery lesions in patients with WS who aren’t diagnosed with SVAS can be monitored, as many patients with lesions in this area show gradual improvement with the lesions resolving over time.&lt;br /&gt;
&lt;br /&gt;
===Genitourinary Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of hypercalcemia involves constant monitoring of the patients’ blood calcium levels including before the administration of any anesthetic or sedative agent and prior to any invasive procedure. Food intake should also be regulated and monitored. &amp;lt;ref name=&amp;quot;PMID15466114 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;15466114  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt; 15% of patients with Williams-Beuren Syndrome show signs of hypercalcemia and it is important to note as the condition contributes to the presence of extreme irritability, vomiting, constipation, and muscle cramps. Treatment options for hypercalcemia include restricted dietary calcium intake and bisphosphonate therapy. In any case, the WS patient should be referred to a nephrologist in order to treat renal abnormalities as they arise. &amp;lt;ref name=&amp;quot;PMID20301427  &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;20301427  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Treatment for hypertension in WS patients is individualised and should be treated when identified.&lt;br /&gt;
&lt;br /&gt;
Osteopenia can be difficult to treat in patients with Williams-Beuren syndrome as its treatment could have reverse effects on, and increase the severity of hypercalcemia. &lt;br /&gt;
&lt;br /&gt;
===Endocrine Treatment===&lt;br /&gt;
&lt;br /&gt;
The treatment of endocrine abnormalities affiliated with Williams syndrome such as hypothyroidism requires regular monitoring and the prescribing of thyroid hormone related medicine should be done so if absolutely necessary. As glucose intolerance amongst WS patients is invariably high, adult patients should be screened regularly. As early puberty may bring an abundance of further challenges and complications to the management of WS, especially in females, it is also possible to delay menarche with the use of a gonadotropin-releasing hormone such as leuprolide. &amp;lt;ref name=&amp;quot;PMID12219071 &amp;quot;&amp;gt;&amp;lt;pubmed&amp;gt;12219071  &amp;lt;/pubmed&amp;gt;&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Behavioural Treatment===&lt;br /&gt;
&lt;br /&gt;
In terms of the emotional and psychiatric tendencies associated with Williams syndrome, these go some way in determining the quality of life for adult patients. Approximately half of adolescents and adults are being treated or have been treated with an antianxiety agent. Types of drugs prescribed include selective serotonin-reuptake inhibitors such as Zoloft and Prozac.&lt;br /&gt;
&lt;br /&gt;
Counselling benefits those patients with relatively strong verbal skills. Patients may practice relaxation techniques and utilise strategies to deal with potentially anxiety-provoking situations.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Specialised Facilities and Supportive Associations==&lt;br /&gt;
&lt;br /&gt;
===Australia===&lt;br /&gt;
&lt;br /&gt;
In Australia, there are a number of supportive associations and groups helping both individuals and families affected by Williams syndrome. These include:&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group (Victoria)'''&lt;br /&gt;
&lt;br /&gt;
This group is described as a “community of families with Williams syndrome members, based in Victoria, Australia.” Its aims include:&lt;br /&gt;
&lt;br /&gt;
•	To provide help and support for families with a child or adult with Williams syndrome &lt;br /&gt;
&lt;br /&gt;
•	To provide resources for parents, teachers, students, employers and the medical profession&lt;br /&gt;
&lt;br /&gt;
•       To provide information on current research &lt;br /&gt;
&lt;br /&gt;
•	To empower those with WS to reach their full potential &lt;br /&gt;
&lt;br /&gt;
•	To increase awareness and understanding of WS among the medical and teaching professions and the general public &lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Honorary Secretary: Catherine Stenford&lt;br /&gt;
&lt;br /&gt;
PO Box 389, Balnarring, Victoria 3926&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Family Support Group (Victoria) may be accessed here: [http://www.vicnet.net.au/~wsfsg]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of South East Queensland'''&lt;br /&gt;
&lt;br /&gt;
This group may be contacted using the following details:&lt;br /&gt;
&lt;br /&gt;
Rebecca Carter&lt;br /&gt;
&lt;br /&gt;
15 Azalea Place, Currimundi, Queensland 4551, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: (07) 5493 1185&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Family Support Group of Western Australia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Secretary: Mr Rob Hendry &lt;br /&gt;
&lt;br /&gt;
Tel: (08) 9459 3716&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome Association of South Australia'''&lt;br /&gt;
&lt;br /&gt;
Regional Director: Gerry Mitchell &lt;br /&gt;
&lt;br /&gt;
Contact: Amanda Strybos or Mandy Turner &lt;br /&gt;
&lt;br /&gt;
PO Box 247, Salisbury, Adelaide 5108, Australia &lt;br /&gt;
&lt;br /&gt;
Tel: 8258 3867&lt;br /&gt;
&lt;br /&gt;
The website of the Williams Syndrome Association of South Australia may be accessed here:&lt;br /&gt;
[http://www.wsasa.org.au/index.html]&lt;br /&gt;
&lt;br /&gt;
'''Williams Syndrome (IHC) Association of New South Wales, part of the Association of Genetic Support of Australasia (Inc)'''&lt;br /&gt;
&lt;br /&gt;
Dianne Petrie &lt;br /&gt;
c/o Association of Genetic Support of Australasia Inc&lt;br /&gt;
&lt;br /&gt;
66 Albion Street, Surry Hills, New South Wales 2021 &lt;br /&gt;
&lt;br /&gt;
Australia &lt;br /&gt;
&lt;br /&gt;
Tel: +61 2 9211 1462&lt;br /&gt;
&lt;br /&gt;
'''Online Australian Williams Syndrome Forum'''&lt;br /&gt;
&lt;br /&gt;
===International Supportive Associations===&lt;br /&gt;
Outside of Australia, the most notable Williams syndrome supportive association is found in the United States of America with the Williams Syndrome Association (WSA). According to its mission statement the WSA “is a non-profit organisation that strives to enrich the lives of individuals and families affected by Williams syndrome and similar conditions through support, research and education. The WSA also provides the contact details and locations of various Williams syndrome clinics established throughout the U.S. These clinics are specialty clinics where those with Williams syndrome may be examined by a team of WS specialists and referred onwards to other services which may help.&lt;br /&gt;
&lt;br /&gt;
The website of the WSA can be accessed here: [http://www.williams-syndrome.org/]&lt;br /&gt;
&lt;br /&gt;
==Current research and developments==&lt;br /&gt;
&lt;br /&gt;
'''Current Research Projects funded by the Williams Syndrome Foundation'''&lt;br /&gt;
&lt;br /&gt;
•	Mayada Elsabbagh, Mazal Cohen &amp;amp; Annette Karmiloff-Smith&lt;br /&gt;
&lt;br /&gt;
Hearing and Hypersensitivity to Sound, Institute of Child Health London started Autumn 2004.&lt;br /&gt;
 &lt;br /&gt;
•	Professors Janette Atkinson &amp;amp; Oliver Braddick&lt;br /&gt;
&lt;br /&gt;
Long Term Research into how Visual &amp;amp; Visuo-cognitive abilities develop in the eyes and brain in people with Williams Syndrome. &lt;br /&gt;
Visual Development Unit, Dept of Psychology, UCL London.&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Foundation can be found here:[http://www.williams-syndrome.org.uk/resources/research/research.html]&lt;br /&gt;
&lt;br /&gt;
'''Current research projects in affiliation with the Williams Syndrome Association'''&lt;br /&gt;
&lt;br /&gt;
•	Dr. Carolyn Mervis, University of Louisville &lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies primarily devoted to the cognitive processes in WS. Her team is conducting longitudinal studies of Language and Cognition in WS, as well as studies of language in very young children and the relationships between language, cognition and adaptive behaviour in Williams syndrome.&amp;quot; &lt;br /&gt;
&lt;br /&gt;
•	Dr. Helen Tager-Flusberg, Boston University&lt;br /&gt;
&lt;br /&gt;
&amp;quot;Conducting clinical research studies of the sociability of individuals with Williams syndrome. Dr. Flusberg's primary studies in this area are with teens and adults with WS.&amp;quot;&lt;br /&gt;
&lt;br /&gt;
More research projects funded by the Williams Syndrome Association can be found here: [http://williams-syndrome.org/researcher/current-studies]&lt;br /&gt;
&lt;br /&gt;
===Mouse Models===&lt;br /&gt;
In recent years research has been focused on investigating the genetic origins of the physical, behavioural and psychological characteristics of Williams Syndrome, this is mainly being achieved through the use of mouse models. Mice share many genes with humans therefore [[#Glossary | '''&amp;quot;Knock-out mouse&amp;quot;''']] models can be developed to examine the results of gene deletion. The genes on chromosome 7 believed to be the cause of a particular manifestation in Williams Syndrome can be inactivated or &amp;quot;knocked-out&amp;quot; so that the implications of this action can be observed in the mouses' phenotype, including its appearance, behaviour and other observable physical and biochemical characteristics. This technique provides valuable clues about what these genes normally do and how their deletion contributes to Williams Syndrome. &amp;lt;ref&amp;gt;http://www.genome.gov/12514551&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Glossary ==&lt;br /&gt;
&lt;br /&gt;
'''Autosomal inheritance:''' Some hereditary diseases are described as autosomal which means that the disease is due to a DNA error in one of the 22 pairs that are not sex chromosomes. Both boys and girls can then inherit this error. If the error is in a sex chromosome, the inheritance is said to be sex-linked. &lt;br /&gt;
&lt;br /&gt;
'''Congenital anomalies:''' Developmental abnormalities detected before or present at birth. There are no internationally agreed definitions for congenital anomalies and there are a range of classifications including the International Classification of Diseases (ICD), developed by the World Health Organization (WHO) to enable comparability for mortality statistics. &lt;br /&gt;
&lt;br /&gt;
'''Elastin ateriopathy:''' Broken and disorganized elastin fibers caused by the mutation of the Elatin gene on chromosome 7.&lt;br /&gt;
&lt;br /&gt;
'''FISH:''' Fluorescence in situ hybridisation; a technique used to detect the presence or absence of targeted DNA sequences on chromosomes.&lt;br /&gt;
&lt;br /&gt;
'''Haploinsufficiency:'''The incomplete or partial dominance, as a heterozygote (with one mutant and one normal allele) displays a phenotypic effect.&lt;br /&gt;
&lt;br /&gt;
'''Hemizygous:''' Only having a single copy of a gene as opposed to the normal two copies.&lt;br /&gt;
&lt;br /&gt;
'''Joint contractures:''' Abnormal stiffness of the joints causing the muscle to be shorter and unable to extend.&lt;br /&gt;
&lt;br /&gt;
'''&amp;quot;Knock-out&amp;quot; mouse:'''a transgenic mouse that has been genetically engineered to inactivate a particular existing gene by disrupting it or replacing it with an artificial piece of DNA&lt;br /&gt;
&lt;br /&gt;
'''Kyphosis:'''An abnormal curvature of the spine, specifically at the upper thoracic segments creating a &amp;quot;hunch&amp;quot;.&lt;br /&gt;
&lt;br /&gt;
'''Lordosis:''' An abnormal curvature of the spine, usually at the lower half of the back.&lt;br /&gt;
&lt;br /&gt;
'''LCR:''' Low Copy Reapeats.&lt;br /&gt;
&lt;br /&gt;
'''LVOT:''' Left ventricular outflow tract.&lt;br /&gt;
&lt;br /&gt;
'''Microdeletion:''' The absence of a gene or part of a gene usually caused by inheritance.&lt;br /&gt;
&lt;br /&gt;
'''Nonallelic homologous recombination(NAHR):''' Is a form of homologous recombination occuring between two lengths of DNA which are not alleles but have high sequence homology.&lt;br /&gt;
&lt;br /&gt;
'''STRs:''' short tandem repeats.&lt;br /&gt;
&lt;br /&gt;
'''SVAS:''' Supravalvular Aortic Stenosis; an obstruction occurring in the left ventricular outflow tract (LVOT).&lt;br /&gt;
&lt;br /&gt;
'''WS:''' Williams Syndrome&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Z3331556</name></author>
	</entry>
</feed>